#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Polygenic Risk Score for Schizophrenia and Face-Processing Network in Young Adulthood
#Text=Abstract
#Text=Development of schizophrenia relates to both genetic and environmental factors.
1-1	0-9	Polygenic	_	
1-2	10-14	Risk	_	
1-3	15-20	Score	_	
1-4	21-24	for	_	
1-5	25-38	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-6	39-42	and	_	
1-7	43-58	Face-Processing	_	
1-8	59-66	Network	_	
1-9	67-69	in	_	
1-10	70-75	Young	_	
1-11	76-85	Adulthood	_	
1-12	86-94	Abstract	_	
1-13	95-106	Development	_	
1-14	107-109	of	_	
1-15	110-123	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-16	124-131	relates	_	
1-17	132-134	to	_	
1-18	135-139	both	_	
1-19	140-147	genetic	_	
1-20	148-151	and	_	
1-21	152-165	environmental	_	
1-22	166-173	factors	_	
1-23	173-174	.	_	

#Text=Functional deficits in many cognitive domains, including the ability to communicate in social interactions and impaired recognition of facial expressions, are common for patients with schizophrenia and might also be present in individuals at risk of developing schizophrenia.
2-1	175-185	Functional	_	
2-2	186-194	deficits	_	
2-3	195-197	in	_	
2-4	198-202	many	_	
2-5	203-212	cognitive	_	
2-6	213-220	domains	_	
2-7	220-221	,	_	
2-8	222-231	including	_	
2-9	232-235	the	_	
2-10	236-243	ability	_	
2-11	244-246	to	_	
2-12	247-258	communicate	_	
2-13	259-261	in	_	
2-14	262-268	social	_	
2-15	269-281	interactions	_	
2-16	282-285	and	_	
2-17	286-294	impaired	_	
2-18	295-306	recognition	_	
2-19	307-309	of	_	
2-20	310-316	facial	_	
2-21	317-328	expressions	_	
2-22	328-329	,	_	
2-23	330-333	are	_	
2-24	334-340	common	_	
2-25	341-344	for	_	
2-26	345-353	patients	_	
2-27	354-358	with	_	
2-28	359-372	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
2-29	373-376	and	_	
2-30	377-382	might	_	
2-31	383-387	also	_	
2-32	388-390	be	_	
2-33	391-398	present	_	
2-34	399-401	in	_	
2-35	402-413	individuals	_	
2-36	414-416	at	_	
2-37	417-421	risk	_	
2-38	422-424	of	_	
2-39	425-435	developing	_	
2-40	436-449	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
2-41	449-450	.	_	

#Text=Here we explore whether an individual’s polygenic risk score (PRS) for schizophrenia is associated with the degree of interregional similarities in blood oxygen level–dependent (BOLD) signal and gray matter volume of the face-processing network and whether the exposure to early adversity moderates this association.
3-1	451-455	Here	_	
3-2	456-458	we	_	
3-3	459-466	explore	_	
3-4	467-474	whether	_	
3-5	475-477	an	_	
3-6	478-488	individual	_	
3-7	488-489	’	_	
3-8	489-490	s	_	
3-9	491-500	polygenic	_	
3-10	501-505	risk	_	
3-11	506-511	score	_	
3-12	512-513	(	_	
3-13	513-516	PRS	_	
3-14	516-517	)	_	
3-15	518-521	for	_	
3-16	522-535	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
3-17	536-538	is	_	
3-18	539-549	associated	_	
3-19	550-554	with	_	
3-20	555-558	the	_	
3-21	559-565	degree	_	
3-22	566-568	of	_	
3-23	569-582	interregional	_	
3-24	583-595	similarities	_	
3-25	596-598	in	_	
3-26	599-604	blood	_	
3-27	605-611	oxygen	_	
3-28	612-627	level–dependent	_	
3-29	628-629	(	_	
3-30	629-633	BOLD	_	
3-31	633-634	)	_	
3-32	635-641	signal	_	
3-33	642-645	and	_	
3-34	646-650	gray	_	
3-35	651-657	matter	_	
3-36	658-664	volume	_	
3-37	665-667	of	_	
3-38	668-671	the	_	
3-39	672-687	face-processing	_	
3-40	688-695	network	_	
3-41	696-699	and	_	
3-42	700-707	whether	_	
3-43	708-711	the	_	
3-44	712-720	exposure	_	
3-45	721-723	to	_	
3-46	724-729	early	_	
3-47	730-739	adversity	_	
3-48	740-749	moderates	_	
3-49	750-754	this	_	
3-50	755-766	association	_	
3-51	766-767	.	_	

#Text=A total of 90 individuals (mean age 22 years, both functional and structural data available) were used for discovery analyses, and 211 individuals (mean age 26 years, structural data available) were used for replication of the structural findings.
4-1	768-769	A	_	
4-2	770-775	total	_	
4-3	776-778	of	_	
4-4	779-781	90	_	
4-5	782-793	individuals	_	
4-6	794-795	(	_	
4-7	795-799	mean	_	
4-8	800-803	age	_	
4-9	804-806	22	_	
4-10	807-812	years	_	
4-11	812-813	,	_	
4-12	814-818	both	_	
4-13	819-829	functional	_	
4-14	830-833	and	_	
4-15	834-844	structural	_	
4-16	845-849	data	_	
4-17	850-859	available	_	
4-18	859-860	)	_	
4-19	861-865	were	_	
4-20	866-870	used	_	
4-21	871-874	for	_	
4-22	875-884	discovery	_	
4-23	885-893	analyses	_	
4-24	893-894	,	_	
4-25	895-898	and	_	
4-26	899-902	211	_	
4-27	903-914	individuals	_	
4-28	915-916	(	_	
4-29	916-920	mean	_	
4-30	921-924	age	_	
4-31	925-927	26	_	
4-32	928-933	years	_	
4-33	933-934	,	_	
4-34	935-945	structural	_	
4-35	946-950	data	_	
4-36	951-960	available	_	
4-37	960-961	)	_	
4-38	962-966	were	_	
4-39	967-971	used	_	
4-40	972-975	for	_	
4-41	976-987	replication	_	
4-42	988-990	of	_	
4-43	991-994	the	_	
4-44	995-1005	structural	_	
4-45	1006-1014	findings	_	
4-46	1014-1015	.	_	

#Text=Both samples were drawn from the Northern Finland Birth Cohort 1986.
5-1	1016-1020	Both	_	
5-2	1021-1028	samples	_	
5-3	1029-1033	were	_	
5-4	1034-1039	drawn	_	
5-5	1040-1044	from	_	
5-6	1045-1048	the	_	
5-7	1049-1057	Northern	_	
5-8	1058-1065	Finland	_	
5-9	1066-1071	Birth	_	
5-10	1072-1078	Cohort	_	
5-11	1079-1083	1986	_	
5-12	1083-1084	.	_	

#Text=We found that the degree of interregional similarities in BOLD signal and gray matter volume vary as a function of PRS; lowest interregional correlation (both measures) was observed in individuals with high PRS.
6-1	1085-1087	We	_	
6-2	1088-1093	found	_	
6-3	1094-1098	that	_	
6-4	1099-1102	the	_	
6-5	1103-1109	degree	_	
6-6	1110-1112	of	_	
6-7	1113-1126	interregional	_	
6-8	1127-1139	similarities	_	
6-9	1140-1142	in	_	
6-10	1143-1147	BOLD	_	
6-11	1148-1154	signal	_	
6-12	1155-1158	and	_	
6-13	1159-1163	gray	_	
6-14	1164-1170	matter	_	
6-15	1171-1177	volume	_	
6-16	1178-1182	vary	_	
6-17	1183-1185	as	_	
6-18	1186-1187	a	_	
6-19	1188-1196	function	_	
6-20	1197-1199	of	_	
6-21	1200-1203	PRS	_	
6-22	1203-1204	;	_	
6-23	1205-1211	lowest	_	
6-24	1212-1225	interregional	_	
6-25	1226-1237	correlation	_	
6-26	1238-1239	(	_	
6-27	1239-1243	both	_	
6-28	1244-1252	measures	_	
6-29	1252-1253	)	_	
6-30	1254-1257	was	_	
6-31	1258-1266	observed	_	
6-32	1267-1269	in	_	
6-33	1270-1281	individuals	_	
6-34	1282-1286	with	_	
6-35	1287-1291	high	_	
6-36	1292-1295	PRS	_	
6-37	1295-1296	.	_	

#Text=We also replicated the gray matter volume finding.
7-1	1297-1299	We	_	
7-2	1300-1304	also	_	
7-3	1305-1315	replicated	_	
7-4	1316-1319	the	_	
7-5	1320-1324	gray	_	
7-6	1325-1331	matter	_	
7-7	1332-1338	volume	_	
7-8	1339-1346	finding	_	
7-9	1346-1347	.	_	

#Text=We did not find evidence for an interaction between early adversity and PRS on the interregional correlation of BOLD signal and gray matter volume.
8-1	1348-1350	We	_	
8-2	1351-1354	did	_	
8-3	1355-1358	not	_	
8-4	1359-1363	find	_	
8-5	1364-1372	evidence	_	
8-6	1373-1376	for	_	
8-7	1377-1379	an	_	
8-8	1380-1391	interaction	_	
8-9	1392-1399	between	_	
8-10	1400-1405	early	_	
8-11	1406-1415	adversity	_	
8-12	1416-1419	and	_	
8-13	1420-1423	PRS	_	
8-14	1424-1426	on	_	
8-15	1427-1430	the	_	
8-16	1431-1444	interregional	_	
8-17	1445-1456	correlation	_	
8-18	1457-1459	of	_	
8-19	1460-1464	BOLD	_	
8-20	1465-1471	signal	_	
8-21	1472-1475	and	_	
8-22	1476-1480	gray	_	
8-23	1481-1487	matter	_	
8-24	1488-1494	volume	_	
8-25	1494-1495	.	_	

#Text=We speculate that the observed group differences in PRS-related correlations in both modalities may result from differences in the concurrent functional engagement of the face-processing regions over time, eg, via differences in exposure to social interaction with other people.
9-1	1496-1498	We	_	
9-2	1499-1508	speculate	_	
9-3	1509-1513	that	_	
9-4	1514-1517	the	_	
9-5	1518-1526	observed	_	
9-6	1527-1532	group	_	
9-7	1533-1544	differences	_	
9-8	1545-1547	in	_	
9-9	1548-1559	PRS-related	_	
9-10	1560-1572	correlations	_	
9-11	1573-1575	in	_	
9-12	1576-1580	both	_	
9-13	1581-1591	modalities	_	
9-14	1592-1595	may	_	
9-15	1596-1602	result	_	
9-16	1603-1607	from	_	
9-17	1608-1619	differences	_	
9-18	1620-1622	in	_	
9-19	1623-1626	the	_	
9-20	1627-1637	concurrent	_	
9-21	1638-1648	functional	_	
9-22	1649-1659	engagement	_	
9-23	1660-1662	of	_	
9-24	1663-1666	the	_	
9-25	1667-1682	face-processing	_	
9-26	1683-1690	regions	_	
9-27	1691-1695	over	_	
9-28	1696-1700	time	_	
9-29	1700-1701	,	_	
9-30	1702-1704	eg	_	
9-31	1704-1705	,	_	
9-32	1706-1709	via	_	
9-33	1710-1721	differences	_	
9-34	1722-1724	in	_	
9-35	1725-1733	exposure	_	
9-36	1734-1736	to	_	
9-37	1737-1743	social	_	
9-38	1744-1755	interaction	_	
9-39	1756-1760	with	_	
9-40	1761-1766	other	_	
9-41	1767-1773	people	_	
9-42	1773-1774	.	_	

#Text=Introduction
#Text=Schizophrenia has one of the highest heritability estimates in psychiatry.
10-1	1775-1787	Introduction	_	
10-2	1788-1801	Schizophrenia	_	
10-3	1802-1805	has	_	
10-4	1806-1809	one	_	
10-5	1810-1812	of	_	
10-6	1813-1816	the	_	
10-7	1817-1824	highest	_	
10-8	1825-1837	heritability	_	
10-9	1838-1847	estimates	_	
10-10	1848-1850	in	_	
10-11	1851-1861	psychiatry	_	
10-12	1861-1862	.	_	

#Text=For example, in identical twins, the heritability estimate has been estimated as 80%.
11-1	1863-1866	For	_	
11-2	1867-1874	example	_	
11-3	1874-1875	,	_	
11-4	1876-1878	in	_	
11-5	1879-1888	identical	_	
11-6	1889-1894	twins	_	
11-7	1894-1895	,	_	
11-8	1896-1899	the	_	
11-9	1900-1912	heritability	_	
11-10	1913-1921	estimate	_	
11-11	1922-1925	has	_	
11-12	1926-1930	been	_	
11-13	1931-1940	estimated	_	
11-14	1941-1943	as	_	
11-15	1944-1947	80%	_	
11-16	1947-1948	.	_	

#Text=A large genome-wide association study (GWAS) identified 108 independent loci associated with schizophrenia.
12-1	1949-1950	A	_	
12-2	1951-1956	large	_	
12-3	1957-1968	genome-wide	_	
12-4	1969-1980	association	_	
12-5	1981-1986	study	_	
12-6	1987-1988	(	_	
12-7	1988-1992	GWAS	_	
12-8	1992-1993	)	_	
12-9	1994-2004	identified	_	
12-10	2005-2008	108	_	
12-11	2009-2020	independent	_	
12-12	2021-2025	loci	_	
12-13	2026-2036	associated	_	
12-14	2037-2041	with	_	
12-15	2042-2055	schizophrenia	_	
12-16	2055-2056	.	_	

#Text=Both impaired face identification and poor performance in emotion processing from faces are common in patients with schizophrenia.
13-1	2057-2061	Both	_	
13-2	2062-2070	impaired	_	
13-3	2071-2075	face	_	
13-4	2076-2090	identification	_	
13-5	2091-2094	and	_	
13-6	2095-2099	poor	_	
13-7	2100-2111	performance	_	
13-8	2112-2114	in	_	
13-9	2115-2122	emotion	_	
13-10	2123-2133	processing	_	
13-11	2134-2138	from	_	
13-12	2139-2144	faces	_	
13-13	2145-2148	are	_	
13-14	2149-2155	common	_	
13-15	2156-2158	in	_	
13-16	2159-2167	patients	_	
13-17	2168-2172	with	_	
13-18	2173-2186	schizophrenia	_	
13-19	2186-2187	.	_	

#Text=Visual analysis of faces involves many cortical regions, including the fusiform face area (FFA), posterior superior temporal sulcus (STS), and occipital face area.
14-1	2188-2194	Visual	_	
14-2	2195-2203	analysis	_	
14-3	2204-2206	of	_	
14-4	2207-2212	faces	_	
14-5	2213-2221	involves	_	
14-6	2222-2226	many	_	
14-7	2227-2235	cortical	_	
14-8	2236-2243	regions	_	
14-9	2243-2244	,	_	
14-10	2245-2254	including	_	
14-11	2255-2258	the	_	
14-12	2259-2267	fusiform	_	
14-13	2268-2272	face	_	
14-14	2273-2277	area	_	
14-15	2278-2279	(	_	
14-16	2279-2282	FFA	_	
14-17	2282-2283	)	_	
14-18	2283-2284	,	_	
14-19	2285-2294	posterior	_	
14-20	2295-2303	superior	_	
14-21	2304-2312	temporal	_	
14-22	2313-2319	sulcus	_	
14-23	2320-2321	(	_	
14-24	2321-2324	STS	_	
14-25	2324-2325	)	_	
14-26	2325-2326	,	_	
14-27	2327-2330	and	_	
14-28	2331-2340	occipital	_	
14-29	2341-2345	face	_	
14-30	2346-2350	area	_	
14-31	2350-2351	.	_	

#Text=These regions form the “core system” and provide face selectivity during visual exposure to faces.
15-1	2352-2357	These	_	
15-2	2358-2365	regions	_	
15-3	2366-2370	form	_	
15-4	2371-2374	the	_	
15-5	2375-2376	“	_	
15-6	2376-2380	core	_	
15-7	2381-2387	system	_	
15-8	2387-2388	”	_	
15-9	2389-2392	and	_	
15-10	2393-2400	provide	_	
15-11	2401-2405	face	_	
15-12	2406-2417	selectivity	_	
15-13	2418-2424	during	_	
15-14	2425-2431	visual	_	
15-15	2432-2440	exposure	_	
15-16	2441-2443	to	_	
15-17	2444-2449	faces	_	
15-18	2449-2450	.	_	

#Text=In a previous study, we found that regions within the core system exhibit a high number of connections with other face-processing regions but low population variance in connectivity.
16-1	2451-2453	In	_	
16-2	2454-2455	a	_	
16-3	2456-2464	previous	_	
16-4	2465-2470	study	_	
16-5	2470-2471	,	_	
16-6	2472-2474	we	_	
16-7	2475-2480	found	_	
16-8	2481-2485	that	_	
16-9	2486-2493	regions	_	
16-10	2494-2500	within	_	
16-11	2501-2504	the	_	
16-12	2505-2509	core	_	
16-13	2510-2516	system	_	
16-14	2517-2524	exhibit	_	
16-15	2525-2526	a	_	
16-16	2527-2531	high	_	
16-17	2532-2538	number	_	
16-18	2539-2541	of	_	
16-19	2542-2553	connections	_	
16-20	2554-2558	with	_	
16-21	2559-2564	other	_	
16-22	2565-2580	face-processing	_	
16-23	2581-2588	regions	_	
16-24	2589-2592	but	_	
16-25	2593-2596	low	_	
16-26	2597-2607	population	_	
16-27	2608-2616	variance	_	
16-28	2617-2619	in	_	
16-29	2620-2632	connectivity	_	
16-30	2632-2633	.	_	

#Text=The core system connects with the “extended system” that provides further processing of faces (eg, emotion).
17-1	2634-2637	The	_	
17-2	2638-2642	core	_	
17-3	2643-2649	system	_	
17-4	2650-2658	connects	_	
17-5	2659-2663	with	_	
17-6	2664-2667	the	_	
17-7	2668-2669	“	_	
17-8	2669-2677	extended	_	
17-9	2678-2684	system	_	
17-10	2684-2685	”	_	
17-11	2686-2690	that	_	
17-12	2691-2699	provides	_	
17-13	2700-2707	further	_	
17-14	2708-2718	processing	_	
17-15	2719-2721	of	_	
17-16	2722-2727	faces	_	
17-17	2728-2729	(	_	
17-18	2729-2731	eg	_	
17-19	2731-2732	,	_	
17-20	2733-2740	emotion	_	
17-21	2740-2741	)	_	
17-22	2741-2742	.	_	

#Text=Considering the central role of the core system in face processing, it is possible that impairments in face processing present in patients with schizophrenia are mediated in part via dysfunction in the core system and its neural connections to other face-processing regions.
18-1	2743-2754	Considering	_	
18-2	2755-2758	the	_	
18-3	2759-2766	central	_	
18-4	2767-2771	role	_	
18-5	2772-2774	of	_	
18-6	2775-2778	the	_	
18-7	2779-2783	core	_	
18-8	2784-2790	system	_	
18-9	2791-2793	in	_	
18-10	2794-2798	face	_	
18-11	2799-2809	processing	_	
18-12	2809-2810	,	_	
18-13	2811-2813	it	_	
18-14	2814-2816	is	_	
18-15	2817-2825	possible	_	
18-16	2826-2830	that	_	
18-17	2831-2842	impairments	_	
18-18	2843-2845	in	_	
18-19	2846-2850	face	_	
18-20	2851-2861	processing	_	
18-21	2862-2869	present	_	
18-22	2870-2872	in	_	
18-23	2873-2881	patients	_	
18-24	2882-2886	with	_	
18-25	2887-2900	schizophrenia	_	
18-26	2901-2904	are	_	
18-27	2905-2913	mediated	_	
18-28	2914-2916	in	_	
18-29	2917-2921	part	_	
18-30	2922-2925	via	_	
18-31	2926-2937	dysfunction	_	
18-32	2938-2940	in	_	
18-33	2941-2944	the	_	
18-34	2945-2949	core	_	
18-35	2950-2956	system	_	
18-36	2957-2960	and	_	
18-37	2961-2964	its	_	
18-38	2965-2971	neural	_	
18-39	2972-2983	connections	_	
18-40	2984-2986	to	_	
18-41	2987-2992	other	_	
18-42	2993-3008	face-processing	_	
18-43	3009-3016	regions	_	
18-44	3016-3017	.	_	

#Text=One possibility might be that genetic variants that predispose to schizophrenia affect neural interactions within the core system.
19-1	3018-3021	One	_	
19-2	3022-3033	possibility	_	
19-3	3034-3039	might	_	
19-4	3040-3042	be	_	
19-5	3043-3047	that	_	
19-6	3048-3055	genetic	_	
19-7	3056-3064	variants	_	
19-8	3065-3069	that	_	
19-9	3070-3080	predispose	_	
19-10	3081-3083	to	_	
19-11	3084-3097	schizophrenia	_	
19-12	3098-3104	affect	_	
19-13	3105-3111	neural	_	
19-14	3112-3124	interactions	_	
19-15	3125-3131	within	_	
19-16	3132-3135	the	_	
19-17	3136-3140	core	_	
19-18	3141-3147	system	_	
19-19	3147-3148	.	_	

#Text=A second possibility is that these genetic variants influence the interactions between the core and the extended system.
20-1	3149-3150	A	_	
20-2	3151-3157	second	_	
20-3	3158-3169	possibility	_	
20-4	3170-3172	is	_	
20-5	3173-3177	that	_	
20-6	3178-3183	these	_	
20-7	3184-3191	genetic	_	
20-8	3192-3200	variants	_	
20-9	3201-3210	influence	_	
20-10	3211-3214	the	_	
20-11	3215-3227	interactions	_	
20-12	3228-3235	between	_	
20-13	3236-3239	the	_	
20-14	3240-3244	core	_	
20-15	3245-3248	and	_	
20-16	3249-3252	the	_	
20-17	3253-3261	extended	_	
20-18	3262-3268	system	_	
20-19	3268-3269	.	_	

#Text=Robust epidemiological evidence implicates that exposure to different forms of early stress contributes to the development of schizophrenia, possibly in interaction with genetic vulnerability.
21-1	3270-3276	Robust	_	
21-2	3277-3292	epidemiological	_	
21-3	3293-3301	evidence	_	
21-4	3302-3312	implicates	_	
21-5	3313-3317	that	_	
21-6	3318-3326	exposure	_	
21-7	3327-3329	to	_	
21-8	3330-3339	different	_	
21-9	3340-3345	forms	_	
21-10	3346-3348	of	_	
21-11	3349-3354	early	_	
21-12	3355-3361	stress	_	
21-13	3362-3373	contributes	_	
21-14	3374-3376	to	_	
21-15	3377-3380	the	_	
21-16	3381-3392	development	_	
21-17	3393-3395	of	_	
21-18	3396-3409	schizophrenia	_	
21-19	3409-3410	,	_	
21-20	3411-3419	possibly	_	
21-21	3420-3422	in	_	
21-22	3423-3434	interaction	_	
21-23	3435-3439	with	_	
21-24	3440-3447	genetic	_	
21-25	3448-3461	vulnerability	_	
21-26	3461-3462	.	_	

#Text=Previous studies have shown that children exposed to early adversities have difficulties in recognizing different facial expressions.
22-1	3463-3471	Previous	_	
22-2	3472-3479	studies	_	
22-3	3480-3484	have	_	
22-4	3485-3490	shown	_	
22-5	3491-3495	that	_	
22-6	3496-3504	children	_	
22-7	3505-3512	exposed	_	
22-8	3513-3515	to	_	
22-9	3516-3521	early	_	
22-10	3522-3533	adversities	_	
22-11	3534-3538	have	_	
22-12	3539-3551	difficulties	_	
22-13	3552-3554	in	_	
22-14	3555-3566	recognizing	_	
22-15	3567-3576	different	_	
22-16	3577-3583	facial	_	
22-17	3584-3595	expressions	_	
22-18	3595-3596	.	_	

#Text=In our previous study, we found that early adversity correlates with brain response to faces and that this association varies—across the face-processing network—as a function of regional variation in glucocorticoid gene expression.
23-1	3597-3599	In	_	
23-2	3600-3603	our	_	
23-3	3604-3612	previous	_	
23-4	3613-3618	study	_	
23-5	3618-3619	,	_	
23-6	3620-3622	we	_	
23-7	3623-3628	found	_	
23-8	3629-3633	that	_	
23-9	3634-3639	early	_	
23-10	3640-3649	adversity	_	
23-11	3650-3660	correlates	_	
23-12	3661-3665	with	_	
23-13	3666-3671	brain	_	
23-14	3672-3680	response	_	
23-15	3681-3683	to	_	
23-16	3684-3689	faces	_	
23-17	3690-3693	and	_	
23-18	3694-3698	that	_	
23-19	3699-3703	this	_	
23-20	3704-3715	association	_	
23-21	3716-3729	varies—across	_	
23-22	3730-3733	the	_	
23-23	3734-3749	face-processing	_	
23-24	3750-3760	network—as	_	
23-25	3761-3762	a	_	
23-26	3763-3771	function	_	
23-27	3772-3774	of	_	
23-28	3775-3783	regional	_	
23-29	3784-3793	variation	_	
23-30	3794-3796	in	_	
23-31	3797-3811	glucocorticoid	_	
23-32	3812-3816	gene	_	
23-33	3817-3827	expression	_	
23-34	3827-3828	.	_	

#Text=Here we explore the possibility that interindividual differences in genetic predisposition to schizophrenia, as assessed with a polygenic risk score (PRS), are reflected in the variation of brain function and structure in the face-processing network.
24-1	3829-3833	Here	_	
24-2	3834-3836	we	_	
24-3	3837-3844	explore	_	
24-4	3845-3848	the	_	
24-5	3849-3860	possibility	_	
24-6	3861-3865	that	_	
24-7	3866-3881	interindividual	_	
24-8	3882-3893	differences	_	
24-9	3894-3896	in	_	
24-10	3897-3904	genetic	_	
24-11	3905-3919	predisposition	_	
24-12	3920-3922	to	_	
24-13	3923-3936	schizophrenia	_	
24-14	3936-3937	,	_	
24-15	3938-3940	as	_	
24-16	3941-3949	assessed	_	
24-17	3950-3954	with	_	
24-18	3955-3956	a	_	
24-19	3957-3966	polygenic	_	
24-20	3967-3971	risk	_	
24-21	3972-3977	score	_	
24-22	3978-3979	(	_	
24-23	3979-3982	PRS	_	
24-24	3982-3983	)	_	
24-25	3983-3984	,	_	
24-26	3985-3988	are	_	
24-27	3989-3998	reflected	_	
24-28	3999-4001	in	_	
24-29	4002-4005	the	_	
24-30	4006-4015	variation	_	
24-31	4016-4018	of	_	
24-32	4019-4024	brain	_	
24-33	4025-4033	function	_	
24-34	4034-4037	and	_	
24-35	4038-4047	structure	_	
24-36	4048-4050	in	_	
24-37	4051-4054	the	_	
24-38	4055-4070	face-processing	_	
24-39	4071-4078	network	_	
24-40	4078-4079	.	_	

#Text=Second, given the importance of the interplay between genetic and environmental factors on the genesis of schizophrenia, we explore the possibility that early adversities interact with genetic predisposition to schizophrenia in functional and structural covariance within the face-processing network.
25-1	4080-4086	Second	_	
25-2	4086-4087	,	_	
25-3	4088-4093	given	_	
25-4	4094-4097	the	_	
25-5	4098-4108	importance	_	
25-6	4109-4111	of	_	
25-7	4112-4115	the	_	
25-8	4116-4125	interplay	_	
25-9	4126-4133	between	_	
25-10	4134-4141	genetic	_	
25-11	4142-4145	and	_	
25-12	4146-4159	environmental	_	
25-13	4160-4167	factors	_	
25-14	4168-4170	on	_	
25-15	4171-4174	the	_	
25-16	4175-4182	genesis	_	
25-17	4183-4185	of	_	
25-18	4186-4199	schizophrenia	_	
25-19	4199-4200	,	_	
25-20	4201-4203	we	_	
25-21	4204-4211	explore	_	
25-22	4212-4215	the	_	
25-23	4216-4227	possibility	_	
25-24	4228-4232	that	_	
25-25	4233-4238	early	_	
25-26	4239-4250	adversities	_	
25-27	4251-4259	interact	_	
25-28	4260-4264	with	_	
25-29	4265-4272	genetic	_	
25-30	4273-4287	predisposition	_	
25-31	4288-4290	to	_	
25-32	4291-4304	schizophrenia	_	
25-33	4305-4307	in	_	
25-34	4308-4318	functional	_	
25-35	4319-4322	and	_	
25-36	4323-4333	structural	_	
25-37	4334-4344	covariance	_	
25-38	4345-4351	within	_	
25-39	4352-4355	the	_	
25-40	4356-4371	face-processing	_	
25-41	4372-4379	network	_	
25-42	4379-4380	.	_	

#Text=According to the disconnection hypothesis of schizophrenia, a failure of functional integration of the brain is central to the neural pathogenesis of schizophrenia.
26-1	4381-4390	According	_	
26-2	4391-4393	to	_	
26-3	4394-4397	the	_	
26-4	4398-4411	disconnection	_	
26-5	4412-4422	hypothesis	_	
26-6	4423-4425	of	_	
26-7	4426-4439	schizophrenia	_	
26-8	4439-4440	,	_	
26-9	4441-4442	a	_	
26-10	4443-4450	failure	_	
26-11	4451-4453	of	_	
26-12	4454-4464	functional	_	
26-13	4465-4476	integration	_	
26-14	4477-4479	of	_	
26-15	4480-4483	the	_	
26-16	4484-4489	brain	_	
26-17	4490-4492	is	_	
26-18	4493-4500	central	_	
26-19	4501-4503	to	_	
26-20	4504-4507	the	_	
26-21	4508-4514	neural	_	
26-22	4515-4527	pathogenesis	_	
26-23	4528-4530	of	_	
26-24	4531-4544	schizophrenia	_	
26-25	4544-4545	.	_	

#Text=We hypothesized that the aggregation of schizophrenia-related genetic variants would reduce functional connectivity within the face-processing network.
27-1	4546-4548	We	_	
27-2	4549-4561	hypothesized	_	
27-3	4562-4566	that	_	
27-4	4567-4570	the	_	
27-5	4571-4582	aggregation	_	
27-6	4583-4585	of	_	
27-7	4586-4607	schizophrenia-related	_	
27-8	4608-4615	genetic	_	
27-9	4616-4624	variants	_	
27-10	4625-4630	would	_	
27-11	4631-4637	reduce	_	
27-12	4638-4648	functional	_	
27-13	4649-4661	connectivity	_	
27-14	4662-4668	within	_	
27-15	4669-4672	the	_	
27-16	4673-4688	face-processing	_	
27-17	4689-4696	network	_	
27-18	4696-4697	.	_	

#Text=Also, we hypothesized that this reduced functional connectivity would—over time—result in a lower similarity in structural features of the critical nodes of the circuit.
28-1	4698-4702	Also	_	
28-2	4702-4703	,	_	
28-3	4704-4706	we	_	
28-4	4707-4719	hypothesized	_	
28-5	4720-4724	that	_	
28-6	4725-4729	this	_	
28-7	4730-4737	reduced	_	
28-8	4738-4748	functional	_	
28-9	4749-4761	connectivity	_	
28-10	4762-4772	would—over	_	
28-11	4773-4784	time—result	_	
28-12	4785-4787	in	_	
28-13	4788-4789	a	_	
28-14	4790-4795	lower	_	
28-15	4796-4806	similarity	_	
28-16	4807-4809	in	_	
28-17	4810-4820	structural	_	
28-18	4821-4829	features	_	
28-19	4830-4832	of	_	
28-20	4833-4836	the	_	
28-21	4837-4845	critical	_	
28-22	4846-4851	nodes	_	
28-23	4852-4854	of	_	
28-24	4855-4858	the	_	
28-25	4859-4866	circuit	_	
28-26	4866-4867	.	_	

#Text=We computed PRS in a sample from the Northern Finland Birth Cohort 1986 (NFBC 1986).
29-1	4868-4870	We	_	
29-2	4871-4879	computed	_	
29-3	4880-4883	PRS	_	
29-4	4884-4886	in	_	
29-5	4887-4888	a	_	
29-6	4889-4895	sample	_	
29-7	4896-4900	from	_	
29-8	4901-4904	the	_	
29-9	4905-4913	Northern	_	
29-10	4914-4921	Finland	_	
29-11	4922-4927	Birth	_	
29-12	4928-4934	Cohort	_	
29-13	4935-4939	1986	_	
29-14	4940-4941	(	_	
29-15	4941-4945	NFBC	_	
29-16	4946-4950	1986	_	
29-17	4950-4951	)	_	
29-18	4951-4952	.	_	

#Text=Self-reported questionnaire data were used to assess the level of early adversity retrospectively.
30-1	4953-4966	Self-reported	_	
30-2	4967-4980	questionnaire	_	
30-3	4981-4985	data	_	
30-4	4986-4990	were	_	
30-5	4991-4995	used	_	
30-6	4996-4998	to	_	
30-7	4999-5005	assess	_	
30-8	5006-5009	the	_	
30-9	5010-5015	level	_	
30-10	5016-5018	of	_	
30-11	5019-5024	early	_	
30-12	5025-5034	adversity	_	
30-13	5035-5050	retrospectively	_	
30-14	5050-5051	.	_	

#Text=We used magnetic resonance imaging (MRI)–derived functional (blood oxygen level–dependent [BOLD] signal) and structural (gray matter volume) covariances as proxies of “connectivity” in the face-processing network.
31-1	5052-5054	We	_	
31-2	5055-5059	used	_	
31-3	5060-5068	magnetic	_	
31-4	5069-5078	resonance	_	
31-5	5079-5086	imaging	_	
31-6	5087-5088	(	_	
31-7	5088-5091	MRI	_	
31-8	5091-5092	)	_	
31-9	5092-5093	–	_	
31-10	5093-5100	derived	_	
31-11	5101-5111	functional	_	
31-12	5112-5113	(	_	
31-13	5113-5118	blood	_	
31-14	5119-5125	oxygen	_	
31-15	5126-5141	level–dependent	_	
31-16	5142-5143	[	_	
31-17	5143-5147	BOLD	_	
31-18	5147-5148	]	_	
31-19	5149-5155	signal	_	
31-20	5155-5156	)	_	
31-21	5157-5160	and	_	
31-22	5161-5171	structural	_	
31-23	5172-5173	(	_	
31-24	5173-5177	gray	_	
31-25	5178-5184	matter	_	
31-26	5185-5191	volume	_	
31-27	5191-5192	)	_	
31-28	5193-5204	covariances	_	
31-29	5205-5207	as	_	
31-30	5208-5215	proxies	_	
31-31	5216-5218	of	_	
31-32	5219-5220	“	_	
31-33	5220-5232	connectivity	_	
31-34	5232-5233	”	_	
31-35	5234-5236	in	_	
31-36	5237-5240	the	_	
31-37	5241-5256	face-processing	_	
31-38	5257-5264	network	_	
31-39	5264-5265	.	_	

#Text=A total of 25 face-specific regions of interest (ROIs) were used to determine the face-processing network.
32-1	5266-5267	A	_	
32-2	5268-5273	total	_	
32-3	5274-5276	of	_	
32-4	5277-5279	25	_	
32-5	5280-5293	face-specific	_	
32-6	5294-5301	regions	_	
32-7	5302-5304	of	_	
32-8	5305-5313	interest	_	
32-9	5314-5315	(	_	
32-10	5315-5319	ROIs	_	
32-11	5319-5320	)	_	
32-12	5321-5325	were	_	
32-13	5326-5330	used	_	
32-14	5331-5333	to	_	
32-15	5334-5343	determine	_	
32-16	5344-5347	the	_	
32-17	5348-5363	face-processing	_	
32-18	5364-5371	network	_	
32-19	5371-5372	.	_	

#Text=Two independent samples drawn from the NFBC 1986 were used for the discovery (functional MRI [fMRI] and structural MRI available) and replication (structural MRI available) analyses.
33-1	5373-5376	Two	_	
33-2	5377-5388	independent	_	
33-3	5389-5396	samples	_	
33-4	5397-5402	drawn	_	
33-5	5403-5407	from	_	
33-6	5408-5411	the	_	
33-7	5412-5416	NFBC	_	
33-8	5417-5421	1986	_	
33-9	5422-5426	were	_	
33-10	5427-5431	used	_	
33-11	5432-5435	for	_	
33-12	5436-5439	the	_	
33-13	5440-5449	discovery	_	
33-14	5450-5451	(	_	
33-15	5451-5461	functional	_	
33-16	5462-5465	MRI	_	
33-17	5466-5467	[	_	
33-18	5467-5471	fMRI	_	
33-19	5471-5472	]	_	
33-20	5473-5476	and	_	
33-21	5477-5487	structural	_	
33-22	5488-5491	MRI	_	
33-23	5492-5501	available	_	
33-24	5501-5502	)	_	
33-25	5503-5506	and	_	
33-26	5507-5518	replication	_	
33-27	5519-5520	(	_	
33-28	5520-5530	structural	_	
33-29	5531-5534	MRI	_	
33-30	5535-5544	available	_	
33-31	5544-5545	)	_	
33-32	5546-5554	analyses	_	
33-33	5554-5555	.	_	

#Text=Materials and Methods
#Text=Participants
#Text=Participants were born between July 1, 1985, and June 30, 1986, in the Northern Finland provinces.
34-1	5556-5565	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
34-2	5566-5569	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
34-3	5570-5577	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[1]	
34-4	5578-5590	Participants	_	
34-5	5591-5603	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-6	5604-5608	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-7	5609-5613	born	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-8	5614-5621	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-9	5622-5626	July	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-10	5627-5628	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-11	5628-5629	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-12	5630-5634	1985	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-13	5634-5635	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-14	5636-5639	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-15	5640-5644	June	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-16	5645-5647	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-17	5647-5648	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-18	5649-5653	1986	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-19	5653-5654	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-20	5655-5657	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-21	5658-5661	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-22	5662-5670	Northern	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-23	5671-5678	Finland	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-24	5679-5688	provinces	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
34-25	5688-5689	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	

#Text=The local ethical committee approved the study.
35-1	5690-5693	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
35-2	5694-5699	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
35-3	5700-5707	ethical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
35-4	5708-5717	committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
35-5	5718-5726	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
35-6	5727-5730	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
35-7	5731-5736	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
35-8	5736-5737	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	

#Text=GWAS data in the NFBC 1986 originates from the visit conducted between August 2001 and June 2002 (N = 3743 in the final sample).
36-1	5738-5742	GWAS	_	
36-2	5743-5747	data	_	
36-3	5748-5750	in	_	
36-4	5751-5754	the	_	
36-5	5755-5759	NFBC	_	
36-6	5760-5764	1986	_	
36-7	5765-5775	originates	_	
36-8	5776-5780	from	_	
36-9	5781-5784	the	_	
36-10	5785-5790	visit	_	
36-11	5791-5800	conducted	_	
36-12	5801-5808	between	_	
36-13	5809-5815	August	_	
36-14	5816-5820	2001	_	
36-15	5821-5824	and	_	
36-16	5825-5829	June	_	
36-17	5830-5834	2002	_	
36-18	5835-5836	(	_	
36-19	5836-5837	N	_	
36-20	5838-5839	=	_	
36-21	5840-5844	3743	_	
36-22	5845-5847	in	_	
36-23	5848-5851	the	_	
36-24	5852-5857	final	_	
36-25	5858-5864	sample	_	
36-26	5864-5865	)	_	
36-27	5865-5866	.	_	

#Text=Using this sample, we explored whether PRS relates to later-life schizophrenia diagnosis.
37-1	5867-5872	Using	_	
37-2	5873-5877	this	_	
37-3	5878-5884	sample	_	
37-4	5884-5885	,	_	
37-5	5886-5888	we	_	
37-6	5889-5897	explored	_	
37-7	5898-5905	whether	_	
37-8	5906-5909	PRS	_	
37-9	5910-5917	relates	_	
37-10	5918-5920	to	_	
37-11	5921-5931	later-life	_	
37-12	5932-5945	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
37-13	5946-5955	diagnosis	_	
37-14	5955-5956	.	_	

#Text=The register-based information about the individual’s later-life schizophrenia (followed until 2016) was formed by using the following nation-wide registry: Care Register for Health Care, Finnish Centre for Pensions, and the registers of the National Social Insurance Institute.
38-1	5957-5960	The	_	
38-2	5961-5975	register-based	_	
38-3	5976-5987	information	_	
38-4	5988-5993	about	_	
38-5	5994-5997	the	_	
38-6	5998-6008	individual	_	
38-7	6008-6009	’	_	
38-8	6009-6010	s	_	
38-9	6011-6021	later-life	_	
38-10	6022-6035	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
38-11	6036-6037	(	_	
38-12	6037-6045	followed	_	
38-13	6046-6051	until	_	
38-14	6052-6056	2016	_	
38-15	6056-6057	)	_	
38-16	6058-6061	was	_	
38-17	6062-6068	formed	_	
38-18	6069-6071	by	_	
38-19	6072-6077	using	_	
38-20	6078-6081	the	_	
38-21	6082-6091	following	_	
38-22	6092-6103	nation-wide	_	
38-23	6104-6112	registry	_	
38-24	6112-6113	:	_	
38-25	6114-6118	Care	_	
38-26	6119-6127	Register	_	
38-27	6128-6131	for	_	
38-28	6132-6138	Health	_	
38-29	6139-6143	Care	_	
38-30	6143-6144	,	_	
38-31	6145-6152	Finnish	_	
38-32	6153-6159	Centre	_	
38-33	6160-6163	for	_	
38-34	6164-6172	Pensions	_	
38-35	6172-6173	,	_	
38-36	6174-6177	and	_	
38-37	6178-6181	the	_	
38-38	6182-6191	registers	_	
38-39	6192-6194	of	_	
38-40	6195-6198	the	_	
38-41	6199-6207	National	_	
38-42	6208-6214	Social	_	
38-43	6215-6224	Insurance	_	
38-44	6225-6234	Institute	_	
38-45	6234-6235	.	_	

#Text=We used both “broad” (International Classification of Diseases, Tenth Revision [ICD-10]: F20, F22, F24, and F25) and “narrow” (ICD-10: F20) definition of schizophrenia.
39-1	6236-6238	We	_	
39-2	6239-6243	used	_	
39-3	6244-6248	both	_	
39-4	6249-6250	“	_	
39-5	6250-6255	broad	_	
39-6	6255-6256	”	_	
39-7	6257-6258	(	_	
39-8	6258-6271	International	_	
39-9	6272-6286	Classification	_	
39-10	6287-6289	of	_	
39-11	6290-6298	Diseases	_	
39-12	6298-6299	,	_	
39-13	6300-6305	Tenth	_	
39-14	6306-6314	Revision	_	
39-15	6315-6316	[	_	
39-16	6316-6319	ICD	_	
39-17	6319-6320	-	_	
39-18	6320-6322	10	_	
39-19	6322-6323	]	_	
39-20	6323-6324	:	_	
39-21	6325-6328	F20	_	
39-22	6328-6329	,	_	
39-23	6330-6333	F22	_	
39-24	6333-6334	,	_	
39-25	6335-6338	F24	_	
39-26	6338-6339	,	_	
39-27	6340-6343	and	_	
39-28	6344-6347	F25	_	
39-29	6347-6348	)	_	
39-30	6349-6352	and	_	
39-31	6353-6354	“	_	
39-32	6354-6360	narrow	_	
39-33	6360-6361	”	_	
39-34	6362-6363	(	_	
39-35	6363-6366	ICD	_	
39-36	6366-6367	-	_	
39-37	6367-6369	10	_	
39-38	6369-6370	:	_	
39-39	6371-6374	F20	_	
39-40	6374-6375	)	_	
39-41	6376-6386	definition	_	
39-42	6387-6389	of	_	
39-43	6390-6403	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
39-44	6403-6404	.	_	

#Text=Next, two NFBC 1986 subsamples (referred to as neuroimaging subsamples hereinafter) were used for discovery and replication analyses.
40-1	6405-6409	Next	_	
40-2	6409-6410	,	_	
40-3	6411-6414	two	_	
40-4	6415-6419	NFBC	_	
40-5	6420-6424	1986	_	
40-6	6425-6435	subsamples	_	
40-7	6436-6437	(	_	
40-8	6437-6445	referred	_	
40-9	6446-6448	to	_	
40-10	6449-6451	as	_	
40-11	6452-6464	neuroimaging	_	
40-12	6465-6475	subsamples	_	
40-13	6476-6487	hereinafter	_	
40-14	6487-6488	)	_	
40-15	6489-6493	were	_	
40-16	6494-6498	used	_	
40-17	6499-6502	for	_	
40-18	6503-6512	discovery	_	
40-19	6513-6516	and	_	
40-20	6517-6528	replication	_	
40-21	6529-6537	analyses	_	
40-22	6537-6538	.	_	

#Text=These subsamples are described in detail in the supplementary material.
41-1	6539-6544	These	_	
41-2	6545-6555	subsamples	_	
41-3	6556-6559	are	_	
41-4	6560-6569	described	_	
41-5	6570-6572	in	_	
41-6	6573-6579	detail	_	
41-7	6580-6582	in	_	
41-8	6583-6586	the	_	
41-9	6587-6600	supplementary	_	
41-10	6601-6609	material	_	
41-11	6609-6610	.	_	

#Text=Briefly, the discovery sample (N = 90) was collected between 2007 and 2010 to investigate the risk of psychosis and the replication sample (N = 211) was obtained between 2011 and 2013 to examine associations between maternal smoking during pregnancy and the offspring’s brain and mental health.
42-1	6611-6618	Briefly	_	
42-2	6618-6619	,	_	
42-3	6620-6623	the	_	
42-4	6624-6633	discovery	_	
42-5	6634-6640	sample	_	
42-6	6641-6642	(	_	
42-7	6642-6643	N	_	
42-8	6644-6645	=	_	
42-9	6646-6648	90	_	
42-10	6648-6649	)	_	
42-11	6650-6653	was	_	
42-12	6654-6663	collected	_	
42-13	6664-6671	between	_	
42-14	6672-6676	2007	_	
42-15	6677-6680	and	_	
42-16	6681-6685	2010	_	
42-17	6686-6688	to	_	
42-18	6689-6700	investigate	_	
42-19	6701-6704	the	_	
42-20	6705-6709	risk	_	
42-21	6710-6712	of	_	
42-22	6713-6722	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
42-23	6723-6726	and	_	
42-24	6727-6730	the	_	
42-25	6731-6742	replication	_	
42-26	6743-6749	sample	_	
42-27	6750-6751	(	_	
42-28	6751-6752	N	_	
42-29	6753-6754	=	_	
42-30	6755-6758	211	_	
42-31	6758-6759	)	_	
42-32	6760-6763	was	_	
42-33	6764-6772	obtained	_	
42-34	6773-6780	between	_	
42-35	6781-6785	2011	_	
42-36	6786-6789	and	_	
42-37	6790-6794	2013	_	
42-38	6795-6797	to	_	
42-39	6798-6805	examine	_	
42-40	6806-6818	associations	_	
42-41	6819-6826	between	_	
42-42	6827-6835	maternal	_	
42-43	6836-6843	smoking	_	
42-44	6844-6850	during	_	
42-45	6851-6860	pregnancy	_	
42-46	6861-6864	and	_	
42-47	6865-6868	the	_	
42-48	6869-6878	offspring	_	
42-49	6878-6879	’	_	
42-50	6879-6880	s	_	
42-51	6881-6886	brain	_	
42-52	6887-6890	and	_	
42-53	6891-6897	mental	_	
42-54	6898-6904	health	_	
42-55	6904-6905	.	_	

#Text=Polygenic Risk Score
#Text=Detailed information on the collection of the genetic samples and quality control of the genome-wide data are provided in the supplementary material.
43-1	6906-6915	Polygenic	_	
43-2	6916-6920	Risk	_	
43-3	6921-6926	Score	_	
43-4	6927-6935	Detailed	_	
43-5	6936-6947	information	_	
43-6	6948-6950	on	_	
43-7	6951-6954	the	_	
43-8	6955-6965	collection	_	
43-9	6966-6968	of	_	
43-10	6969-6972	the	_	
43-11	6973-6980	genetic	_	
43-12	6981-6988	samples	_	
43-13	6989-6992	and	_	
43-14	6993-7000	quality	_	
43-15	7001-7008	control	_	
43-16	7009-7011	of	_	
43-17	7012-7015	the	_	
43-18	7016-7027	genome-wide	_	
43-19	7028-7032	data	_	
43-20	7033-7036	are	_	
43-21	7037-7045	provided	_	
43-22	7046-7048	in	_	
43-23	7049-7052	the	_	
43-24	7053-7066	supplementary	_	
43-25	7067-7075	material	_	
43-26	7075-7076	.	_	

#Text=The results of the GWAS by the Schizophrenia Working Group of the Psychiatric Genomics Consortium were used for the calculation of PRS for schizophrenia in the NFBC 1986 sample (N = 3743).
44-1	7077-7080	The	_	
44-2	7081-7088	results	_	
44-3	7089-7091	of	_	
44-4	7092-7095	the	_	
44-5	7096-7100	GWAS	_	
44-6	7101-7103	by	_	
44-7	7104-7107	the	_	
44-8	7108-7121	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
44-9	7122-7129	Working	_	
44-10	7130-7135	Group	_	
44-11	7136-7138	of	_	
44-12	7139-7142	the	_	
44-13	7143-7154	Psychiatric	_	
44-14	7155-7163	Genomics	_	
44-15	7164-7174	Consortium	_	
44-16	7175-7179	were	_	
44-17	7180-7184	used	_	
44-18	7185-7188	for	_	
44-19	7189-7192	the	_	
44-20	7193-7204	calculation	_	
44-21	7205-7207	of	_	
44-22	7208-7211	PRS	_	
44-23	7212-7215	for	_	
44-24	7216-7229	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
44-25	7230-7232	in	_	
44-26	7233-7236	the	_	
44-27	7237-7241	NFBC	_	
44-28	7242-7246	1986	_	
44-29	7247-7253	sample	_	
44-30	7254-7255	(	_	
44-31	7255-7256	N	_	
44-32	7257-7258	=	_	
44-33	7259-7263	3743	_	
44-34	7263-7264	)	_	
44-35	7264-7265	.	_	

#Text=The score was calculated on single-nucleotide polymorphisms (SNPs) reaching genome-wide significance (P = 5 × 10−8).
45-1	7266-7269	The	_	
45-2	7270-7275	score	_	
45-3	7276-7279	was	_	
45-4	7280-7290	calculated	_	
45-5	7291-7293	on	_	
45-6	7294-7311	single-nucleotide	_	
45-7	7312-7325	polymorphisms	_	
45-8	7326-7327	(	_	
45-9	7327-7331	SNPs	_	
45-10	7331-7332	)	_	
45-11	7333-7341	reaching	_	
45-12	7342-7353	genome-wide	_	
45-13	7354-7366	significance	_	
45-14	7367-7368	(	_	
45-15	7368-7369	P	_	
45-16	7370-7371	=	_	
45-17	7372-7373	5	_	
45-18	7374-7375	×	_	
45-19	7376-7378	10	_	
45-20	7378-7379	−	_	
45-21	7379-7380	8	_	
45-22	7380-7381	)	_	
45-23	7381-7382	.	_	

#Text=A total of 112 SNPs were found in the imputed NFBC 1986 GWAS dataset.
46-1	7383-7384	A	_	
46-2	7385-7390	total	_	
46-3	7391-7393	of	_	
46-4	7394-7397	112	_	
46-5	7398-7402	SNPs	_	
46-6	7403-7407	were	_	
46-7	7408-7413	found	_	
46-8	7414-7416	in	_	
46-9	7417-7420	the	_	
46-10	7421-7428	imputed	_	
46-11	7429-7433	NFBC	_	
46-12	7434-7438	1986	_	
46-13	7439-7443	GWAS	_	
46-14	7444-7451	dataset	_	
46-15	7451-7452	.	_	

#Text=For each participant (N = 3743), we calculated the sum of the risk SNPs multiplied by the effect size (logarithm of the odds ratio for schizophrenia).
47-1	7453-7456	For	_	
47-2	7457-7461	each	_	
47-3	7462-7473	participant	_	
47-4	7474-7475	(	_	
47-5	7475-7476	N	_	
47-6	7477-7478	=	_	
47-7	7479-7483	3743	_	
47-8	7483-7484	)	_	
47-9	7484-7485	,	_	
47-10	7486-7488	we	_	
47-11	7489-7499	calculated	_	
47-12	7500-7503	the	_	
47-13	7504-7507	sum	_	
47-14	7508-7510	of	_	
47-15	7511-7514	the	_	
47-16	7515-7519	risk	_	
47-17	7520-7524	SNPs	_	
47-18	7525-7535	multiplied	_	
47-19	7536-7538	by	_	
47-20	7539-7542	the	_	
47-21	7543-7549	effect	_	
47-22	7550-7554	size	_	
47-23	7555-7556	(	_	
47-24	7556-7565	logarithm	_	
47-25	7566-7568	of	_	
47-26	7569-7572	the	_	
47-27	7573-7577	odds	_	
47-28	7578-7583	ratio	_	
47-29	7584-7587	for	_	
47-30	7588-7601	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
47-31	7601-7602	)	_	
47-32	7602-7603	.	_	

#Text=PRS was adjusted for 4 principal components to account for population stratification.
48-1	7604-7607	PRS	_	
48-2	7608-7611	was	_	
48-3	7612-7620	adjusted	_	
48-4	7621-7624	for	_	
48-5	7625-7626	4	_	
48-6	7627-7636	principal	_	
48-7	7637-7647	components	_	
48-8	7648-7650	to	_	
48-9	7651-7658	account	_	
48-10	7659-7662	for	_	
48-11	7663-7673	population	_	
48-12	7674-7688	stratification	_	
48-13	7688-7689	.	_	

#Text=In the neuroimaging subsamples, we used the median split of PRS to create “high” and “low” PRS groups.
49-1	7690-7692	In	_	
49-2	7693-7696	the	_	
49-3	7697-7709	neuroimaging	_	
49-4	7710-7720	subsamples	_	
49-5	7720-7721	,	_	
49-6	7722-7724	we	_	
49-7	7725-7729	used	_	
49-8	7730-7733	the	_	
49-9	7734-7740	median	_	
49-10	7741-7746	split	_	
49-11	7747-7749	of	_	
49-12	7750-7753	PRS	_	
49-13	7754-7756	to	_	
49-14	7757-7763	create	_	
49-15	7764-7765	“	_	
49-16	7765-7769	high	_	
49-17	7769-7770	”	_	
49-18	7771-7774	and	_	
49-19	7775-7776	“	_	
49-20	7776-7779	low	_	
49-21	7779-7780	”	_	
49-22	7781-7784	PRS	_	
49-23	7785-7791	groups	_	
49-24	7791-7792	.	_	

#Text=Early Adversity
#Text=Early adversities in the neuroimaging subsamples were evaluated with the Trauma and Distress Scale (TADS).
50-1	7793-7798	Early	_	
50-2	7799-7808	Adversity	_	
50-3	7809-7814	Early	_	
50-4	7815-7826	adversities	_	
50-5	7827-7829	in	_	
50-6	7830-7833	the	_	
50-7	7834-7846	neuroimaging	_	
50-8	7847-7857	subsamples	_	
50-9	7858-7862	were	_	
50-10	7863-7872	evaluated	_	
50-11	7873-7877	with	_	
50-12	7878-7881	the	_	
50-13	7882-7888	Trauma	_	
50-14	7889-7892	and	_	
50-15	7893-7901	Distress	_	
50-16	7902-7907	Scale	_	
50-17	7908-7909	(	_	
50-18	7909-7913	TADS	_	
50-19	7913-7914	)	_	
50-20	7914-7915	.	_	

#Text=TADS self-report contains 43 statements, of which 25 statements are used to evaluate psychological traumas (emotional abuse, physical abuse, sexual abuse, emotional neglect, and physical neglect).
51-1	7916-7920	TADS	_	
51-2	7921-7932	self-report	_	
51-3	7933-7941	contains	_	
51-4	7942-7944	43	_	
51-5	7945-7955	statements	_	
51-6	7955-7956	,	_	
51-7	7957-7959	of	_	
51-8	7960-7965	which	_	
51-9	7966-7968	25	_	
51-10	7969-7979	statements	_	
51-11	7980-7983	are	_	
51-12	7984-7988	used	_	
51-13	7989-7991	to	_	
51-14	7992-8000	evaluate	_	
51-15	8001-8014	psychological	_	
51-16	8015-8022	traumas	_	
51-17	8023-8024	(	_	
51-18	8024-8033	emotional	_	
51-19	8034-8039	abuse	_	
51-20	8039-8040	,	_	
51-21	8041-8049	physical	_	
51-22	8050-8055	abuse	_	
51-23	8055-8056	,	_	
51-24	8057-8063	sexual	_	
51-25	8064-8069	abuse	_	
51-26	8069-8070	,	_	
51-27	8071-8080	emotional	_	
51-28	8081-8088	neglect	_	
51-29	8088-8089	,	_	
51-30	8090-8093	and	_	
51-31	8094-8102	physical	_	
51-32	8103-8110	neglect	_	
51-33	8110-8111	)	_	
51-34	8111-8112	.	_	

#Text=All statements have 5 responding options scored on a scale from 0 to 4: Never, Rarely, Sometimes, Often, and Nearly always.
52-1	8113-8116	All	_	
52-2	8117-8127	statements	_	
52-3	8128-8132	have	_	
52-4	8133-8134	5	_	
52-5	8135-8145	responding	_	
52-6	8146-8153	options	_	
52-7	8154-8160	scored	_	
52-8	8161-8163	on	_	
52-9	8164-8165	a	_	
52-10	8166-8171	scale	_	
52-11	8172-8176	from	_	
52-12	8177-8178	0	_	
52-13	8179-8181	to	_	
52-14	8182-8183	4	_	
52-15	8183-8184	:	_	
52-16	8185-8190	Never	_	
52-17	8190-8191	,	_	
52-18	8192-8198	Rarely	_	
52-19	8198-8199	,	_	
52-20	8200-8209	Sometimes	_	
52-21	8209-8210	,	_	
52-22	8211-8216	Often	_	
52-23	8216-8217	,	_	
52-24	8218-8221	and	_	
52-25	8222-8228	Nearly	_	
52-26	8229-8235	always	_	
52-27	8235-8236	.	_	

#Text=This study used total TADS scores.
53-1	8237-8241	This	_	
53-2	8242-8247	study	_	
53-3	8248-8252	used	_	
53-4	8253-8258	total	_	
53-5	8259-8263	TADS	_	
53-6	8264-8270	scores	_	
53-7	8270-8271	.	_	

#Text=In a previous study, the internal consistency of TADS self-reports was 0.92 (Cronbach’s α), and intraclass coefficients for TADS were good to excellent when compared with the interviewed TADS as a gold standard.
54-1	8272-8274	In	_	
54-2	8275-8276	a	_	
54-3	8277-8285	previous	_	
54-4	8286-8291	study	_	
54-5	8291-8292	,	_	
54-6	8293-8296	the	_	
54-7	8297-8305	internal	_	
54-8	8306-8317	consistency	_	
54-9	8318-8320	of	_	
54-10	8321-8325	TADS	_	
54-11	8326-8338	self-reports	_	
54-12	8339-8342	was	_	
54-13	8343-8347	0.92	_	
54-14	8348-8349	(	_	
54-15	8349-8357	Cronbach	_	
54-16	8357-8358	’	_	
54-17	8358-8359	s	_	
54-18	8360-8361	α	_	
54-19	8361-8362	)	_	
54-20	8362-8363	,	_	
54-21	8364-8367	and	_	
54-22	8368-8378	intraclass	_	
54-23	8379-8391	coefficients	_	
54-24	8392-8395	for	_	
54-25	8396-8400	TADS	_	
54-26	8401-8405	were	_	
54-27	8406-8410	good	_	
54-28	8411-8413	to	_	
54-29	8414-8423	excellent	_	
54-30	8424-8428	when	_	
54-31	8429-8437	compared	_	
54-32	8438-8442	with	_	
54-33	8443-8446	the	_	
54-34	8447-8458	interviewed	_	
54-35	8459-8463	TADS	_	
54-36	8464-8466	as	_	
54-37	8467-8468	a	_	
54-38	8469-8473	gold	_	
54-39	8474-8482	standard	_	
54-40	8482-8483	.	_	

#Text=TADS has been shown to associate with depression and help-seeking for mental problems.
55-1	8484-8488	TADS	_	
55-2	8489-8492	has	_	
55-3	8493-8497	been	_	
55-4	8498-8503	shown	_	
55-5	8504-8506	to	_	
55-6	8507-8516	associate	_	
55-7	8517-8521	with	_	
55-8	8522-8532	depression	_	
55-9	8533-8536	and	_	
55-10	8537-8549	help-seeking	_	
55-11	8550-8553	for	_	
55-12	8554-8560	mental	_	
55-13	8561-8569	problems	_	
55-14	8569-8570	.	_	

#Text=In the discovery sample, TADS scores correlated with the prodromal syndrome as diagnosed with the SIPS interview.
56-1	8571-8573	In	_	
56-2	8574-8577	the	_	
56-3	8578-8587	discovery	_	
56-4	8588-8594	sample	_	
56-5	8594-8595	,	_	
56-6	8596-8600	TADS	_	
56-7	8601-8607	scores	_	
56-8	8608-8618	correlated	_	
56-9	8619-8623	with	_	
56-10	8624-8627	the	_	
56-11	8628-8637	prodromal	_	
56-12	8638-8646	syndrome	_	
56-13	8647-8649	as	_	
56-14	8650-8659	diagnosed	_	
56-15	8660-8664	with	_	
56-16	8665-8668	the	_	
56-17	8669-8673	SIPS	_	
56-18	8674-8683	interview	_	
56-19	8683-8684	.	_	

#Text=Furthermore, TADS scores were higher in individuals exposed (vs nonexposed) to maternal cigarette smoking during pregnancy (replication sample).
57-1	8685-8696	Furthermore	_	
57-2	8696-8697	,	_	
57-3	8698-8702	TADS	_	
57-4	8703-8709	scores	_	
57-5	8710-8714	were	_	
57-6	8715-8721	higher	_	
57-7	8722-8724	in	_	
57-8	8725-8736	individuals	_	
57-9	8737-8744	exposed	_	
57-10	8745-8746	(	_	
57-11	8746-8748	vs	_	
57-12	8749-8759	nonexposed	_	
57-13	8759-8760	)	_	
57-14	8761-8763	to	_	
57-15	8764-8772	maternal	_	
57-16	8773-8782	cigarette	_	
57-17	8783-8790	smoking	_	
57-18	8791-8797	during	_	
57-19	8798-8807	pregnancy	_	
57-20	8808-8809	(	_	
57-21	8809-8820	replication	_	
57-22	8821-8827	sample	_	
57-23	8827-8828	)	_	
57-24	8828-8829	.	_	

#Text=For this reason, TADS scores were adjusted for the prodromal syndrome (discovery sample) and maternal smoking during pregnancy (replication sample) using linear regression.
58-1	8830-8833	For	_	
58-2	8834-8838	this	_	
58-3	8839-8845	reason	_	
58-4	8845-8846	,	_	
58-5	8847-8851	TADS	_	
58-6	8852-8858	scores	_	
58-7	8859-8863	were	_	
58-8	8864-8872	adjusted	_	
58-9	8873-8876	for	_	
58-10	8877-8880	the	_	
58-11	8881-8890	prodromal	_	
58-12	8891-8899	syndrome	_	
58-13	8900-8901	(	_	
58-14	8901-8910	discovery	_	
58-15	8911-8917	sample	_	
58-16	8917-8918	)	_	
58-17	8919-8922	and	_	
58-18	8923-8931	maternal	_	
58-19	8932-8939	smoking	_	
58-20	8940-8946	during	_	
58-21	8947-8956	pregnancy	_	
58-22	8957-8958	(	_	
58-23	8958-8969	replication	_	
58-24	8970-8976	sample	_	
58-25	8976-8977	)	_	
58-26	8978-8983	using	_	
58-27	8984-8990	linear	_	
58-28	8991-9001	regression	_	
58-29	9001-9002	.	_	

#Text=A median split of adjusted TADS scores was used to create “high” and “low” adversity groups in both samples.
59-1	9003-9004	A	_	
59-2	9005-9011	median	_	
59-3	9012-9017	split	_	
59-4	9018-9020	of	_	
59-5	9021-9029	adjusted	_	
59-6	9030-9034	TADS	_	
59-7	9035-9041	scores	_	
59-8	9042-9045	was	_	
59-9	9046-9050	used	_	
59-10	9051-9053	to	_	
59-11	9054-9060	create	_	
59-12	9061-9062	“	_	
59-13	9062-9066	high	_	
59-14	9066-9067	”	_	
59-15	9068-9071	and	_	
59-16	9072-9073	“	_	
59-17	9073-9076	low	_	
59-18	9076-9077	”	_	
59-19	9078-9087	adversity	_	
59-20	9088-9094	groups	_	
59-21	9095-9097	in	_	
59-22	9098-9102	both	_	
59-23	9103-9110	samples	_	
59-24	9110-9111	.	_	

#Text=Neuroimaging Data
#Text=Detailed descriptions relating to the neuroimaging parameters and preprocessing are provided in the supplementary material.
60-1	9112-9124	Neuroimaging	_	
60-2	9125-9129	Data	_	
60-3	9130-9138	Detailed	_	
60-4	9139-9151	descriptions	_	
60-5	9152-9160	relating	_	
60-6	9161-9163	to	_	
60-7	9164-9167	the	_	
60-8	9168-9180	neuroimaging	_	
60-9	9181-9191	parameters	_	
60-10	9192-9195	and	_	
60-11	9196-9209	preprocessing	_	
60-12	9210-9213	are	_	
60-13	9214-9222	provided	_	
60-14	9223-9225	in	_	
60-15	9226-9229	the	_	
60-16	9230-9243	supplementary	_	
60-17	9244-9252	material	_	
60-18	9252-9253	.	_	

#Text=Face-task fMRI data were available only in the discovery sample.
61-1	9254-9263	Face-task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[4]	
61-2	9264-9268	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[4]	
61-3	9269-9273	data	_	
61-4	9274-9278	were	_	
61-5	9279-9288	available	_	
61-6	9289-9293	only	_	
61-7	9294-9296	in	_	
61-8	9297-9300	the	_	
61-9	9301-9310	discovery	_	
61-10	9311-9317	sample	_	
61-11	9317-9318	.	_	

#Text=T1-weighted MRI scans were available in both the discovery and the replication samples.
62-1	9319-9321	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
62-2	9321-9322	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
62-3	9322-9330	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
62-4	9331-9334	MRI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
62-5	9335-9340	scans	_	
62-6	9341-9345	were	_	
62-7	9346-9355	available	_	
62-8	9356-9358	in	_	
62-9	9359-9363	both	_	
62-10	9364-9367	the	_	
62-11	9368-9377	discovery	_	
62-12	9378-9381	and	_	
62-13	9382-9385	the	_	
62-14	9386-9397	replication	_	
62-15	9398-9405	samples	_	
62-16	9405-9406	.	_	

#Text=Neuroimaging data were analyzed with FMRIB Software Library (FSL) and Analysis of Functional NeuroImages (AFNI) using the standard pipeline that included brain extraction, motion correction, spatial smoothing, prewhitening, high-pass filtering, and nonlinear normalization to the standard MNI-152 template (described in detail in the supplementary material).
63-1	9407-9419	Neuroimaging	_	
63-2	9420-9424	data	_	
63-3	9425-9429	were	_	
63-4	9430-9438	analyzed	_	
63-5	9439-9443	with	_	
63-6	9444-9449	FMRIB	_	
63-7	9450-9458	Software	_	
63-8	9459-9466	Library	_	
63-9	9467-9468	(	_	
63-10	9468-9471	FSL	_	
63-11	9471-9472	)	_	
63-12	9473-9476	and	_	
63-13	9477-9485	Analysis	_	
63-14	9486-9488	of	_	
63-15	9489-9499	Functional	_	
63-16	9500-9511	NeuroImages	_	
63-17	9512-9513	(	_	
63-18	9513-9517	AFNI	_	
63-19	9517-9518	)	_	
63-20	9519-9524	using	_	
63-21	9525-9528	the	_	
63-22	9529-9537	standard	_	
63-23	9538-9546	pipeline	_	
63-24	9547-9551	that	_	
63-25	9552-9560	included	_	
63-26	9561-9566	brain	_	
63-27	9567-9577	extraction	_	
63-28	9577-9578	,	_	
63-29	9579-9585	motion	_	
63-30	9586-9596	correction	_	
63-31	9596-9597	,	_	
63-32	9598-9605	spatial	_	
63-33	9606-9615	smoothing	_	
63-34	9615-9616	,	_	
63-35	9617-9629	prewhitening	_	
63-36	9629-9630	,	_	
63-37	9631-9640	high-pass	_	
63-38	9641-9650	filtering	_	
63-39	9650-9651	,	_	
63-40	9652-9655	and	_	
63-41	9656-9665	nonlinear	_	
63-42	9666-9679	normalization	_	
63-43	9680-9682	to	_	
63-44	9683-9686	the	_	
63-45	9687-9695	standard	_	
63-46	9696-9699	MNI	_	
63-47	9699-9700	-	_	
63-48	9700-9703	152	_	
63-49	9704-9712	template	_	
63-50	9713-9714	(	_	
63-51	9714-9723	described	_	
63-52	9724-9726	in	_	
63-53	9727-9733	detail	_	
63-54	9734-9736	in	_	
63-55	9737-9740	the	_	
63-56	9741-9754	supplementary	_	
63-57	9755-9763	material	_	
63-58	9763-9764	)	_	
63-59	9764-9765	.	_	

#Text=Face-Task fMRI
#Text=We conducted fMRI while participants viewed 4 blocks of video clips of happy and 4 blocks of video clips of fearful facial expressions presented in pseudorandom order separated by blocks of a dynamic mosaic baseline (control stimulus).
64-1	9766-9775	Face-Task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[6]	
64-2	9776-9780	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[6]	
64-3	9781-9783	We	_	
64-4	9784-9793	conducted	_	
64-5	9794-9798	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
64-6	9799-9804	while	_	
64-7	9805-9817	participants	_	
64-8	9818-9824	viewed	_	
64-9	9825-9826	4	_	
64-10	9827-9833	blocks	_	
64-11	9834-9836	of	_	
64-12	9837-9842	video	_	
64-13	9843-9848	clips	_	
64-14	9849-9851	of	_	
64-15	9852-9857	happy	_	
64-16	9858-9861	and	_	
64-17	9862-9863	4	_	
64-18	9864-9870	blocks	_	
64-19	9871-9873	of	_	
64-20	9874-9879	video	_	
64-21	9880-9885	clips	_	
64-22	9886-9888	of	_	
64-23	9889-9896	fearful	_	
64-24	9897-9903	facial	_	
64-25	9904-9915	expressions	_	
64-26	9916-9925	presented	_	
64-27	9926-9928	in	_	
64-28	9929-9941	pseudorandom	_	
64-29	9942-9947	order	_	
64-30	9948-9957	separated	_	
64-31	9958-9960	by	_	
64-32	9961-9967	blocks	_	
64-33	9968-9970	of	_	
64-34	9971-9972	a	_	
64-35	9973-9980	dynamic	_	
64-36	9981-9987	mosaic	_	
64-37	9988-9996	baseline	_	
64-38	9997-9998	(	_	
64-39	9998-10005	control	_	
64-40	10006-10014	stimulus	_	
64-41	10014-10015	)	_	
64-42	10015-10016	.	_	

#Text=The baseline stimulus was generated from the mosaic images of the facial expressions in the happy and fearful blocks.
65-1	10017-10020	The	_	
65-2	10021-10029	baseline	_	
65-3	10030-10038	stimulus	_	
65-4	10039-10042	was	_	
65-5	10043-10052	generated	_	
65-6	10053-10057	from	_	
65-7	10058-10061	the	_	
65-8	10062-10068	mosaic	_	
65-9	10069-10075	images	_	
65-10	10076-10078	of	_	
65-11	10079-10082	the	_	
65-12	10083-10089	facial	_	
65-13	10090-10101	expressions	_	
65-14	10102-10104	in	_	
65-15	10105-10108	the	_	
65-16	10109-10114	happy	_	
65-17	10115-10118	and	_	
65-18	10119-10126	fearful	_	
65-19	10127-10133	blocks	_	
65-20	10133-10134	.	_	

#Text=Blocks of happy and fearful facial expressions consisted of 12 × 2.5-second dynamic video clips showing a neutral facial expression changing into a happy/fearful expression (figure 1).
66-1	10135-10141	Blocks	_	
66-2	10142-10144	of	_	
66-3	10145-10150	happy	_	
66-4	10151-10154	and	_	
66-5	10155-10162	fearful	_	
66-6	10163-10169	facial	_	
66-7	10170-10181	expressions	_	
66-8	10182-10191	consisted	_	
66-9	10192-10194	of	_	
66-10	10195-10197	12	_	
66-11	10198-10199	×	_	
66-12	10200-10203	2.5	_	
66-13	10203-10204	-	_	
66-14	10204-10210	second	_	
66-15	10211-10218	dynamic	_	
66-16	10219-10224	video	_	
66-17	10225-10230	clips	_	
66-18	10231-10238	showing	_	
66-19	10239-10240	a	_	
66-20	10241-10248	neutral	_	
66-21	10249-10255	facial	_	
66-22	10256-10266	expression	_	
66-23	10267-10275	changing	_	
66-24	10276-10280	into	_	
66-25	10281-10282	a	_	
66-26	10283-10288	happy	_	
66-27	10288-10289	/	_	
66-28	10289-10296	fearful	_	
66-29	10297-10307	expression	_	
66-30	10308-10309	(	_	
66-31	10309-10315	figure	_	
66-32	10316-10317	1	_	
66-33	10317-10318	)	_	
66-34	10318-10319	.	_	

#Text=The total duration of each block (facial expressions and dynamic mosaic) was 30 seconds.
67-1	10320-10323	The	_	
67-2	10324-10329	total	_	
67-3	10330-10338	duration	_	
67-4	10339-10341	of	_	
67-5	10342-10346	each	_	
67-6	10347-10352	block	_	
67-7	10353-10354	(	_	
67-8	10354-10360	facial	_	
67-9	10361-10372	expressions	_	
67-10	10373-10376	and	_	
67-11	10377-10384	dynamic	_	
67-12	10385-10391	mosaic	_	
67-13	10391-10392	)	_	
67-14	10393-10396	was	_	
67-15	10397-10399	30	_	
67-16	10400-10407	seconds	_	
67-17	10407-10408	.	_	

#Text=Six different people, each shown twice, performed the happy facial expressions.
68-1	10409-10412	Six	_	
68-2	10413-10422	different	_	
68-3	10423-10429	people	_	
68-4	10429-10430	,	_	
68-5	10431-10435	each	_	
68-6	10436-10441	shown	_	
68-7	10442-10447	twice	_	
68-8	10447-10448	,	_	
68-9	10449-10458	performed	_	
68-10	10459-10462	the	_	
68-11	10463-10468	happy	_	
68-12	10469-10475	facial	_	
68-13	10476-10487	expressions	_	
68-14	10487-10488	.	_	

#Text=Fearful facial expression blocks consisted of facial expressions of 5 different people, each shown 2 or 3 times.
69-1	10489-10496	Fearful	_	
69-2	10497-10503	facial	_	
69-3	10504-10514	expression	_	
69-4	10515-10521	blocks	_	
69-5	10522-10531	consisted	_	
69-6	10532-10534	of	_	
69-7	10535-10541	facial	_	
69-8	10542-10553	expressions	_	
69-9	10554-10556	of	_	
69-10	10557-10558	5	_	
69-11	10559-10568	different	_	
69-12	10569-10575	people	_	
69-13	10575-10576	,	_	
69-14	10577-10581	each	_	
69-15	10582-10587	shown	_	
69-16	10588-10589	2	_	
69-17	10590-10592	or	_	
69-18	10593-10594	3	_	
69-19	10595-10600	times	_	
69-20	10600-10601	.	_	

#Text=The whole imaging session lasted 8 minutes 10 seconds.
70-1	10602-10605	The	_	
70-2	10606-10611	whole	_	
70-3	10612-10619	imaging	_	
70-4	10620-10627	session	_	
70-5	10628-10634	lasted	_	
70-6	10635-10636	8	_	
70-7	10637-10644	minutes	_	
70-8	10645-10647	10	_	
70-9	10648-10655	seconds	_	
70-10	10655-10656	.	_	

#Text=The stimulus used in this study.
71-1	10657-10660	The	_	
71-2	10661-10669	stimulus	_	
71-3	10670-10674	used	_	
71-4	10675-10677	in	_	
71-5	10678-10682	this	_	
71-6	10683-10688	study	_	
71-7	10688-10689	.	_	

#Text=Interregional Correlation of BOLD and Gray Matter Volume in the Face-Processing Network
#Text=We used ROIs that were defined in the IMAGEN subsample of 1110 adolescents (mean age = 14 years).
72-1	10690-10703	Interregional	_	
72-2	10704-10715	Correlation	_	
72-3	10716-10718	of	_	
72-4	10719-10723	BOLD	_	
72-5	10724-10727	and	_	
72-6	10728-10732	Gray	_	
72-7	10733-10739	Matter	_	
72-8	10740-10746	Volume	_	
72-9	10747-10749	in	_	
72-10	10750-10753	the	_	
72-11	10754-10769	Face-Processing	_	
72-12	10770-10777	Network	_	
72-13	10778-10780	We	_	
72-14	10781-10785	used	_	
72-15	10786-10790	ROIs	_	
72-16	10791-10795	that	_	
72-17	10796-10800	were	_	
72-18	10801-10808	defined	_	
72-19	10809-10811	in	_	
72-20	10812-10815	the	_	
72-21	10816-10822	IMAGEN	_	
72-22	10823-10832	subsample	_	
72-23	10833-10835	of	_	
72-24	10836-10840	1110	_	
72-25	10841-10852	adolescents	_	
72-26	10853-10854	(	_	
72-27	10854-10858	mean	_	
72-28	10859-10862	age	_	
72-29	10863-10864	=	_	
72-30	10865-10867	14	_	
72-31	10868-10873	years	_	
72-32	10873-10874	)	_	
72-33	10874-10875	.	_	

#Text=A total of 25 ROIs relevant for face processing were identified using a probabilistic map as described in detail elsewhere.
73-1	10876-10877	A	_	
73-2	10878-10883	total	_	
73-3	10884-10886	of	_	
73-4	10887-10889	25	_	
73-5	10890-10894	ROIs	_	
73-6	10895-10903	relevant	_	
73-7	10904-10907	for	_	
73-8	10908-10912	face	_	
73-9	10913-10923	processing	_	
73-10	10924-10928	were	_	
73-11	10929-10939	identified	_	
73-12	10940-10945	using	_	
73-13	10946-10947	a	_	
73-14	10948-10961	probabilistic	_	
73-15	10962-10965	map	_	
73-16	10966-10968	as	_	
73-17	10969-10978	described	_	
73-18	10979-10981	in	_	
73-19	10982-10988	detail	_	
73-20	10989-10998	elsewhere	_	
73-21	10998-10999	.	_	

#Text=Our previous study showed that these ROIs highly overlap with BOLD response to faces in the NFBC 1986 sample.
74-1	11000-11003	Our	_	
74-2	11004-11012	previous	_	
74-3	11013-11018	study	_	
74-4	11019-11025	showed	_	
74-5	11026-11030	that	_	
74-6	11031-11036	these	_	
74-7	11037-11041	ROIs	_	
74-8	11042-11048	highly	_	
74-9	11049-11056	overlap	_	
74-10	11057-11061	with	_	
74-11	11062-11066	BOLD	_	
74-12	11067-11075	response	_	
74-13	11076-11078	to	_	
74-14	11079-11084	faces	_	
74-15	11085-11087	in	_	
74-16	11088-11091	the	_	
74-17	11092-11096	NFBC	_	
74-18	11097-11101	1986	_	
74-19	11102-11108	sample	_	
74-20	11108-11109	.	_	

#Text=The fMRI data were analyzed as follows (figure 2).
75-1	11110-11113	The	_	
75-2	11114-11118	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
75-3	11119-11123	data	_	
75-4	11124-11128	were	_	
75-5	11129-11137	analyzed	_	
75-6	11138-11140	as	_	
75-7	11141-11148	follows	_	
75-8	11149-11150	(	_	
75-9	11150-11156	figure	_	
75-10	11157-11158	2	_	
75-11	11158-11159	)	_	
75-12	11159-11160	.	_	

#Text=For each individual and each ROI, the mean BOLD signal time series was calculated by averaging the BOLD signal from all voxels constituting the ROI at every time point (150 in total).
76-1	11161-11164	For	_	
76-2	11165-11169	each	_	
76-3	11170-11180	individual	_	
76-4	11181-11184	and	_	
76-5	11185-11189	each	_	
76-6	11190-11193	ROI	_	
76-7	11193-11194	,	_	
76-8	11195-11198	the	_	
76-9	11199-11203	mean	_	
76-10	11204-11208	BOLD	_	
76-11	11209-11215	signal	_	
76-12	11216-11220	time	_	
76-13	11221-11227	series	_	
76-14	11228-11231	was	_	
76-15	11232-11242	calculated	_	
76-16	11243-11245	by	_	
76-17	11246-11255	averaging	_	
76-18	11256-11259	the	_	
76-19	11260-11264	BOLD	_	
76-20	11265-11271	signal	_	
76-21	11272-11276	from	_	
76-22	11277-11280	all	_	
76-23	11281-11287	voxels	_	
76-24	11288-11300	constituting	_	
76-25	11301-11304	the	_	
76-26	11305-11308	ROI	_	
76-27	11309-11311	at	_	
76-28	11312-11317	every	_	
76-29	11318-11322	time	_	
76-30	11323-11328	point	_	
76-31	11329-11330	(	_	
76-32	11330-11333	150	_	
76-33	11334-11336	in	_	
76-34	11337-11342	total	_	
76-35	11342-11343	)	_	
76-36	11343-11344	.	_	

#Text=The BOLD time series for each face condition was realized by concatenating the BOLD signal from the corresponding blocks.
77-1	11345-11348	The	_	
77-2	11349-11353	BOLD	_	
77-3	11354-11358	time	_	
77-4	11359-11365	series	_	
77-5	11366-11369	for	_	
77-6	11370-11374	each	_	
77-7	11375-11379	face	_	
77-8	11380-11389	condition	_	
77-9	11390-11393	was	_	
77-10	11394-11402	realized	_	
77-11	11403-11405	by	_	
77-12	11406-11419	concatenating	_	
77-13	11420-11423	the	_	
77-14	11424-11428	BOLD	_	
77-15	11429-11435	signal	_	
77-16	11436-11440	from	_	
77-17	11441-11444	the	_	
77-18	11445-11458	corresponding	_	
77-19	11459-11465	blocks	_	
77-20	11465-11466	.	_	

#Text=Nuisance covariates including white matter signals, and cerebrospinal fluid signals, and 6 motion parameters were regressed out from the BOLD signals.
78-1	11467-11475	Nuisance	_	
78-2	11476-11486	covariates	_	
78-3	11487-11496	including	_	
78-4	11497-11502	white	_	
78-5	11503-11509	matter	_	
78-6	11510-11517	signals	_	
78-7	11517-11518	,	_	
78-8	11519-11522	and	_	
78-9	11523-11536	cerebrospinal	_	
78-10	11537-11542	fluid	_	
78-11	11543-11550	signals	_	
78-12	11550-11551	,	_	
78-13	11552-11555	and	_	
78-14	11556-11557	6	_	
78-15	11558-11564	motion	_	
78-16	11565-11575	parameters	_	
78-17	11576-11580	were	_	
78-18	11581-11590	regressed	_	
78-19	11591-11594	out	_	
78-20	11595-11599	from	_	
78-21	11600-11603	the	_	
78-22	11604-11608	BOLD	_	
78-23	11609-11616	signals	_	
78-24	11616-11617	.	_	

#Text=For each group, we then created mean 25 × 25 correlation matrices for the BOLD signal by averaging Pearson correlation coefficients between each pair of ROIs.
79-1	11618-11621	For	_	
79-2	11622-11626	each	_	
79-3	11627-11632	group	_	
79-4	11632-11633	,	_	
79-5	11634-11636	we	_	
79-6	11637-11641	then	_	
79-7	11642-11649	created	_	
79-8	11650-11654	mean	_	
79-9	11655-11657	25	_	
79-10	11658-11659	×	_	
79-11	11660-11662	25	_	
79-12	11663-11674	correlation	_	
79-13	11675-11683	matrices	_	
79-14	11684-11687	for	_	
79-15	11688-11691	the	_	
79-16	11692-11696	BOLD	_	
79-17	11697-11703	signal	_	
79-18	11704-11706	by	_	
79-19	11707-11716	averaging	_	
79-20	11717-11724	Pearson	_	
79-21	11725-11736	correlation	_	
79-22	11737-11749	coefficients	_	
79-23	11750-11757	between	_	
79-24	11758-11762	each	_	
79-25	11763-11767	pair	_	
79-26	11768-11770	of	_	
79-27	11771-11775	ROIs	_	
79-28	11775-11776	.	_	

#Text=Group comparisons of fMRI data were conducted using these average correlation matrices.
80-1	11777-11782	Group	_	
80-2	11783-11794	comparisons	_	
80-3	11795-11797	of	_	
80-4	11798-11802	fMRI	_	
80-5	11803-11807	data	_	
80-6	11808-11812	were	_	
80-7	11813-11822	conducted	_	
80-8	11823-11828	using	_	
80-9	11829-11834	these	_	
80-10	11835-11842	average	_	
80-11	11843-11854	correlation	_	
80-12	11855-11863	matrices	_	
80-13	11863-11864	.	_	

#Text=(a) Workflow of processing of functional magnetic resonance imaging (fMRI) and structural data.
81-1	11865-11866	(	_	
81-2	11866-11867	a	_	
81-3	11867-11868	)	_	
81-4	11869-11877	Workflow	_	
81-5	11878-11880	of	_	
81-6	11881-11891	processing	_	
81-7	11892-11894	of	_	
81-8	11895-11905	functional	_	
81-9	11906-11914	magnetic	_	
81-10	11915-11924	resonance	_	
81-11	11925-11932	imaging	_	
81-12	11933-11934	(	_	
81-13	11934-11938	fMRI	_	
81-14	11938-11939	)	_	
81-15	11940-11943	and	_	
81-16	11944-11954	structural	_	
81-17	11955-11959	data	_	
81-18	11959-11960	.	_	

#Text=(b) Regions used for the core and other face-processing regions, and “links” (ie, interregional correlation coefficients) of these systems.
82-1	11961-11962	(	_	
82-2	11962-11963	b	_	
82-3	11963-11964	)	_	
82-4	11965-11972	Regions	_	
82-5	11973-11977	used	_	
82-6	11978-11981	for	_	
82-7	11982-11985	the	_	
82-8	11986-11990	core	_	
82-9	11991-11994	and	_	
82-10	11995-12000	other	_	
82-11	12001-12016	face-processing	_	
82-12	12017-12024	regions	_	
82-13	12024-12025	,	_	
82-14	12026-12029	and	_	
82-15	12030-12031	“	_	
82-16	12031-12036	links	_	
82-17	12036-12037	”	_	
82-18	12038-12039	(	_	
82-19	12039-12041	ie	_	
82-20	12041-12042	,	_	
82-21	12043-12056	interregional	_	
82-22	12057-12068	correlation	_	
82-23	12069-12081	coefficients	_	
82-24	12081-12082	)	_	
82-25	12083-12085	of	_	
82-26	12086-12091	these	_	
82-27	12092-12099	systems	_	
82-28	12099-12100	.	_	

#Text=ROI, region of interest.
83-1	12101-12104	ROI	_	
83-2	12104-12105	,	_	
83-3	12106-12112	region	_	
83-4	12113-12115	of	_	
83-5	12116-12124	interest	_	
83-6	12124-12125	.	_	

#Text=Structural data were analyzed as follows (figure 2).
84-1	12126-12136	Structural	_	
84-2	12137-12141	data	_	
84-3	12142-12146	were	_	
84-4	12147-12155	analyzed	_	
84-5	12156-12158	as	_	
84-6	12159-12166	follows	_	
84-7	12167-12168	(	_	
84-8	12168-12174	figure	_	
84-9	12175-12176	2	_	
84-10	12176-12177	)	_	
84-11	12177-12178	.	_	

#Text=T1-weighted MRI scans were used to measure regional gray matter volume and were processed using FSL’s optimized voxel-based morphometry pipeline.
85-1	12179-12181	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[7]	
85-2	12181-12182	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[7]	
85-3	12182-12190	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[7]	
85-4	12191-12194	MRI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[7]	
85-5	12195-12200	scans	_	
85-6	12201-12205	were	_	
85-7	12206-12210	used	_	
85-8	12211-12213	to	_	
85-9	12214-12221	measure	_	
85-10	12222-12230	regional	_	
85-11	12231-12235	gray	_	
85-12	12236-12242	matter	_	
85-13	12243-12249	volume	_	
85-14	12250-12253	and	_	
85-15	12254-12258	were	_	
85-16	12259-12268	processed	_	
85-17	12269-12274	using	_	
85-18	12275-12278	FSL	_	
85-19	12278-12279	’	_	
85-20	12279-12280	s	_	
85-21	12281-12290	optimized	_	
85-22	12291-12302	voxel-based	_	
85-23	12303-12314	morphometry	_	
85-24	12315-12323	pipeline	_	
85-25	12323-12324	.	_	

#Text=From each of the 25 ROIs, we extracted the gray matter volume for each participant.
86-1	12325-12329	From	_	
86-2	12330-12334	each	_	
86-3	12335-12337	of	_	
86-4	12338-12341	the	_	
86-5	12342-12344	25	_	
86-6	12345-12349	ROIs	_	
86-7	12349-12350	,	_	
86-8	12351-12353	we	_	
86-9	12354-12363	extracted	_	
86-10	12364-12367	the	_	
86-11	12368-12372	gray	_	
86-12	12373-12379	matter	_	
86-13	12380-12386	volume	_	
86-14	12387-12390	for	_	
86-15	12391-12395	each	_	
86-16	12396-12407	participant	_	
86-17	12407-12408	.	_	

#Text=For each group, we created 25 × 25 correlation matrices of gray matter data by correlating participants’ gray matter volume across the 25 ROIs.
87-1	12409-12412	For	_	
87-2	12413-12417	each	_	
87-3	12418-12423	group	_	
87-4	12423-12424	,	_	
87-5	12425-12427	we	_	
87-6	12428-12435	created	_	
87-7	12436-12438	25	_	
87-8	12439-12440	×	_	
87-9	12441-12443	25	_	
87-10	12444-12455	correlation	_	
87-11	12456-12464	matrices	_	
87-12	12465-12467	of	_	
87-13	12468-12472	gray	_	
87-14	12473-12479	matter	_	
87-15	12480-12484	data	_	
87-16	12485-12487	by	_	
87-17	12488-12499	correlating	_	
87-18	12500-12512	participants	_	
87-19	12512-12513	’	_	
87-20	12514-12518	gray	_	
87-21	12519-12525	matter	_	
87-22	12526-12532	volume	_	
87-23	12533-12539	across	_	
87-24	12540-12543	the	_	
87-25	12544-12546	25	_	
87-26	12547-12551	ROIs	_	
87-27	12551-12552	.	_	

#Text=Group comparisons were conducted using these average correlation matrices of interregional gray matter volume.
88-1	12553-12558	Group	_	
88-2	12559-12570	comparisons	_	
88-3	12571-12575	were	_	
88-4	12576-12585	conducted	_	
88-5	12586-12591	using	_	
88-6	12592-12597	these	_	
88-7	12598-12605	average	_	
88-8	12606-12617	correlation	_	
88-9	12618-12626	matrices	_	
88-10	12627-12629	of	_	
88-11	12630-12643	interregional	_	
88-12	12644-12648	gray	_	
88-13	12649-12655	matter	_	
88-14	12656-12662	volume	_	
88-15	12662-12663	.	_	

#Text=Statistical Analyses
#Text=For statistical analyses, we used R (http://cran.r-project.org), version 3.4.0.
89-1	12664-12675	Statistical	_	
89-2	12676-12684	Analyses	_	
89-3	12685-12688	For	_	
89-4	12689-12700	statistical	_	
89-5	12701-12709	analyses	_	
89-6	12709-12710	,	_	
89-7	12711-12713	we	_	
89-8	12714-12718	used	_	
89-9	12719-12720	R	_	
89-10	12721-12722	(	_	
89-11	12722-12726	http	_	
89-12	12726-12727	:	_	
89-13	12727-12728	/	_	
89-14	12728-12729	/	_	
89-15	12729-12747	cran.r-project.org	_	
89-16	12747-12748	)	_	
89-17	12748-12749	,	_	
89-18	12750-12757	version	_	
89-19	12758-12763	3.4.0	_	
89-20	12763-12764	.	_	

#Text=Data were visually inspected to check for normality.
90-1	12765-12769	Data	_	
90-2	12770-12774	were	_	
90-3	12775-12783	visually	_	
90-4	12784-12793	inspected	_	
90-5	12794-12796	to	_	
90-6	12797-12802	check	_	
90-7	12803-12806	for	_	
90-8	12807-12816	normality	_	
90-9	12816-12817	.	_	

#Text=If necessary, we used Box–Cox power transformation on the data to fulfill the normality criteria.
91-1	12818-12820	If	_	
91-2	12821-12830	necessary	_	
91-3	12830-12831	,	_	
91-4	12832-12834	we	_	
91-5	12835-12839	used	_	
91-6	12840-12847	Box–Cox	_	
91-7	12848-12853	power	_	
91-8	12854-12868	transformation	_	
91-9	12869-12871	on	_	
91-10	12872-12875	the	_	
91-11	12876-12880	data	_	
91-12	12881-12883	to	_	
91-13	12884-12891	fulfill	_	
91-14	12892-12895	the	_	
91-15	12896-12905	normality	_	
91-16	12906-12914	criteria	_	
91-17	12914-12915	.	_	

#Text=ANOVA, linear regression, linear mixed model, logistic regression, Pearson correlation, and t tests were used as specified in “Results” section.
92-1	12916-12921	ANOVA	_	
92-2	12921-12922	,	_	
92-3	12923-12929	linear	_	
92-4	12930-12940	regression	_	
92-5	12940-12941	,	_	
92-6	12942-12948	linear	_	
92-7	12949-12954	mixed	_	
92-8	12955-12960	model	_	
92-9	12960-12961	,	_	
92-10	12962-12970	logistic	_	
92-11	12971-12981	regression	_	
92-12	12981-12982	,	_	
92-13	12983-12990	Pearson	_	
92-14	12991-13002	correlation	_	
92-15	13002-13003	,	_	
92-16	13004-13007	and	_	
92-17	13008-13009	t	_	
92-18	13010-13015	tests	_	
92-19	13016-13020	were	_	
92-20	13021-13025	used	_	
92-21	13026-13028	as	_	
92-22	13029-13038	specified	_	
92-23	13039-13041	in	_	
92-24	13042-13043	“	_	
92-25	13043-13050	Results	_	
92-26	13050-13051	”	_	
92-27	13052-13059	section	_	
92-28	13059-13060	.	_	

#Text=Results are visualized with BrainNet Viewer, gplots, and the pirateplot.
93-1	13061-13068	Results	_	
93-2	13069-13072	are	_	
93-3	13073-13083	visualized	_	
93-4	13084-13088	with	_	
93-5	13089-13097	BrainNet	_	
93-6	13098-13104	Viewer	_	
93-7	13104-13105	,	_	
93-8	13106-13112	gplots	_	
93-9	13112-13113	,	_	
93-10	13114-13117	and	_	
93-11	13118-13121	the	_	
93-12	13122-13132	pirateplot	_	
93-13	13132-13133	.	_	

#Text=The interregional correlation coefficients were estimated in the each groups’ average correlation matrices.
94-1	13134-13137	The	_	
94-2	13138-13151	interregional	_	
94-3	13152-13163	correlation	_	
94-4	13164-13176	coefficients	_	
94-5	13177-13181	were	_	
94-6	13182-13191	estimated	_	
94-7	13192-13194	in	_	
94-8	13195-13198	the	_	
94-9	13199-13203	each	_	
94-10	13204-13210	groups	_	
94-11	13210-13211	’	_	
94-12	13212-13219	average	_	
94-13	13220-13231	correlation	_	
94-14	13232-13240	matrices	_	
94-15	13240-13241	.	_	

#Text=Note, therefore, that we conducted the following group comparisons at the level of average correlation coefficients of each group.
95-1	13242-13246	Note	_	
95-2	13246-13247	,	_	
95-3	13248-13257	therefore	_	
95-4	13257-13258	,	_	
95-5	13259-13263	that	_	
95-6	13264-13266	we	_	
95-7	13267-13276	conducted	_	
95-8	13277-13280	the	_	
95-9	13281-13290	following	_	
95-10	13291-13296	group	_	
95-11	13297-13308	comparisons	_	
95-12	13309-13311	at	_	
95-13	13312-13315	the	_	
95-14	13316-13321	level	_	
95-15	13322-13324	of	_	
95-16	13325-13332	average	_	
95-17	13333-13344	correlation	_	
95-18	13345-13357	coefficients	_	
95-19	13358-13360	of	_	
95-20	13361-13365	each	_	
95-21	13366-13371	group	_	
95-22	13371-13372	.	_	

#Text=The group comparisons were carried out separately for BOLD signal (discovery sample) and gray matter volume data (discovery and replication sample).
96-1	13373-13376	The	_	
96-2	13377-13382	group	_	
96-3	13383-13394	comparisons	_	
96-4	13395-13399	were	_	
96-5	13400-13407	carried	_	
96-6	13408-13411	out	_	
96-7	13412-13422	separately	_	
96-8	13423-13426	for	_	
96-9	13427-13431	BOLD	_	
96-10	13432-13438	signal	_	
96-11	13439-13440	(	_	
96-12	13440-13449	discovery	_	
96-13	13450-13456	sample	_	
96-14	13456-13457	)	_	
96-15	13458-13461	and	_	
96-16	13462-13466	gray	_	
96-17	13467-13473	matter	_	
96-18	13474-13480	volume	_	
96-19	13481-13485	data	_	
96-20	13486-13487	(	_	
96-21	13487-13496	discovery	_	
96-22	13497-13500	and	_	
96-23	13501-13512	replication	_	
96-24	13513-13519	sample	_	
96-25	13519-13520	)	_	
96-26	13520-13521	.	_	

#Text=Correlation coefficients in each groups’ average correlation matrices were converted with Fisher r to z before statistical comparisons.
97-1	13522-13533	Correlation	_	
97-2	13534-13546	coefficients	_	
97-3	13547-13549	in	_	
97-4	13550-13554	each	_	
97-5	13555-13561	groups	_	
97-6	13561-13562	’	_	
97-7	13563-13570	average	_	
97-8	13571-13582	correlation	_	
97-9	13583-13591	matrices	_	
97-10	13592-13596	were	_	
97-11	13597-13606	converted	_	
97-12	13607-13611	with	_	
97-13	13612-13618	Fisher	_	
97-14	13619-13620	r	_	
97-15	13621-13623	to	_	
97-16	13624-13625	z	_	
97-17	13626-13632	before	_	
97-18	13633-13644	statistical	_	
97-19	13645-13656	comparisons	_	
97-20	13656-13657	.	_	

#Text=To analyze the PRS-related differences in interregional correlations, we used the following analytical strategy.
98-1	13658-13660	To	_	
98-2	13661-13668	analyze	_	
98-3	13669-13672	the	_	
98-4	13673-13684	PRS-related	_	
98-5	13685-13696	differences	_	
98-6	13697-13699	in	_	
98-7	13700-13713	interregional	_	
98-8	13714-13726	correlations	_	
98-9	13726-13727	,	_	
98-10	13728-13730	we	_	
98-11	13731-13735	used	_	
98-12	13736-13739	the	_	
98-13	13740-13749	following	_	
98-14	13750-13760	analytical	_	
98-15	13761-13769	strategy	_	
98-16	13769-13770	.	_	

#Text=First, we compared study groups for the mean of 300 pair-wise correlation coefficients (obtained from each groups’ average correlation matrices) using unpaired t test.
99-1	13771-13776	First	_	
99-2	13776-13777	,	_	
99-3	13778-13780	we	_	
99-4	13781-13789	compared	_	
99-5	13790-13795	study	_	
99-6	13796-13802	groups	_	
99-7	13803-13806	for	_	
99-8	13807-13810	the	_	
99-9	13811-13815	mean	_	
99-10	13816-13818	of	_	
99-11	13819-13822	300	_	
99-12	13823-13832	pair-wise	_	
99-13	13833-13844	correlation	_	
99-14	13845-13857	coefficients	_	
99-15	13858-13859	(	_	
99-16	13859-13867	obtained	_	
99-17	13868-13872	from	_	
99-18	13873-13877	each	_	
99-19	13878-13884	groups	_	
99-20	13884-13885	’	_	
99-21	13886-13893	average	_	
99-22	13894-13905	correlation	_	
99-23	13906-13914	matrices	_	
99-24	13914-13915	)	_	
99-25	13916-13921	using	_	
99-26	13922-13930	unpaired	_	
99-27	13931-13932	t	_	
99-28	13933-13937	test	_	
99-29	13937-13938	.	_	

#Text=Statistical significance was considered at P value of <.05 as we test here the average of all the interregional correlation coefficients within the face-processing network.
100-1	13939-13950	Statistical	_	
100-2	13951-13963	significance	_	
100-3	13964-13967	was	_	
100-4	13968-13978	considered	_	
100-5	13979-13981	at	_	
100-6	13982-13983	P	_	
100-7	13984-13989	value	_	
100-8	13990-13992	of	_	
100-9	13993-13994	<	_	
100-10	13994-13997	.05	_	
100-11	13998-14000	as	_	
100-12	14001-14003	we	_	
100-13	14004-14008	test	_	
100-14	14009-14013	here	_	
100-15	14014-14017	the	_	
100-16	14018-14025	average	_	
100-17	14026-14028	of	_	
100-18	14029-14032	all	_	
100-19	14033-14036	the	_	
100-20	14037-14050	interregional	_	
100-21	14051-14062	correlation	_	
100-22	14063-14075	coefficients	_	
100-23	14076-14082	within	_	
100-24	14083-14086	the	_	
100-25	14087-14102	face-processing	_	
100-26	14103-14110	network	_	
100-27	14110-14111	.	_	

#Text=Second, if this comparison was significant, we compared study groups’ average correlation matrices for the mean correlation coefficients: (1) between the core and the other face-processing regions (mean of 114 pair-wise correlations) and (2) within the core regions of face processing (mean of 15 pair-wise correlations).
101-1	14112-14118	Second	_	
101-2	14118-14119	,	_	
101-3	14120-14122	if	_	
101-4	14123-14127	this	_	
101-5	14128-14138	comparison	_	
101-6	14139-14142	was	_	
101-7	14143-14154	significant	_	
101-8	14154-14155	,	_	
101-9	14156-14158	we	_	
101-10	14159-14167	compared	_	
101-11	14168-14173	study	_	
101-12	14174-14180	groups	_	
101-13	14180-14181	’	_	
101-14	14182-14189	average	_	
101-15	14190-14201	correlation	_	
101-16	14202-14210	matrices	_	
101-17	14211-14214	for	_	
101-18	14215-14218	the	_	
101-19	14219-14223	mean	_	
101-20	14224-14235	correlation	_	
101-21	14236-14248	coefficients	_	
101-22	14248-14249	:	_	
101-23	14250-14251	(	_	
101-24	14251-14252	1	_	
101-25	14252-14253	)	_	
101-26	14254-14261	between	_	
101-27	14262-14265	the	_	
101-28	14266-14270	core	_	
101-29	14271-14274	and	_	
101-30	14275-14278	the	_	
101-31	14279-14284	other	_	
101-32	14285-14300	face-processing	_	
101-33	14301-14308	regions	_	
101-34	14309-14310	(	_	
101-35	14310-14314	mean	_	
101-36	14315-14317	of	_	
101-37	14318-14321	114	_	
101-38	14322-14331	pair-wise	_	
101-39	14332-14344	correlations	_	
101-40	14344-14345	)	_	
101-41	14346-14349	and	_	
101-42	14350-14351	(	_	
101-43	14351-14352	2	_	
101-44	14352-14353	)	_	
101-45	14354-14360	within	_	
101-46	14361-14364	the	_	
101-47	14365-14369	core	_	
101-48	14370-14377	regions	_	
101-49	14378-14380	of	_	
101-50	14381-14385	face	_	
101-51	14386-14396	processing	_	
101-52	14397-14398	(	_	
101-53	14398-14402	mean	_	
101-54	14403-14405	of	_	
101-55	14406-14408	15	_	
101-56	14409-14418	pair-wise	_	
101-57	14419-14431	correlations	_	
101-58	14431-14432	)	_	
101-59	14432-14433	.	_	

#Text=We defined the core system to include the lateral occipital cortex, posterior STS, and FFA (figure 2).
102-1	14434-14436	We	_	
102-2	14437-14444	defined	_	
102-3	14445-14448	the	_	
102-4	14449-14453	core	_	
102-5	14454-14460	system	_	
102-6	14461-14463	to	_	
102-7	14464-14471	include	_	
102-8	14472-14475	the	_	
102-9	14476-14483	lateral	_	
102-10	14484-14493	occipital	_	
102-11	14494-14500	cortex	_	
102-12	14500-14501	,	_	
102-13	14502-14511	posterior	_	
102-14	14512-14515	STS	_	
102-15	14515-14516	,	_	
102-16	14517-14520	and	_	
102-17	14521-14524	FFA	_	
102-18	14525-14526	(	_	
102-19	14526-14532	figure	_	
102-20	14533-14534	2	_	
102-21	14534-14535	)	_	
102-22	14535-14536	.	_	

#Text=Results
#Text=PRS and Schizophrenia in the NFBC 1986
#Text=Using data from the Finnish healthcare registers, we confirmed that the calculated PRS predicts clinically defined “broad” (1 SD increase in PRS associated with OR = 1.8, 95% CI = 1.2–2.7) and “narrow” (1 SD increase in PRS associated with OR = 2.0, 95% CI = 1.3–3.1) schizophrenia in the NFBC 1986.
103-1	14537-14544	Results	_	
103-2	14545-14548	PRS	_	
103-3	14549-14552	and	_	
103-4	14553-14566	Schizophrenia	_	
103-5	14567-14569	in	_	
103-6	14570-14573	the	_	
103-7	14574-14578	NFBC	_	
103-8	14579-14583	1986	_	
103-9	14584-14589	Using	_	
103-10	14590-14594	data	_	
103-11	14595-14599	from	_	
103-12	14600-14603	the	_	
103-13	14604-14611	Finnish	_	
103-14	14612-14622	healthcare	_	
103-15	14623-14632	registers	_	
103-16	14632-14633	,	_	
103-17	14634-14636	we	_	
103-18	14637-14646	confirmed	_	
103-19	14647-14651	that	_	
103-20	14652-14655	the	_	
103-21	14656-14666	calculated	_	
103-22	14667-14670	PRS	_	
103-23	14671-14679	predicts	_	
103-24	14680-14690	clinically	_	
103-25	14691-14698	defined	_	
103-26	14699-14700	“	_	
103-27	14700-14705	broad	_	
103-28	14705-14706	”	_	
103-29	14707-14708	(	_	
103-30	14708-14709	1	_	
103-31	14710-14712	SD	_	
103-32	14713-14721	increase	_	
103-33	14722-14724	in	_	
103-34	14725-14728	PRS	_	
103-35	14729-14739	associated	_	
103-36	14740-14744	with	_	
103-37	14745-14747	OR	_	
103-38	14748-14749	=	_	
103-39	14750-14753	1.8	_	
103-40	14753-14754	,	_	
103-41	14755-14758	95%	_	
103-42	14759-14761	CI	_	
103-43	14762-14763	=	_	
103-44	14764-14767	1.2	_	
103-45	14767-14768	–	_	
103-46	14768-14771	2.7	_	
103-47	14771-14772	)	_	
103-48	14773-14776	and	_	
103-49	14777-14778	“	_	
103-50	14778-14784	narrow	_	
103-51	14784-14785	”	_	
103-52	14786-14787	(	_	
103-53	14787-14788	1	_	
103-54	14789-14791	SD	_	
103-55	14792-14800	increase	_	
103-56	14801-14803	in	_	
103-57	14804-14807	PRS	_	
103-58	14808-14818	associated	_	
103-59	14819-14823	with	_	
103-60	14824-14826	OR	_	
103-61	14827-14828	=	_	
103-62	14829-14832	2.0	_	
103-63	14832-14833	,	_	
103-64	14834-14837	95%	_	
103-65	14838-14840	CI	_	
103-66	14841-14842	=	_	
103-67	14843-14846	1.3	_	
103-68	14846-14847	–	_	
103-69	14847-14850	3.1	_	
103-70	14850-14851	)	_	
103-71	14852-14865	schizophrenia	_	
103-72	14866-14868	in	_	
103-73	14869-14872	the	_	
103-74	14873-14877	NFBC	_	
103-75	14878-14882	1986	_	
103-76	14882-14883	.	_	

#Text=Supplementary figure S1 presents the level of PRS in the NFBC 1986.
104-1	14884-14897	Supplementary	_	
104-2	14898-14904	figure	_	
104-3	14905-14907	S1	_	
104-4	14908-14916	presents	_	
104-5	14917-14920	the	_	
104-6	14921-14926	level	_	
104-7	14927-14929	of	_	
104-8	14930-14933	PRS	_	
104-9	14934-14936	in	_	
104-10	14937-14940	the	_	
104-11	14941-14945	NFBC	_	
104-12	14946-14950	1986	_	
104-13	14950-14951	.	_	

#Text=Demographic Data for the Neuroimaging Subsamples
#Text=We present demographic tables for the discovery and replication samples in the supplementary material.
105-1	14952-14963	Demographic	_	
105-2	14964-14968	Data	_	
105-3	14969-14972	for	_	
105-4	14973-14976	the	_	
105-5	14977-14989	Neuroimaging	_	
105-6	14990-15000	Subsamples	_	
105-7	15001-15003	We	_	
105-8	15004-15011	present	_	
105-9	15012-15023	demographic	_	
105-10	15024-15030	tables	_	
105-11	15031-15034	for	_	
105-12	15035-15038	the	_	
105-13	15039-15048	discovery	_	
105-14	15049-15052	and	_	
105-15	15053-15064	replication	_	
105-16	15065-15072	samples	_	
105-17	15073-15075	in	_	
105-18	15076-15079	the	_	
105-19	15080-15093	supplementary	_	
105-20	15094-15102	material	_	
105-21	15102-15103	.	_	

#Text=There were no PRS-related differences in age, sex, intelligence quotient, body mass index, reporting of TADS, alcohol dependency (Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders [Fourth Edition] Axis I disorders), smoking, prodromal syndrome, the parental risk of psychosis, and exposure to maternal cigarette smoking.
106-1	15104-15109	There	_	
106-2	15110-15114	were	_	
106-3	15115-15117	no	_	
106-4	15118-15129	PRS-related	_	
106-5	15130-15141	differences	_	
106-6	15142-15144	in	_	
106-7	15145-15148	age	_	
106-8	15148-15149	,	_	
106-9	15150-15153	sex	_	
106-10	15153-15154	,	_	
106-11	15155-15167	intelligence	_	
106-12	15168-15176	quotient	_	
106-13	15176-15177	,	_	
106-14	15178-15182	body	_	
106-15	15183-15187	mass	_	
106-16	15188-15193	index	_	
106-17	15193-15194	,	_	
106-18	15195-15204	reporting	_	
106-19	15205-15207	of	_	
106-20	15208-15212	TADS	_	
106-21	15212-15213	,	_	
106-22	15214-15221	alcohol	_	
106-23	15222-15232	dependency	_	
106-24	15233-15234	(	_	
106-25	15234-15244	Structured	_	
106-26	15245-15253	Clinical	_	
106-27	15254-15263	Interview	_	
106-28	15264-15267	for	_	
106-29	15268-15278	Diagnostic	_	
106-30	15279-15282	and	_	
106-31	15283-15294	Statistical	_	
106-32	15295-15301	Manual	_	
106-33	15302-15304	of	_	
106-34	15305-15311	Mental	_	
106-35	15312-15321	Disorders	_	
106-36	15322-15323	[	_	
106-37	15323-15329	Fourth	_	
106-38	15330-15337	Edition	_	
106-39	15337-15338	]	_	
106-40	15339-15343	Axis	_	
106-41	15344-15345	I	_	
106-42	15346-15355	disorders	_	
106-43	15355-15356	)	_	
106-44	15356-15357	,	_	
106-45	15358-15365	smoking	_	
106-46	15365-15366	,	_	
106-47	15367-15376	prodromal	_	
106-48	15377-15385	syndrome	_	
106-49	15385-15386	,	_	
106-50	15387-15390	the	_	
106-51	15391-15399	parental	_	
106-52	15400-15404	risk	_	
106-53	15405-15407	of	_	
106-54	15408-15417	psychosis	_	
106-55	15417-15418	,	_	
106-56	15419-15422	and	_	
106-57	15423-15431	exposure	_	
106-58	15432-15434	to	_	
106-59	15435-15443	maternal	_	
106-60	15444-15453	cigarette	_	
106-61	15454-15461	smoking	_	
106-62	15461-15462	.	_	

#Text=Internal consistency of TADS was acceptable (Cronbach’s α > .7) in both the discovery and the replication samples: 0.76 and 0.79, respectively.
107-1	15463-15471	Internal	_	
107-2	15472-15483	consistency	_	
107-3	15484-15486	of	_	
107-4	15487-15491	TADS	_	
107-5	15492-15495	was	_	
107-6	15496-15506	acceptable	_	
107-7	15507-15508	(	_	
107-8	15508-15516	Cronbach	_	
107-9	15516-15517	’	_	
107-10	15517-15518	s	_	
107-11	15519-15520	α	_	
107-12	15521-15522	>	_	
107-13	15523-15525	.7	_	
107-14	15525-15526	)	_	
107-15	15527-15529	in	_	
107-16	15530-15534	both	_	
107-17	15535-15538	the	_	
107-18	15539-15548	discovery	_	
107-19	15549-15552	and	_	
107-20	15553-15556	the	_	
107-21	15557-15568	replication	_	
107-22	15569-15576	samples	_	
107-23	15576-15577	:	_	
107-24	15578-15582	0.76	_	
107-25	15583-15586	and	_	
107-26	15587-15591	0.79	_	
107-27	15591-15592	,	_	
107-28	15593-15605	respectively	_	
107-29	15605-15606	.	_	

#Text=The Interregional Similarity in BOLD Signal (Discovery Sample)
#Text= Figure 3 provides correlation matrices and interregional pair-wise correlations for “high” and “low” PRS.
108-1	15607-15610	The	_	
108-2	15611-15624	Interregional	_	
108-3	15625-15635	Similarity	_	
108-4	15636-15638	in	_	
108-5	15639-15643	BOLD	_	
108-6	15644-15650	Signal	_	
108-7	15651-15652	(	_	
108-8	15652-15661	Discovery	_	
108-9	15662-15668	Sample	_	
108-10	15668-15669	)	_	
108-11	15671-15677	Figure	_	
108-12	15678-15679	3	_	
108-13	15680-15688	provides	_	
108-14	15689-15700	correlation	_	
108-15	15701-15709	matrices	_	
108-16	15710-15713	and	_	
108-17	15714-15727	interregional	_	
108-18	15728-15737	pair-wise	_	
108-19	15738-15750	correlations	_	
108-20	15751-15754	for	_	
108-21	15755-15756	“	_	
108-22	15756-15760	high	_	
108-23	15760-15761	”	_	
108-24	15762-15765	and	_	
108-25	15766-15767	“	_	
108-26	15767-15770	low	_	
108-27	15770-15771	”	_	
108-28	15772-15775	PRS	_	
108-29	15775-15776	.	_	

#Text=For happy facial expressions, we did not find any associations between PRS and mean interregional correlation coefficients in the BOLD signal (“high” vs “low” PRS, t test, P = .46, Cohen’s d = 0.06).
109-1	15777-15780	For	_	
109-2	15781-15786	happy	_	
109-3	15787-15793	facial	_	
109-4	15794-15805	expressions	_	
109-5	15805-15806	,	_	
109-6	15807-15809	we	_	
109-7	15810-15813	did	_	
109-8	15814-15817	not	_	
109-9	15818-15822	find	_	
109-10	15823-15826	any	_	
109-11	15827-15839	associations	_	
109-12	15840-15847	between	_	
109-13	15848-15851	PRS	_	
109-14	15852-15855	and	_	
109-15	15856-15860	mean	_	
109-16	15861-15874	interregional	_	
109-17	15875-15886	correlation	_	
109-18	15887-15899	coefficients	_	
109-19	15900-15902	in	_	
109-20	15903-15906	the	_	
109-21	15907-15911	BOLD	_	
109-22	15912-15918	signal	_	
109-23	15919-15920	(	_	
109-24	15920-15921	“	_	
109-25	15921-15925	high	_	
109-26	15925-15926	”	_	
109-27	15927-15929	vs	_	
109-28	15930-15931	“	_	
109-29	15931-15934	low	_	
109-30	15934-15935	”	_	
109-31	15936-15939	PRS	_	
109-32	15939-15940	,	_	
109-33	15941-15942	t	_	
109-34	15943-15947	test	_	
109-35	15947-15948	,	_	
109-36	15949-15950	P	_	
109-37	15951-15952	=	_	
109-38	15953-15956	.46	_	
109-39	15956-15957	,	_	
109-40	15958-15963	Cohen	_	
109-41	15963-15964	’	_	
109-42	15964-15965	s	_	
109-43	15966-15967	d	_	
109-44	15968-15969	=	_	
109-45	15970-15974	0.06	_	
109-46	15974-15975	)	_	
109-47	15975-15976	.	_	

#Text=For fearful faces, interregional similarities in the BOLD signal differed between “high” and “low” PRS groups (t test, P = .04, Cohen’s d = 0.17); the lowest interregional pair-wise correlation was observed in “high” PRS.
110-1	15977-15980	For	_	
110-2	15981-15988	fearful	_	
110-3	15989-15994	faces	_	
110-4	15994-15995	,	_	
110-5	15996-16009	interregional	_	
110-6	16010-16022	similarities	_	
110-7	16023-16025	in	_	
110-8	16026-16029	the	_	
110-9	16030-16034	BOLD	_	
110-10	16035-16041	signal	_	
110-11	16042-16050	differed	_	
110-12	16051-16058	between	_	
110-13	16059-16060	“	_	
110-14	16060-16064	high	_	
110-15	16064-16065	”	_	
110-16	16066-16069	and	_	
110-17	16070-16071	“	_	
110-18	16071-16074	low	_	
110-19	16074-16075	”	_	
110-20	16076-16079	PRS	_	
110-21	16080-16086	groups	_	
110-22	16087-16088	(	_	
110-23	16088-16089	t	_	
110-24	16090-16094	test	_	
110-25	16094-16095	,	_	
110-26	16096-16097	P	_	
110-27	16098-16099	=	_	
110-28	16100-16103	.04	_	
110-29	16103-16104	,	_	
110-30	16105-16110	Cohen	_	
110-31	16110-16111	’	_	
110-32	16111-16112	s	_	
110-33	16113-16114	d	_	
110-34	16115-16116	=	_	
110-35	16117-16121	0.17	_	
110-36	16121-16122	)	_	
110-37	16122-16123	;	_	
110-38	16124-16127	the	_	
110-39	16128-16134	lowest	_	
110-40	16135-16148	interregional	_	
110-41	16149-16158	pair-wise	_	
110-42	16159-16170	correlation	_	
110-43	16171-16174	was	_	
110-44	16175-16183	observed	_	
110-45	16184-16186	in	_	
110-46	16187-16188	“	_	
110-47	16188-16192	high	_	
110-48	16192-16193	”	_	
110-49	16194-16197	PRS	_	
110-50	16197-16198	.	_	

#Text=(a) Correlation matrices for fMRI data.
111-1	16199-16200	(	_	
111-2	16200-16201	a	_	
111-3	16201-16202	)	_	
111-4	16203-16214	Correlation	_	
111-5	16215-16223	matrices	_	
111-6	16224-16227	for	_	
111-7	16228-16232	fMRI	_	
111-8	16233-16237	data	_	
111-9	16237-16238	.	_	

#Text=Abbreviations: mid-ventrolateral frontal cortex (MVLFC), mid-dorsolateral frontal cortex (MDLFC), premotor cortex (PMC), pre-supplementary motor area (PreSMA), superior temporal sulcus (STS), fusiform face area (FFA), lateral occipital cortex (LOC), left (L), right (R), anterior (Ant), posterior (Post).
112-1	16239-16252	Abbreviations	_	
112-2	16252-16253	:	_	
112-3	16254-16271	mid-ventrolateral	_	
112-4	16272-16279	frontal	_	
112-5	16280-16286	cortex	_	
112-6	16287-16288	(	_	
112-7	16288-16293	MVLFC	_	
112-8	16293-16294	)	_	
112-9	16294-16295	,	_	
112-10	16296-16312	mid-dorsolateral	_	
112-11	16313-16320	frontal	_	
112-12	16321-16327	cortex	_	
112-13	16328-16329	(	_	
112-14	16329-16334	MDLFC	_	
112-15	16334-16335	)	_	
112-16	16335-16336	,	_	
112-17	16337-16345	premotor	_	
112-18	16346-16352	cortex	_	
112-19	16353-16354	(	_	
112-20	16354-16357	PMC	_	
112-21	16357-16358	)	_	
112-22	16358-16359	,	_	
112-23	16360-16377	pre-supplementary	_	
112-24	16378-16383	motor	_	
112-25	16384-16388	area	_	
112-26	16389-16390	(	_	
112-27	16390-16396	PreSMA	_	
112-28	16396-16397	)	_	
112-29	16397-16398	,	_	
112-30	16399-16407	superior	_	
112-31	16408-16416	temporal	_	
112-32	16417-16423	sulcus	_	
112-33	16424-16425	(	_	
112-34	16425-16428	STS	_	
112-35	16428-16429	)	_	
112-36	16429-16430	,	_	
112-37	16431-16439	fusiform	_	
112-38	16440-16444	face	_	
112-39	16445-16449	area	_	
112-40	16450-16451	(	_	
112-41	16451-16454	FFA	_	
112-42	16454-16455	)	_	
112-43	16455-16456	,	_	
112-44	16457-16464	lateral	_	
112-45	16465-16474	occipital	_	
112-46	16475-16481	cortex	_	
112-47	16482-16483	(	_	
112-48	16483-16486	LOC	_	
112-49	16486-16487	)	_	
112-50	16487-16488	,	_	
112-51	16489-16493	left	_	
112-52	16494-16495	(	_	
112-53	16495-16496	L	_	
112-54	16496-16497	)	_	
112-55	16497-16498	,	_	
112-56	16499-16504	right	_	
112-57	16505-16506	(	_	
112-58	16506-16507	R	_	
112-59	16507-16508	)	_	
112-60	16508-16509	,	_	
112-61	16510-16518	anterior	_	
112-62	16519-16520	(	_	
112-63	16520-16523	Ant	_	
112-64	16523-16524	)	_	
112-65	16524-16525	,	_	
112-66	16526-16535	posterior	_	
112-67	16536-16537	(	_	
112-68	16537-16541	Post	_	
112-69	16541-16542	)	_	
112-70	16542-16543	.	_	

#Text=(b) Interregional similarities in blood oxygen level–dependent (BOLD) fMRI signal during happy and fearful facial expressions and dynamic mosaic (control stimulus).
113-1	16544-16545	(	_	
113-2	16545-16546	b	_	
113-3	16546-16547	)	_	
113-4	16548-16561	Interregional	_	
113-5	16562-16574	similarities	_	
113-6	16575-16577	in	_	
113-7	16578-16583	blood	_	
113-8	16584-16590	oxygen	_	
113-9	16591-16606	level–dependent	_	
113-10	16607-16608	(	_	
113-11	16608-16612	BOLD	_	
113-12	16612-16613	)	_	
113-13	16614-16618	fMRI	_	
113-14	16619-16625	signal	_	
113-15	16626-16632	during	_	
113-16	16633-16638	happy	_	
113-17	16639-16642	and	_	
113-18	16643-16650	fearful	_	
113-19	16651-16657	facial	_	
113-20	16658-16669	expressions	_	
113-21	16670-16673	and	_	
113-22	16674-16681	dynamic	_	
113-23	16682-16688	mosaic	_	
113-24	16689-16690	(	_	
113-25	16690-16697	control	_	
113-26	16698-16706	stimulus	_	
113-27	16706-16707	)	_	
113-28	16707-16708	.	_	

#Text=Asterisk represents statistical significance (P < .05).
114-1	16709-16717	Asterisk	_	
114-2	16718-16728	represents	_	
114-3	16729-16740	statistical	_	
114-4	16741-16753	significance	_	
114-5	16754-16755	(	_	
114-6	16755-16756	P	_	
114-7	16757-16758	<	_	
114-8	16759-16762	.05	_	
114-9	16762-16763	)	_	
114-10	16763-16764	.	_	

#Text=PRS, polygenic risk score; ROI, region of interest.
115-1	16765-16768	PRS	_	
115-2	16768-16769	,	_	
115-3	16770-16779	polygenic	_	
115-4	16780-16784	risk	_	
115-5	16785-16790	score	_	
115-6	16790-16791	;	_	
115-7	16792-16795	ROI	_	
115-8	16795-16796	,	_	
115-9	16797-16803	region	_	
115-10	16804-16806	of	_	
115-11	16807-16815	interest	_	
115-12	16815-16816	.	_	

#Text=The mean correlation in BOLD signal across the core and the other face-processing regions also varied as a function of the PRS; the lowest correlation was observed in the high PRS (“high” vs “low,” t test, P = .03, Cohen’s d = 0.28).
116-1	16817-16820	The	_	
116-2	16821-16825	mean	_	
116-3	16826-16837	correlation	_	
116-4	16838-16840	in	_	
116-5	16841-16845	BOLD	_	
116-6	16846-16852	signal	_	
116-7	16853-16859	across	_	
116-8	16860-16863	the	_	
116-9	16864-16868	core	_	
116-10	16869-16872	and	_	
116-11	16873-16876	the	_	
116-12	16877-16882	other	_	
116-13	16883-16898	face-processing	_	
116-14	16899-16906	regions	_	
116-15	16907-16911	also	_	
116-16	16912-16918	varied	_	
116-17	16919-16921	as	_	
116-18	16922-16923	a	_	
116-19	16924-16932	function	_	
116-20	16933-16935	of	_	
116-21	16936-16939	the	_	
116-22	16940-16943	PRS	_	
116-23	16943-16944	;	_	
116-24	16945-16948	the	_	
116-25	16949-16955	lowest	_	
116-26	16956-16967	correlation	_	
116-27	16968-16971	was	_	
116-28	16972-16980	observed	_	
116-29	16981-16983	in	_	
116-30	16984-16987	the	_	
116-31	16988-16992	high	_	
116-32	16993-16996	PRS	_	
116-33	16997-16998	(	_	
116-34	16998-16999	“	_	
116-35	16999-17003	high	_	
116-36	17003-17004	”	_	
116-37	17005-17007	vs	_	
116-38	17008-17009	“	_	
116-39	17009-17012	low	_	
116-40	17012-17013	,	_	
116-41	17013-17014	”	_	
116-42	17015-17016	t	_	
116-43	17017-17021	test	_	
116-44	17021-17022	,	_	
116-45	17023-17024	P	_	
116-46	17025-17026	=	_	
116-47	17027-17030	.03	_	
116-48	17030-17031	,	_	
116-49	17032-17037	Cohen	_	
116-50	17037-17038	’	_	
116-51	17038-17039	s	_	
116-52	17040-17041	d	_	
116-53	17042-17043	=	_	
116-54	17044-17048	0.28	_	
116-55	17048-17049	)	_	
116-56	17049-17050	.	_	

#Text=There were no significant PRS-related correlation differences in BOLD signal within the core system in the discovery sample (“high” vs “low,” t test, P = .52, Cohen’s d = 0.24).
117-1	17051-17056	There	_	
117-2	17057-17061	were	_	
117-3	17062-17064	no	_	
117-4	17065-17076	significant	_	
117-5	17077-17088	PRS-related	_	
117-6	17089-17100	correlation	_	
117-7	17101-17112	differences	_	
117-8	17113-17115	in	_	
117-9	17116-17120	BOLD	_	
117-10	17121-17127	signal	_	
117-11	17128-17134	within	_	
117-12	17135-17138	the	_	
117-13	17139-17143	core	_	
117-14	17144-17150	system	_	
117-15	17151-17153	in	_	
117-16	17154-17157	the	_	
117-17	17158-17167	discovery	_	
117-18	17168-17174	sample	_	
117-19	17175-17176	(	_	
117-20	17176-17177	“	_	
117-21	17177-17181	high	_	
117-22	17181-17182	”	_	
117-23	17183-17185	vs	_	
117-24	17186-17187	“	_	
117-25	17187-17190	low	_	
117-26	17190-17191	,	_	
117-27	17191-17192	”	_	
117-28	17193-17194	t	_	
117-29	17195-17199	test	_	
117-30	17199-17200	,	_	
117-31	17201-17202	P	_	
117-32	17203-17204	=	_	
117-33	17205-17208	.52	_	
117-34	17208-17209	,	_	
117-35	17210-17215	Cohen	_	
117-36	17215-17216	’	_	
117-37	17216-17217	s	_	
117-38	17218-17219	d	_	
117-39	17220-17221	=	_	
117-40	17222-17226	0.24	_	
117-41	17226-17227	)	_	
117-42	17227-17228	.	_	

#Text=We also conducted linear mixed effects analyses of interregional correlations of the 25 ROIs to test for PRS (ie “high” vs “low”) × fMRI Stimulus interactions.
118-1	17229-17231	We	_	
118-2	17232-17236	also	_	
118-3	17237-17246	conducted	_	
118-4	17247-17253	linear	_	
118-5	17254-17259	mixed	_	
118-6	17260-17267	effects	_	
118-7	17268-17276	analyses	_	
118-8	17277-17279	of	_	
118-9	17280-17293	interregional	_	
118-10	17294-17306	correlations	_	
118-11	17307-17309	of	_	
118-12	17310-17313	the	_	
118-13	17314-17316	25	_	
118-14	17317-17321	ROIs	_	
118-15	17322-17324	to	_	
118-16	17325-17329	test	_	
118-17	17330-17333	for	_	
118-18	17334-17337	PRS	_	
118-19	17338-17339	(	_	
118-20	17339-17341	ie	_	
118-21	17342-17343	“	_	
118-22	17343-17347	high	_	
118-23	17347-17348	”	_	
118-24	17349-17351	vs	_	
118-25	17352-17353	“	_	
118-26	17353-17356	low	_	
118-27	17356-17357	”	_	
118-28	17357-17358	)	_	
118-29	17359-17360	×	_	
118-30	17361-17365	fMRI	_	
118-31	17366-17374	Stimulus	_	
118-32	17375-17387	interactions	_	
118-33	17387-17388	.	_	

#Text=PRS (“high” vs “low”) and Stimulus (dynamic mosaic control stimulus, and happy and fearful facial expressions) represented fixed effects.
119-1	17389-17392	PRS	_	
119-2	17393-17394	(	_	
119-3	17394-17395	“	_	
119-4	17395-17399	high	_	
119-5	17399-17400	”	_	
119-6	17401-17403	vs	_	
119-7	17404-17405	“	_	
119-8	17405-17408	low	_	
119-9	17408-17409	”	_	
119-10	17409-17410	)	_	
119-11	17411-17414	and	_	
119-12	17415-17423	Stimulus	_	
119-13	17424-17425	(	_	
119-14	17425-17432	dynamic	_	
119-15	17433-17439	mosaic	_	
119-16	17440-17447	control	_	
119-17	17448-17456	stimulus	_	
119-18	17456-17457	,	_	
119-19	17458-17461	and	_	
119-20	17462-17467	happy	_	
119-21	17468-17471	and	_	
119-22	17472-17479	fearful	_	
119-23	17480-17486	facial	_	
119-24	17487-17498	expressions	_	
119-25	17498-17499	)	_	
119-26	17500-17511	represented	_	
119-27	17512-17517	fixed	_	
119-28	17518-17525	effects	_	
119-29	17525-17526	.	_	

#Text=Random slope terms were included to take into account interstimuli variability of individual correlations (eg, between the amygdala and FFA) of the face-processing network.
120-1	17527-17533	Random	_	
120-2	17534-17539	slope	_	
120-3	17540-17545	terms	_	
120-4	17546-17550	were	_	
120-5	17551-17559	included	_	
120-6	17560-17562	to	_	
120-7	17563-17567	take	_	
120-8	17568-17572	into	_	
120-9	17573-17580	account	_	
120-10	17581-17593	interstimuli	_	
120-11	17594-17605	variability	_	
120-12	17606-17608	of	_	
120-13	17609-17619	individual	_	
120-14	17620-17632	correlations	_	
120-15	17633-17634	(	_	
120-16	17634-17636	eg	_	
120-17	17636-17637	,	_	
120-18	17638-17645	between	_	
120-19	17646-17649	the	_	
120-20	17650-17658	amygdala	_	
120-21	17659-17662	and	_	
120-22	17663-17666	FFA	_	
120-23	17666-17667	)	_	
120-24	17668-17670	of	_	
120-25	17671-17674	the	_	
120-26	17675-17690	face-processing	_	
120-27	17691-17698	network	_	
120-28	17698-17699	.	_	

#Text=Linear mixed effect analysis showed PRS × fMRI Stimulus interaction on the average correlations of the 25 ROIs (ANOVA, F(2,1196) = 8.7, P = .0002) and the average correlations between the core and the other face-processing regions (ANOVA, F(2,1196) = 4.0, P = .02).
121-1	17700-17706	Linear	_	
121-2	17707-17712	mixed	_	
121-3	17713-17719	effect	_	
121-4	17720-17728	analysis	_	
121-5	17729-17735	showed	_	
121-6	17736-17739	PRS	_	
121-7	17740-17741	×	_	
121-8	17742-17746	fMRI	_	
121-9	17747-17755	Stimulus	_	
121-10	17756-17767	interaction	_	
121-11	17768-17770	on	_	
121-12	17771-17774	the	_	
121-13	17775-17782	average	_	
121-14	17783-17795	correlations	_	
121-15	17796-17798	of	_	
121-16	17799-17802	the	_	
121-17	17803-17805	25	_	
121-18	17806-17810	ROIs	_	
121-19	17811-17812	(	_	
121-20	17812-17817	ANOVA	_	
121-21	17817-17818	,	_	
121-22	17819-17820	F	_	
121-23	17820-17821	(	_	
121-24	17821-17827	2,1196	_	
121-25	17827-17828	)	_	
121-26	17829-17830	=	_	
121-27	17831-17834	8.7	_	
121-28	17834-17835	,	_	
121-29	17836-17837	P	_	
121-30	17838-17839	=	_	
121-31	17840-17845	.0002	_	
121-32	17845-17846	)	_	
121-33	17847-17850	and	_	
121-34	17851-17854	the	_	
121-35	17855-17862	average	_	
121-36	17863-17875	correlations	_	
121-37	17876-17883	between	_	
121-38	17884-17887	the	_	
121-39	17888-17892	core	_	
121-40	17893-17896	and	_	
121-41	17897-17900	the	_	
121-42	17901-17906	other	_	
121-43	17907-17922	face-processing	_	
121-44	17923-17930	regions	_	
121-45	17931-17932	(	_	
121-46	17932-17937	ANOVA	_	
121-47	17937-17938	,	_	
121-48	17939-17940	F	_	
121-49	17940-17941	(	_	
121-50	17941-17947	2,1196	_	
121-51	17947-17948	)	_	
121-52	17949-17950	=	_	
121-53	17951-17954	4.0	_	
121-54	17954-17955	,	_	
121-55	17956-17957	P	_	
121-56	17958-17959	=	_	
121-57	17960-17963	.02	_	
121-58	17963-17964	)	_	
121-59	17964-17965	.	_	

#Text=No interactions were observed in the average correlations within the core network (ANOVA, F(2,1196) = 1.9, P = .16).
122-1	17966-17968	No	_	
122-2	17969-17981	interactions	_	
122-3	17982-17986	were	_	
122-4	17987-17995	observed	_	
122-5	17996-17998	in	_	
122-6	17999-18002	the	_	
122-7	18003-18010	average	_	
122-8	18011-18023	correlations	_	
122-9	18024-18030	within	_	
122-10	18031-18034	the	_	
122-11	18035-18039	core	_	
122-12	18040-18047	network	_	
122-13	18048-18049	(	_	
122-14	18049-18054	ANOVA	_	
122-15	18054-18055	,	_	
122-16	18056-18057	F	_	
122-17	18057-18058	(	_	
122-18	18058-18064	2,1196	_	
122-19	18064-18065	)	_	
122-20	18066-18067	=	_	
122-21	18068-18071	1.9	_	
122-22	18071-18072	,	_	
122-23	18073-18074	P	_	
122-24	18075-18076	=	_	
122-25	18077-18080	.16	_	
122-26	18080-18081	)	_	
122-27	18081-18082	.	_	

#Text=The Interregional Similarity in Gray Matter Volume (Discovery and Replication Samples)
#Text= Figure 4 provides an overview of the degree of interregional similarities in gray matter volume across the 25 regions in each of the 2 groups.
123-1	18083-18086	The	_	
123-2	18087-18100	Interregional	_	
123-3	18101-18111	Similarity	_	
123-4	18112-18114	in	_	
123-5	18115-18119	Gray	_	
123-6	18120-18126	Matter	_	
123-7	18127-18133	Volume	_	
123-8	18134-18135	(	_	
123-9	18135-18144	Discovery	_	
123-10	18145-18148	and	_	
123-11	18149-18160	Replication	_	
123-12	18161-18168	Samples	_	
123-13	18168-18169	)	_	
123-14	18171-18177	Figure	_	
123-15	18178-18179	4	_	
123-16	18180-18188	provides	_	
123-17	18189-18191	an	_	
123-18	18192-18200	overview	_	
123-19	18201-18203	of	_	
123-20	18204-18207	the	_	
123-21	18208-18214	degree	_	
123-22	18215-18217	of	_	
123-23	18218-18231	interregional	_	
123-24	18232-18244	similarities	_	
123-25	18245-18247	in	_	
123-26	18248-18252	gray	_	
123-27	18253-18259	matter	_	
123-28	18260-18266	volume	_	
123-29	18267-18273	across	_	
123-30	18274-18277	the	_	
123-31	18278-18280	25	_	
123-32	18281-18288	regions	_	
123-33	18289-18291	in	_	
123-34	18292-18296	each	_	
123-35	18297-18299	of	_	
123-36	18300-18303	the	_	
123-37	18304-18305	2	_	
123-38	18306-18312	groups	_	
123-39	18312-18313	.	_	

#Text=In the discovery sample, the mean correlation across the 25 regions varied as a function of the PRS; the mean interregional correlation coefficient was the lowest in the high PRS (t test, P = .03, Cohen’s d = 0.18).
124-1	18314-18316	In	_	
124-2	18317-18320	the	_	
124-3	18321-18330	discovery	_	
124-4	18331-18337	sample	_	
124-5	18337-18338	,	_	
124-6	18339-18342	the	_	
124-7	18343-18347	mean	_	
124-8	18348-18359	correlation	_	
124-9	18360-18366	across	_	
124-10	18367-18370	the	_	
124-11	18371-18373	25	_	
124-12	18374-18381	regions	_	
124-13	18382-18388	varied	_	
124-14	18389-18391	as	_	
124-15	18392-18393	a	_	
124-16	18394-18402	function	_	
124-17	18403-18405	of	_	
124-18	18406-18409	the	_	
124-19	18410-18413	PRS	_	
124-20	18413-18414	;	_	
124-21	18415-18418	the	_	
124-22	18419-18423	mean	_	
124-23	18424-18437	interregional	_	
124-24	18438-18449	correlation	_	
124-25	18450-18461	coefficient	_	
124-26	18462-18465	was	_	
124-27	18466-18469	the	_	
124-28	18470-18476	lowest	_	
124-29	18477-18479	in	_	
124-30	18480-18483	the	_	
124-31	18484-18488	high	_	
124-32	18489-18492	PRS	_	
124-33	18493-18494	(	_	
124-34	18494-18495	t	_	
124-35	18496-18500	test	_	
124-36	18500-18501	,	_	
124-37	18502-18503	P	_	
124-38	18504-18505	=	_	
124-39	18506-18509	.03	_	
124-40	18509-18510	,	_	
124-41	18511-18516	Cohen	_	
124-42	18516-18517	’	_	
124-43	18517-18518	s	_	
124-44	18519-18520	d	_	
124-45	18521-18522	=	_	
124-46	18523-18527	0.18	_	
124-47	18527-18528	)	_	
124-48	18528-18529	.	_	

#Text=This result was similar in the replication sample: the mean interregional correlation coefficient was the lowest in the high PRS group (t test, P = .003, Cohen’s d = 0.24).
125-1	18530-18534	This	_	
125-2	18535-18541	result	_	
125-3	18542-18545	was	_	
125-4	18546-18553	similar	_	
125-5	18554-18556	in	_	
125-6	18557-18560	the	_	
125-7	18561-18572	replication	_	
125-8	18573-18579	sample	_	
125-9	18579-18580	:	_	
125-10	18581-18584	the	_	
125-11	18585-18589	mean	_	
125-12	18590-18603	interregional	_	
125-13	18604-18615	correlation	_	
125-14	18616-18627	coefficient	_	
125-15	18628-18631	was	_	
125-16	18632-18635	the	_	
125-17	18636-18642	lowest	_	
125-18	18643-18645	in	_	
125-19	18646-18649	the	_	
125-20	18650-18654	high	_	
125-21	18655-18658	PRS	_	
125-22	18659-18664	group	_	
125-23	18665-18666	(	_	
125-24	18666-18667	t	_	
125-25	18668-18672	test	_	
125-26	18672-18673	,	_	
125-27	18674-18675	P	_	
125-28	18676-18677	=	_	
125-29	18678-18682	.003	_	
125-30	18682-18683	,	_	
125-31	18684-18689	Cohen	_	
125-32	18689-18690	’	_	
125-33	18690-18691	s	_	
125-34	18692-18693	d	_	
125-35	18694-18695	=	_	
125-36	18696-18700	0.24	_	
125-37	18700-18701	)	_	
125-38	18701-18702	.	_	

#Text=The mean correlation in gray matter between the core and the other regions varied as a function of the PRS; the lowest correlation was observed in the high PRS in both the discovery (“high” vs “low”, t test, P = .03, Cohen’s d = 0.30) and the replication (“high” vs “low”, t test, P = .002, Cohen’s d = 0.42) samples.
126-1	18703-18706	The	_	
126-2	18707-18711	mean	_	
126-3	18712-18723	correlation	_	
126-4	18724-18726	in	_	
126-5	18727-18731	gray	_	
126-6	18732-18738	matter	_	
126-7	18739-18746	between	_	
126-8	18747-18750	the	_	
126-9	18751-18755	core	_	
126-10	18756-18759	and	_	
126-11	18760-18763	the	_	
126-12	18764-18769	other	_	
126-13	18770-18777	regions	_	
126-14	18778-18784	varied	_	
126-15	18785-18787	as	_	
126-16	18788-18789	a	_	
126-17	18790-18798	function	_	
126-18	18799-18801	of	_	
126-19	18802-18805	the	_	
126-20	18806-18809	PRS	_	
126-21	18809-18810	;	_	
126-22	18811-18814	the	_	
126-23	18815-18821	lowest	_	
126-24	18822-18833	correlation	_	
126-25	18834-18837	was	_	
126-26	18838-18846	observed	_	
126-27	18847-18849	in	_	
126-28	18850-18853	the	_	
126-29	18854-18858	high	_	
126-30	18859-18862	PRS	_	
126-31	18863-18865	in	_	
126-32	18866-18870	both	_	
126-33	18871-18874	the	_	
126-34	18875-18884	discovery	_	
126-35	18885-18886	(	_	
126-36	18886-18887	“	_	
126-37	18887-18891	high	_	
126-38	18891-18892	”	_	
126-39	18893-18895	vs	_	
126-40	18896-18897	“	_	
126-41	18897-18900	low	_	
126-42	18900-18901	”	_	
126-43	18901-18902	,	_	
126-44	18903-18904	t	_	
126-45	18905-18909	test	_	
126-46	18909-18910	,	_	
126-47	18911-18912	P	_	
126-48	18913-18914	=	_	
126-49	18915-18918	.03	_	
126-50	18918-18919	,	_	
126-51	18920-18925	Cohen	_	
126-52	18925-18926	’	_	
126-53	18926-18927	s	_	
126-54	18928-18929	d	_	
126-55	18930-18931	=	_	
126-56	18932-18936	0.30	_	
126-57	18936-18937	)	_	
126-58	18938-18941	and	_	
126-59	18942-18945	the	_	
126-60	18946-18957	replication	_	
126-61	18958-18959	(	_	
126-62	18959-18960	“	_	
126-63	18960-18964	high	_	
126-64	18964-18965	”	_	
126-65	18966-18968	vs	_	
126-66	18969-18970	“	_	
126-67	18970-18973	low	_	
126-68	18973-18974	”	_	
126-69	18974-18975	,	_	
126-70	18976-18977	t	_	
126-71	18978-18982	test	_	
126-72	18982-18983	,	_	
126-73	18984-18985	P	_	
126-74	18986-18987	=	_	
126-75	18988-18992	.002	_	
126-76	18992-18993	,	_	
126-77	18994-18999	Cohen	_	
126-78	18999-19000	’	_	
126-79	19000-19001	s	_	
126-80	19002-19003	d	_	
126-81	19004-19005	=	_	
126-82	19006-19010	0.42	_	
126-83	19010-19011	)	_	
126-84	19012-19019	samples	_	
126-85	19019-19020	.	_	

#Text=There were no significant PRS-related correlation differences in gray matter within the core system in the discovery sample (t test, P = .9, Cohen’s d = 0.05) nor in the replication sample (t test, P = .9, Cohen’s d = 0.05).
127-1	19021-19026	There	_	
127-2	19027-19031	were	_	
127-3	19032-19034	no	_	
127-4	19035-19046	significant	_	
127-5	19047-19058	PRS-related	_	
127-6	19059-19070	correlation	_	
127-7	19071-19082	differences	_	
127-8	19083-19085	in	_	
127-9	19086-19090	gray	_	
127-10	19091-19097	matter	_	
127-11	19098-19104	within	_	
127-12	19105-19108	the	_	
127-13	19109-19113	core	_	
127-14	19114-19120	system	_	
127-15	19121-19123	in	_	
127-16	19124-19127	the	_	
127-17	19128-19137	discovery	_	
127-18	19138-19144	sample	_	
127-19	19145-19146	(	_	
127-20	19146-19147	t	_	
127-21	19148-19152	test	_	
127-22	19152-19153	,	_	
127-23	19154-19155	P	_	
127-24	19156-19157	=	_	
127-25	19158-19160	.9	_	
127-26	19160-19161	,	_	
127-27	19162-19167	Cohen	_	
127-28	19167-19168	’	_	
127-29	19168-19169	s	_	
127-30	19170-19171	d	_	
127-31	19172-19173	=	_	
127-32	19174-19178	0.05	_	
127-33	19178-19179	)	_	
127-34	19180-19183	nor	_	
127-35	19184-19186	in	_	
127-36	19187-19190	the	_	
127-37	19191-19202	replication	_	
127-38	19203-19209	sample	_	
127-39	19210-19211	(	_	
127-40	19211-19212	t	_	
127-41	19213-19217	test	_	
127-42	19217-19218	,	_	
127-43	19219-19220	P	_	
127-44	19221-19222	=	_	
127-45	19223-19225	.9	_	
127-46	19225-19226	,	_	
127-47	19227-19232	Cohen	_	
127-48	19232-19233	’	_	
127-49	19233-19234	s	_	
127-50	19235-19236	d	_	
127-51	19237-19238	=	_	
127-52	19239-19243	0.05	_	
127-53	19243-19244	)	_	
127-54	19244-19245	.	_	

#Text=(a) Correlation matrices for gray matter volume data.
128-1	19246-19247	(	_	
128-2	19247-19248	a	_	
128-3	19248-19249	)	_	
128-4	19250-19261	Correlation	_	
128-5	19262-19270	matrices	_	
128-6	19271-19274	for	_	
128-7	19275-19279	gray	_	
128-8	19280-19286	matter	_	
128-9	19287-19293	volume	_	
128-10	19294-19298	data	_	
128-11	19298-19299	.	_	

#Text=(b) The degree of interregional similarities in gray matter volume.
129-1	19300-19301	(	_	
129-2	19301-19302	b	_	
129-3	19302-19303	)	_	
129-4	19304-19307	The	_	
129-5	19308-19314	degree	_	
129-6	19315-19317	of	_	
129-7	19318-19331	interregional	_	
129-8	19332-19344	similarities	_	
129-9	19345-19347	in	_	
129-10	19348-19352	gray	_	
129-11	19353-19359	matter	_	
129-12	19360-19366	volume	_	
129-13	19366-19367	.	_	

#Text=Asterisk represents statistical significance (P < 005).
130-1	19368-19376	Asterisk	_	
130-2	19377-19387	represents	_	
130-3	19388-19399	statistical	_	
130-4	19400-19412	significance	_	
130-5	19413-19414	(	_	
130-6	19414-19415	P	_	
130-7	19416-19417	<	_	
130-8	19418-19421	005	_	
130-9	19421-19422	)	_	
130-10	19422-19423	.	_	

#Text=PRS, polygenic risk score; ROI, region of interest.
131-1	19424-19427	PRS	_	
131-2	19427-19428	,	_	
131-3	19429-19438	polygenic	_	
131-4	19439-19443	risk	_	
131-5	19444-19449	score	_	
131-6	19449-19450	;	_	
131-7	19451-19454	ROI	_	
131-8	19454-19455	,	_	
131-9	19456-19462	region	_	
131-10	19463-19465	of	_	
131-11	19466-19474	interest	_	
131-12	19474-19475	.	_	

#Text=Interplay Between Early Adversity and PRS for Schizophrenia (Discovery and Replication Samples)
#Text=We also explored the interplay between early adversity and PRS for schizophrenia on the mean interregional pair-wise correlations (figure 5).
132-1	19476-19485	Interplay	_	
132-2	19486-19493	Between	_	
132-3	19494-19499	Early	_	
132-4	19500-19509	Adversity	_	
132-5	19510-19513	and	_	
132-6	19514-19517	PRS	_	
132-7	19518-19521	for	_	
132-8	19522-19535	Schizophrenia	_	
132-9	19536-19537	(	_	
132-10	19537-19546	Discovery	_	
132-11	19547-19550	and	_	
132-12	19551-19562	Replication	_	
132-13	19563-19570	Samples	_	
132-14	19570-19571	)	_	
132-15	19572-19574	We	_	
132-16	19575-19579	also	_	
132-17	19580-19588	explored	_	
132-18	19589-19592	the	_	
132-19	19593-19602	interplay	_	
132-20	19603-19610	between	_	
132-21	19611-19616	early	_	
132-22	19617-19626	adversity	_	
132-23	19627-19630	and	_	
132-24	19631-19634	PRS	_	
132-25	19635-19638	for	_	
132-26	19639-19652	schizophrenia	_	
132-27	19653-19655	on	_	
132-28	19656-19659	the	_	
132-29	19660-19664	mean	_	
132-30	19665-19678	interregional	_	
132-31	19679-19688	pair-wise	_	
132-32	19689-19701	correlations	_	
132-33	19702-19703	(	_	
132-34	19703-19709	figure	_	
132-35	19710-19711	5	_	
132-36	19711-19712	)	_	
132-37	19712-19713	.	_	

#Text=We found no adversity by PRS interaction (ANOVA, F(1,1196) = 0.4, P = .5) on interregional similarity in BOLD signal.
133-1	19714-19716	We	_	
133-2	19717-19722	found	_	
133-3	19723-19725	no	_	
133-4	19726-19735	adversity	_	
133-5	19736-19738	by	_	
133-6	19739-19742	PRS	_	
133-7	19743-19754	interaction	_	
133-8	19755-19756	(	_	
133-9	19756-19761	ANOVA	_	
133-10	19761-19762	,	_	
133-11	19763-19764	F	_	
133-12	19764-19765	(	_	
133-13	19765-19771	1,1196	_	
133-14	19771-19772	)	_	
133-15	19773-19774	=	_	
133-16	19775-19778	0.4	_	
133-17	19778-19779	,	_	
133-18	19780-19781	P	_	
133-19	19782-19783	=	_	
133-20	19784-19786	.5	_	
133-21	19786-19787	)	_	
133-22	19788-19790	on	_	
133-23	19791-19804	interregional	_	
133-24	19805-19815	similarity	_	
133-25	19816-19818	in	_	
133-26	19819-19823	BOLD	_	
133-27	19824-19830	signal	_	
133-28	19830-19831	.	_	

#Text=With structural data we did not detect adversity by PRS interactions in the discovery (ANOVA, F(1,1196) = 1.9, P = .16) nor in the replication (ANOVA, F(1,1196) = 1.3, P = .25) sample.
134-1	19832-19836	With	_	
134-2	19837-19847	structural	_	
134-3	19848-19852	data	_	
134-4	19853-19855	we	_	
134-5	19856-19859	did	_	
134-6	19860-19863	not	_	
134-7	19864-19870	detect	_	
134-8	19871-19880	adversity	_	
134-9	19881-19883	by	_	
134-10	19884-19887	PRS	_	
134-11	19888-19900	interactions	_	
134-12	19901-19903	in	_	
134-13	19904-19907	the	_	
134-14	19908-19917	discovery	_	
134-15	19918-19919	(	_	
134-16	19919-19924	ANOVA	_	
134-17	19924-19925	,	_	
134-18	19926-19927	F	_	
134-19	19927-19928	(	_	
134-20	19928-19934	1,1196	_	
134-21	19934-19935	)	_	
134-22	19936-19937	=	_	
134-23	19938-19941	1.9	_	
134-24	19941-19942	,	_	
134-25	19943-19944	P	_	
134-26	19945-19946	=	_	
134-27	19947-19950	.16	_	
134-28	19950-19951	)	_	
134-29	19952-19955	nor	_	
134-30	19956-19958	in	_	
134-31	19959-19962	the	_	
134-32	19963-19974	replication	_	
134-33	19975-19976	(	_	
134-34	19976-19981	ANOVA	_	
134-35	19981-19982	,	_	
134-36	19983-19984	F	_	
134-37	19984-19985	(	_	
134-38	19985-19991	1,1196	_	
134-39	19991-19992	)	_	
134-40	19993-19994	=	_	
134-41	19995-19998	1.3	_	
134-42	19998-19999	,	_	
134-43	20000-20001	P	_	
134-44	20002-20003	=	_	
134-45	20004-20007	.25	_	
134-46	20007-20008	)	_	
134-47	20009-20015	sample	_	
134-48	20015-20016	.	_	

#Text=Early adversity tended to show the main effect in fMRI data (ANOVA, F(1,1197) = 3.6, P = .06).
135-1	20017-20022	Early	_	
135-2	20023-20032	adversity	_	
135-3	20033-20039	tended	_	
135-4	20040-20042	to	_	
135-5	20043-20047	show	_	
135-6	20048-20051	the	_	
135-7	20052-20056	main	_	
135-8	20057-20063	effect	_	
135-9	20064-20066	in	_	
135-10	20067-20071	fMRI	_	
135-11	20072-20076	data	_	
135-12	20077-20078	(	_	
135-13	20078-20083	ANOVA	_	
135-14	20083-20084	,	_	
135-15	20085-20086	F	_	
135-16	20086-20087	(	_	
135-17	20087-20093	1,1197	_	
135-18	20093-20094	)	_	
135-19	20095-20096	=	_	
135-20	20097-20100	3.6	_	
135-21	20100-20101	,	_	
135-22	20102-20103	P	_	
135-23	20104-20105	=	_	
135-24	20106-20109	.06	_	
135-25	20109-20110	)	_	
135-26	20110-20111	.	_	

#Text=With structural data, the main effect of early adversity was significant in both the discovery (ANOVA, F(1,1197) = 6.2, P = .01) and the replication (ANOVA, F(1,1197) = 9.0, P = .003) sample.
136-1	20112-20116	With	_	
136-2	20117-20127	structural	_	
136-3	20128-20132	data	_	
136-4	20132-20133	,	_	
136-5	20134-20137	the	_	
136-6	20138-20142	main	_	
136-7	20143-20149	effect	_	
136-8	20150-20152	of	_	
136-9	20153-20158	early	_	
136-10	20159-20168	adversity	_	
136-11	20169-20172	was	_	
136-12	20173-20184	significant	_	
136-13	20185-20187	in	_	
136-14	20188-20192	both	_	
136-15	20193-20196	the	_	
136-16	20197-20206	discovery	_	
136-17	20207-20208	(	_	
136-18	20208-20213	ANOVA	_	
136-19	20213-20214	,	_	
136-20	20215-20216	F	_	
136-21	20216-20217	(	_	
136-22	20217-20223	1,1197	_	
136-23	20223-20224	)	_	
136-24	20225-20226	=	_	
136-25	20227-20230	6.2	_	
136-26	20230-20231	,	_	
136-27	20232-20233	P	_	
136-28	20234-20235	=	_	
136-29	20236-20239	.01	_	
136-30	20239-20240	)	_	
136-31	20241-20244	and	_	
136-32	20245-20248	the	_	
136-33	20249-20260	replication	_	
136-34	20261-20262	(	_	
136-35	20262-20267	ANOVA	_	
136-36	20267-20268	,	_	
136-37	20269-20270	F	_	
136-38	20270-20271	(	_	
136-39	20271-20277	1,1197	_	
136-40	20277-20278	)	_	
136-41	20279-20280	=	_	
136-42	20281-20284	9.0	_	
136-43	20284-20285	,	_	
136-44	20286-20287	P	_	
136-45	20288-20289	=	_	
136-46	20290-20294	.003	_	
136-47	20294-20295	)	_	
136-48	20296-20302	sample	_	
136-49	20302-20303	.	_	

#Text=The interaction between early adversity (total Trauma and Distress Scale [TADS] scores) and polygenic risk score (PRS) on the degree of interregional similarities of blood oxygen level–dependent (BOLD) fMRI and gray matter volume.
137-1	20304-20307	The	_	
137-2	20308-20319	interaction	_	
137-3	20320-20327	between	_	
137-4	20328-20333	early	_	
137-5	20334-20343	adversity	_	
137-6	20344-20345	(	_	
137-7	20345-20350	total	_	
137-8	20351-20357	Trauma	_	
137-9	20358-20361	and	_	
137-10	20362-20370	Distress	_	
137-11	20371-20376	Scale	_	
137-12	20377-20378	[	_	
137-13	20378-20382	TADS	_	
137-14	20382-20383	]	_	
137-15	20384-20390	scores	_	
137-16	20390-20391	)	_	
137-17	20392-20395	and	_	
137-18	20396-20405	polygenic	_	
137-19	20406-20410	risk	_	
137-20	20411-20416	score	_	
137-21	20417-20418	(	_	
137-22	20418-20421	PRS	_	
137-23	20421-20422	)	_	
137-24	20423-20425	on	_	
137-25	20426-20429	the	_	
137-26	20430-20436	degree	_	
137-27	20437-20439	of	_	
137-28	20440-20453	interregional	_	
137-29	20454-20466	similarities	_	
137-30	20467-20469	of	_	
137-31	20470-20475	blood	_	
137-32	20476-20482	oxygen	_	
137-33	20483-20498	level–dependent	_	
137-34	20499-20500	(	_	
137-35	20500-20504	BOLD	_	
137-36	20504-20505	)	_	
137-37	20506-20510	fMRI	_	
137-38	20511-20514	and	_	
137-39	20515-20519	gray	_	
137-40	20520-20526	matter	_	
137-41	20527-20533	volume	_	
137-42	20533-20534	.	_	

#Text=Discussion
#Text=PRS offers an exciting extension to previous studies using the familial risk of schizophrenia data to investigate schizophrenia-related variation in heritability across healthy individuals.
138-1	20535-20545	Discussion	_	
138-2	20546-20549	PRS	_	
138-3	20550-20556	offers	_	
138-4	20557-20559	an	_	
138-5	20560-20568	exciting	_	
138-6	20569-20578	extension	_	
138-7	20579-20581	to	_	
138-8	20582-20590	previous	_	
138-9	20591-20598	studies	_	
138-10	20599-20604	using	_	
138-11	20605-20608	the	_	
138-12	20609-20617	familial	_	
138-13	20618-20622	risk	_	
138-14	20623-20625	of	_	
138-15	20626-20639	schizophrenia	_	
138-16	20640-20644	data	_	
138-17	20645-20647	to	_	
138-18	20648-20659	investigate	_	
138-19	20660-20681	schizophrenia-related	_	
138-20	20682-20691	variation	_	
138-21	20692-20694	in	_	
138-22	20695-20707	heritability	_	
138-23	20708-20714	across	_	
138-24	20715-20722	healthy	_	
138-25	20723-20734	individuals	_	
138-26	20734-20735	.	_	

#Text=We demonstrated that aggregation of these genetic variants associate with clinically defined schizophrenia in the NFBC 1986.
139-1	20736-20738	We	_	
139-2	20739-20751	demonstrated	_	
139-3	20752-20756	that	_	
139-4	20757-20768	aggregation	_	
139-5	20769-20771	of	_	
139-6	20772-20777	these	_	
139-7	20778-20785	genetic	_	
139-8	20786-20794	variants	_	
139-9	20795-20804	associate	_	
139-10	20805-20809	with	_	
139-11	20810-20820	clinically	_	
139-12	20821-20828	defined	_	
139-13	20829-20842	schizophrenia	_	
139-14	20843-20845	in	_	
139-15	20846-20849	the	_	
139-16	20850-20854	NFBC	_	
139-17	20855-20859	1986	_	
139-18	20859-20860	.	_	

#Text=In this light, PRS can be considered as a proxy for genetic vulnerability for schizophrenia with clinical implications in the NFBC 1986.
140-1	20861-20863	In	_	
140-2	20864-20868	this	_	
140-3	20869-20874	light	_	
140-4	20874-20875	,	_	
140-5	20876-20879	PRS	_	
140-6	20880-20883	can	_	
140-7	20884-20886	be	_	
140-8	20887-20897	considered	_	
140-9	20898-20900	as	_	
140-10	20901-20902	a	_	
140-11	20903-20908	proxy	_	
140-12	20909-20912	for	_	
140-13	20913-20920	genetic	_	
140-14	20921-20934	vulnerability	_	
140-15	20935-20938	for	_	
140-16	20939-20952	schizophrenia	_	
140-17	20953-20957	with	_	
140-18	20958-20966	clinical	_	
140-19	20967-20979	implications	_	
140-20	20980-20982	in	_	
140-21	20983-20986	the	_	
140-22	20987-20991	NFBC	_	
140-23	20992-20996	1986	_	
140-24	20996-20997	.	_	

#Text=Young adults with “high” genetic vulnerability to schizophrenia (vs “low”) appear to differ, albeit with a small effect-size, in the degree of similarity in BOLD signal and gray matter volume across the face-processing network.
141-1	20998-21003	Young	_	
141-2	21004-21010	adults	_	
141-3	21011-21015	with	_	
141-4	21016-21017	“	_	
141-5	21017-21021	high	_	
141-6	21021-21022	”	_	
141-7	21023-21030	genetic	_	
141-8	21031-21044	vulnerability	_	
141-9	21045-21047	to	_	
141-10	21048-21061	schizophrenia	_	
141-11	21062-21063	(	_	
141-12	21063-21065	vs	_	
141-13	21066-21067	“	_	
141-14	21067-21070	low	_	
141-15	21070-21071	”	_	
141-16	21071-21072	)	_	
141-17	21073-21079	appear	_	
141-18	21080-21082	to	_	
141-19	21083-21089	differ	_	
141-20	21089-21090	,	_	
141-21	21091-21097	albeit	_	
141-22	21098-21102	with	_	
141-23	21103-21104	a	_	
141-24	21105-21110	small	_	
141-25	21111-21122	effect-size	_	
141-26	21122-21123	,	_	
141-27	21124-21126	in	_	
141-28	21127-21130	the	_	
141-29	21131-21137	degree	_	
141-30	21138-21140	of	_	
141-31	21141-21151	similarity	_	
141-32	21152-21154	in	_	
141-33	21155-21159	BOLD	_	
141-34	21160-21166	signal	_	
141-35	21167-21170	and	_	
141-36	21171-21175	gray	_	
141-37	21176-21182	matter	_	
141-38	21183-21189	volume	_	
141-39	21190-21196	across	_	
141-40	21197-21200	the	_	
141-41	21201-21216	face-processing	_	
141-42	21217-21224	network	_	
141-43	21224-21225	.	_	

#Text=Specifically, our findings demonstrated that the degree of interregional similarities in BOLD signal and gray matter volume varies as a function of PRS group; lower covariance was observed in individuals with high vs low PRS.
142-1	21226-21238	Specifically	_	
142-2	21238-21239	,	_	
142-3	21240-21243	our	_	
142-4	21244-21252	findings	_	
142-5	21253-21265	demonstrated	_	
142-6	21266-21270	that	_	
142-7	21271-21274	the	_	
142-8	21275-21281	degree	_	
142-9	21282-21284	of	_	
142-10	21285-21298	interregional	_	
142-11	21299-21311	similarities	_	
142-12	21312-21314	in	_	
142-13	21315-21319	BOLD	_	
142-14	21320-21326	signal	_	
142-15	21327-21330	and	_	
142-16	21331-21335	gray	_	
142-17	21336-21342	matter	_	
142-18	21343-21349	volume	_	
142-19	21350-21356	varies	_	
142-20	21357-21359	as	_	
142-21	21360-21361	a	_	
142-22	21362-21370	function	_	
142-23	21371-21373	of	_	
142-24	21374-21377	PRS	_	
142-25	21378-21383	group	_	
142-26	21383-21384	;	_	
142-27	21385-21390	lower	_	
142-28	21391-21401	covariance	_	
142-29	21402-21405	was	_	
142-30	21406-21414	observed	_	
142-31	21415-21417	in	_	
142-32	21418-21429	individuals	_	
142-33	21430-21434	with	_	
142-34	21435-21439	high	_	
142-35	21440-21442	vs	_	
142-36	21443-21446	low	_	
142-37	21447-21450	PRS	_	
142-38	21450-21451	.	_	

#Text=We were able to replicate the above structural-covariance finding.
143-1	21452-21454	We	_	
143-2	21455-21459	were	_	
143-3	21460-21464	able	_	
143-4	21465-21467	to	_	
143-5	21468-21477	replicate	_	
143-6	21478-21481	the	_	
143-7	21482-21487	above	_	
143-8	21488-21509	structural-covariance	_	
143-9	21510-21517	finding	_	
143-10	21517-21518	.	_	

#Text=With fMRI, the association between PRS and interregional correlation appeared to be stimulus-specific (ie, during visual exposure to fearful facial expressions).
144-1	21519-21523	With	_	
144-2	21524-21528	fMRI	_	
144-3	21528-21529	,	_	
144-4	21530-21533	the	_	
144-5	21534-21545	association	_	
144-6	21546-21553	between	_	
144-7	21554-21557	PRS	_	
144-8	21558-21561	and	_	
144-9	21562-21575	interregional	_	
144-10	21576-21587	correlation	_	
144-11	21588-21596	appeared	_	
144-12	21597-21599	to	_	
144-13	21600-21602	be	_	
144-14	21603-21620	stimulus-specific	_	
144-15	21621-21622	(	_	
144-16	21622-21624	ie	_	
144-17	21624-21625	,	_	
144-18	21626-21632	during	_	
144-19	21633-21639	visual	_	
144-20	21640-21648	exposure	_	
144-21	21649-21651	to	_	
144-22	21652-21659	fearful	_	
144-23	21660-21666	facial	_	
144-24	21667-21678	expressions	_	
144-25	21678-21679	)	_	
144-26	21679-21680	.	_	

#Text=We explored further whether the lower interregional similarities in BOLD signal and gray matter volume are partly driven by (1) the interconnection correlations of the core and other face-processing regions or (2) the intraconnection differences within the core system.
145-1	21681-21683	We	_	
145-2	21684-21692	explored	_	
145-3	21693-21700	further	_	
145-4	21701-21708	whether	_	
145-5	21709-21712	the	_	
145-6	21713-21718	lower	_	
145-7	21719-21732	interregional	_	
145-8	21733-21745	similarities	_	
145-9	21746-21748	in	_	
145-10	21749-21753	BOLD	_	
145-11	21754-21760	signal	_	
145-12	21761-21764	and	_	
145-13	21765-21769	gray	_	
145-14	21770-21776	matter	_	
145-15	21777-21783	volume	_	
145-16	21784-21787	are	_	
145-17	21788-21794	partly	_	
145-18	21795-21801	driven	_	
145-19	21802-21804	by	_	
145-20	21805-21806	(	_	
145-21	21806-21807	1	_	
145-22	21807-21808	)	_	
145-23	21809-21812	the	_	
145-24	21813-21828	interconnection	_	
145-25	21829-21841	correlations	_	
145-26	21842-21844	of	_	
145-27	21845-21848	the	_	
145-28	21849-21853	core	_	
145-29	21854-21857	and	_	
145-30	21858-21863	other	_	
145-31	21864-21879	face-processing	_	
145-32	21880-21887	regions	_	
145-33	21888-21890	or	_	
145-34	21891-21892	(	_	
145-35	21892-21893	2	_	
145-36	21893-21894	)	_	
145-37	21895-21898	the	_	
145-38	21899-21914	intraconnection	_	
145-39	21915-21926	differences	_	
145-40	21927-21933	within	_	
145-41	21934-21937	the	_	
145-42	21938-21942	core	_	
145-43	21943-21949	system	_	
145-44	21949-21950	.	_	

#Text=We showed consistently with both modalities that the interregional similarities between the core and the other face processing vary as a function of PRS for schizophrenia; the lowest correlation is observed in individuals with high PRS for schizophrenia.
146-1	21951-21953	We	_	
146-2	21954-21960	showed	_	
146-3	21961-21973	consistently	_	
146-4	21974-21978	with	_	
146-5	21979-21983	both	_	
146-6	21984-21994	modalities	_	
146-7	21995-21999	that	_	
146-8	22000-22003	the	_	
146-9	22004-22017	interregional	_	
146-10	22018-22030	similarities	_	
146-11	22031-22038	between	_	
146-12	22039-22042	the	_	
146-13	22043-22047	core	_	
146-14	22048-22051	and	_	
146-15	22052-22055	the	_	
146-16	22056-22061	other	_	
146-17	22062-22066	face	_	
146-18	22067-22077	processing	_	
146-19	22078-22082	vary	_	
146-20	22083-22085	as	_	
146-21	22086-22087	a	_	
146-22	22088-22096	function	_	
146-23	22097-22099	of	_	
146-24	22100-22103	PRS	_	
146-25	22104-22107	for	_	
146-26	22108-22121	schizophrenia	_	
146-27	22121-22122	;	_	
146-28	22123-22126	the	_	
146-29	22127-22133	lowest	_	
146-30	22134-22145	correlation	_	
146-31	22146-22148	is	_	
146-32	22149-22157	observed	_	
146-33	22158-22160	in	_	
146-34	22161-22172	individuals	_	
146-35	22173-22177	with	_	
146-36	22178-22182	high	_	
146-37	22183-22186	PRS	_	
146-38	22187-22190	for	_	
146-39	22191-22204	schizophrenia	_	
146-40	22204-22205	.	_	

#Text=No such differences, however, were found in the associations within the core system.
147-1	22206-22208	No	_	
147-2	22209-22213	such	_	
147-3	22214-22225	differences	_	
147-4	22225-22226	,	_	
147-5	22227-22234	however	_	
147-6	22234-22235	,	_	
147-7	22236-22240	were	_	
147-8	22241-22246	found	_	
147-9	22247-22249	in	_	
147-10	22250-22253	the	_	
147-11	22254-22266	associations	_	
147-12	22267-22273	within	_	
147-13	22274-22277	the	_	
147-14	22278-22282	core	_	
147-15	22283-22289	system	_	
147-16	22289-22290	.	_	

#Text=We speculate that this finding indicates that the aggregation of PRS may not affect the neural network responsible of recognition of faces (vs other objects) but may lead to perturbations in the extraction of information relating to the significance of faces (eg, identity or different emotions).
148-1	22291-22293	We	_	
148-2	22294-22303	speculate	_	
148-3	22304-22308	that	_	
148-4	22309-22313	this	_	
148-5	22314-22321	finding	_	
148-6	22322-22331	indicates	_	
148-7	22332-22336	that	_	
148-8	22337-22340	the	_	
148-9	22341-22352	aggregation	_	
148-10	22353-22355	of	_	
148-11	22356-22359	PRS	_	
148-12	22360-22363	may	_	
148-13	22364-22367	not	_	
148-14	22368-22374	affect	_	
148-15	22375-22378	the	_	
148-16	22379-22385	neural	_	
148-17	22386-22393	network	_	
148-18	22394-22405	responsible	_	
148-19	22406-22408	of	_	
148-20	22409-22420	recognition	_	
148-21	22421-22423	of	_	
148-22	22424-22429	faces	_	
148-23	22430-22431	(	_	
148-24	22431-22433	vs	_	
148-25	22434-22439	other	_	
148-26	22440-22447	objects	_	
148-27	22447-22448	)	_	
148-28	22449-22452	but	_	
148-29	22453-22456	may	_	
148-30	22457-22461	lead	_	
148-31	22462-22464	to	_	
148-32	22465-22478	perturbations	_	
148-33	22479-22481	in	_	
148-34	22482-22485	the	_	
148-35	22486-22496	extraction	_	
148-36	22497-22499	of	_	
148-37	22500-22511	information	_	
148-38	22512-22520	relating	_	
148-39	22521-22523	to	_	
148-40	22524-22527	the	_	
148-41	22528-22540	significance	_	
148-42	22541-22543	of	_	
148-43	22544-22549	faces	_	
148-44	22550-22551	(	_	
148-45	22551-22553	eg	_	
148-46	22553-22554	,	_	
148-47	22555-22563	identity	_	
148-48	22564-22566	or	_	
148-49	22567-22576	different	_	
148-50	22577-22585	emotions	_	
148-51	22585-22586	)	_	
148-52	22586-22587	.	_	

#Text=To the best of our knowledge, this is the first study to explore the association between PRS and interregional “connectivity” of the face-processing network.
149-1	22588-22590	To	_	
149-2	22591-22594	the	_	
149-3	22595-22599	best	_	
149-4	22600-22602	of	_	
149-5	22603-22606	our	_	
149-6	22607-22616	knowledge	_	
149-7	22616-22617	,	_	
149-8	22618-22622	this	_	
149-9	22623-22625	is	_	
149-10	22626-22629	the	_	
149-11	22630-22635	first	_	
149-12	22636-22641	study	_	
149-13	22642-22644	to	_	
149-14	22645-22652	explore	_	
149-15	22653-22656	the	_	
149-16	22657-22668	association	_	
149-17	22669-22676	between	_	
149-18	22677-22680	PRS	_	
149-19	22681-22684	and	_	
149-20	22685-22698	interregional	_	
149-21	22699-22700	“	_	
149-22	22700-22712	connectivity	_	
149-23	22712-22713	”	_	
149-24	22714-22716	of	_	
149-25	22717-22720	the	_	
149-26	22721-22736	face-processing	_	
149-27	22737-22744	network	_	
149-28	22744-22745	.	_	

#Text=Previous fMRI studies comparing individuals with vs without familial risk of psychosis have found lower functional connectivity between different face-processing regions during visual exposure to faces (eg, between the amygdala and prefrontal cortex).
150-1	22746-22754	Previous	_	
150-2	22755-22759	fMRI	_	
150-3	22760-22767	studies	_	
150-4	22768-22777	comparing	_	
150-5	22778-22789	individuals	_	
150-6	22790-22794	with	_	
150-7	22795-22797	vs	_	
150-8	22798-22805	without	_	
150-9	22806-22814	familial	_	
150-10	22815-22819	risk	_	
150-11	22820-22822	of	_	
150-12	22823-22832	psychosis	_	
150-13	22833-22837	have	_	
150-14	22838-22843	found	_	
150-15	22844-22849	lower	_	
150-16	22850-22860	functional	_	
150-17	22861-22873	connectivity	_	
150-18	22874-22881	between	_	
150-19	22882-22891	different	_	
150-20	22892-22907	face-processing	_	
150-21	22908-22915	regions	_	
150-22	22916-22922	during	_	
150-23	22923-22929	visual	_	
150-24	22930-22938	exposure	_	
150-25	22939-22941	to	_	
150-26	22942-22947	faces	_	
150-27	22948-22949	(	_	
150-28	22949-22951	eg	_	
150-29	22951-22952	,	_	
150-30	22953-22960	between	_	
150-31	22961-22964	the	_	
150-32	22965-22973	amygdala	_	
150-33	22974-22977	and	_	
150-34	22978-22988	prefrontal	_	
150-35	22989-22995	cortex	_	
150-36	22995-22996	)	_	
150-37	22996-22997	.	_	

#Text=These results combined with our findings might suggest that the heritability of schizophrenia plays a role in face processing in the brain, possibly by affecting the links of the face-processing network.
151-1	22998-23003	These	_	
151-2	23004-23011	results	_	
151-3	23012-23020	combined	_	
151-4	23021-23025	with	_	
151-5	23026-23029	our	_	
151-6	23030-23038	findings	_	
151-7	23039-23044	might	_	
151-8	23045-23052	suggest	_	
151-9	23053-23057	that	_	
151-10	23058-23061	the	_	
151-11	23062-23074	heritability	_	
151-12	23075-23077	of	_	
151-13	23078-23091	schizophrenia	_	
151-14	23092-23097	plays	_	
151-15	23098-23099	a	_	
151-16	23100-23104	role	_	
151-17	23105-23107	in	_	
151-18	23108-23112	face	_	
151-19	23113-23123	processing	_	
151-20	23124-23126	in	_	
151-21	23127-23130	the	_	
151-22	23131-23136	brain	_	
151-23	23136-23137	,	_	
151-24	23138-23146	possibly	_	
151-25	23147-23149	by	_	
151-26	23150-23159	affecting	_	
151-27	23160-23163	the	_	
151-28	23164-23169	links	_	
151-29	23170-23172	of	_	
151-30	23173-23176	the	_	
151-31	23177-23192	face-processing	_	
151-32	23193-23200	network	_	
151-33	23200-23201	.	_	

#Text=Similarities in gray matter volume across the brain have been linked to structural maturation (ie, the degree of interregional loss in the gray matter over time).
152-1	23202-23214	Similarities	_	
152-2	23215-23217	in	_	
152-3	23218-23222	gray	_	
152-4	23223-23229	matter	_	
152-5	23230-23236	volume	_	
152-6	23237-23243	across	_	
152-7	23244-23247	the	_	
152-8	23248-23253	brain	_	
152-9	23254-23258	have	_	
152-10	23259-23263	been	_	
152-11	23264-23270	linked	_	
152-12	23271-23273	to	_	
152-13	23274-23284	structural	_	
152-14	23285-23295	maturation	_	
152-15	23296-23297	(	_	
152-16	23297-23299	ie	_	
152-17	23299-23300	,	_	
152-18	23301-23304	the	_	
152-19	23305-23311	degree	_	
152-20	23312-23314	of	_	
152-21	23315-23328	interregional	_	
152-22	23329-23333	loss	_	
152-23	23334-23336	in	_	
152-24	23337-23340	the	_	
152-25	23341-23345	gray	_	
152-26	23346-23352	matter	_	
152-27	23353-23357	over	_	
152-28	23358-23362	time	_	
152-29	23362-23363	)	_	
152-30	23363-23364	.	_	

#Text=Therefore, we cannot entirely rule out the possibility that the observed structural MRI findings arise in part from different global gray matter development patterns in the brain that may encompass other networks in addition to the face-processing network.
153-1	23365-23374	Therefore	_	
153-2	23374-23375	,	_	
153-3	23376-23378	we	_	
153-4	23379-23385	cannot	_	
153-5	23386-23394	entirely	_	
153-6	23395-23399	rule	_	
153-7	23400-23403	out	_	
153-8	23404-23407	the	_	
153-9	23408-23419	possibility	_	
153-10	23420-23424	that	_	
153-11	23425-23428	the	_	
153-12	23429-23437	observed	_	
153-13	23438-23448	structural	_	
153-14	23449-23452	MRI	_	
153-15	23453-23461	findings	_	
153-16	23462-23467	arise	_	
153-17	23468-23470	in	_	
153-18	23471-23475	part	_	
153-19	23476-23480	from	_	
153-20	23481-23490	different	_	
153-21	23491-23497	global	_	
153-22	23498-23502	gray	_	
153-23	23503-23509	matter	_	
153-24	23510-23521	development	_	
153-25	23522-23530	patterns	_	
153-26	23531-23533	in	_	
153-27	23534-23537	the	_	
153-28	23538-23543	brain	_	
153-29	23544-23548	that	_	
153-30	23549-23552	may	_	
153-31	23553-23562	encompass	_	
153-32	23563-23568	other	_	
153-33	23569-23577	networks	_	
153-34	23578-23580	in	_	
153-35	23581-23589	addition	_	
153-36	23590-23592	to	_	
153-37	23593-23596	the	_	
153-38	23597-23612	face-processing	_	
153-39	23613-23620	network	_	
153-40	23620-23621	.	_	

#Text=BOLD fMRI results in our study, however, were in line with the structural findings, which supports the conclusion that the structural results are reflected in part by the functional engagements of the face-processing network.
154-1	23622-23626	BOLD	_	
154-2	23627-23631	fMRI	_	
154-3	23632-23639	results	_	
154-4	23640-23642	in	_	
154-5	23643-23646	our	_	
154-6	23647-23652	study	_	
154-7	23652-23653	,	_	
154-8	23654-23661	however	_	
154-9	23661-23662	,	_	
154-10	23663-23667	were	_	
154-11	23668-23670	in	_	
154-12	23671-23675	line	_	
154-13	23676-23680	with	_	
154-14	23681-23684	the	_	
154-15	23685-23695	structural	_	
154-16	23696-23704	findings	_	
154-17	23704-23705	,	_	
154-18	23706-23711	which	_	
154-19	23712-23720	supports	_	
154-20	23721-23724	the	_	
154-21	23725-23735	conclusion	_	
154-22	23736-23740	that	_	
154-23	23741-23744	the	_	
154-24	23745-23755	structural	_	
154-25	23756-23763	results	_	
154-26	23764-23767	are	_	
154-27	23768-23777	reflected	_	
154-28	23778-23780	in	_	
154-29	23781-23785	part	_	
154-30	23786-23788	by	_	
154-31	23789-23792	the	_	
154-32	23793-23803	functional	_	
154-33	23804-23815	engagements	_	
154-34	23816-23818	of	_	
154-35	23819-23822	the	_	
154-36	23823-23838	face-processing	_	
154-37	23839-23846	network	_	
154-38	23846-23847	.	_	

#Text=This is not implausible as one previous study demonstrated that the properties of functional connectivity in fMRI BOLD signal in different brain regions across the brain are shared in part with the degree of morphological similarities in the gray matter of the same brain regions.
155-1	23848-23852	This	_	
155-2	23853-23855	is	_	
155-3	23856-23859	not	_	
155-4	23860-23871	implausible	_	
155-5	23872-23874	as	_	
155-6	23875-23878	one	_	
155-7	23879-23887	previous	_	
155-8	23888-23893	study	_	
155-9	23894-23906	demonstrated	_	
155-10	23907-23911	that	_	
155-11	23912-23915	the	_	
155-12	23916-23926	properties	_	
155-13	23927-23929	of	_	
155-14	23930-23940	functional	_	
155-15	23941-23953	connectivity	_	
155-16	23954-23956	in	_	
155-17	23957-23961	fMRI	_	
155-18	23962-23966	BOLD	_	
155-19	23967-23973	signal	_	
155-20	23974-23976	in	_	
155-21	23977-23986	different	_	
155-22	23987-23992	brain	_	
155-23	23993-24000	regions	_	
155-24	24001-24007	across	_	
155-25	24008-24011	the	_	
155-26	24012-24017	brain	_	
155-27	24018-24021	are	_	
155-28	24022-24028	shared	_	
155-29	24029-24031	in	_	
155-30	24032-24036	part	_	
155-31	24037-24041	with	_	
155-32	24042-24045	the	_	
155-33	24046-24052	degree	_	
155-34	24053-24055	of	_	
155-35	24056-24069	morphological	_	
155-36	24070-24082	similarities	_	
155-37	24083-24085	in	_	
155-38	24086-24089	the	_	
155-39	24090-24094	gray	_	
155-40	24095-24101	matter	_	
155-41	24102-24104	of	_	
155-42	24105-24108	the	_	
155-43	24109-24113	same	_	
155-44	24114-24119	brain	_	
155-45	24120-24127	regions	_	
155-46	24127-24128	.	_	

#Text=In this light, we speculate that the observed PRS-related correlation differences may result from differences in the concurrent functional engagement of the same areas over time, eg, via differences in exposure to social interaction with other people.
156-1	24129-24131	In	_	
156-2	24132-24136	this	_	
156-3	24137-24142	light	_	
156-4	24142-24143	,	_	
156-5	24144-24146	we	_	
156-6	24147-24156	speculate	_	
156-7	24157-24161	that	_	
156-8	24162-24165	the	_	
156-9	24166-24174	observed	_	
156-10	24175-24186	PRS-related	_	
156-11	24187-24198	correlation	_	
156-12	24199-24210	differences	_	
156-13	24211-24214	may	_	
156-14	24215-24221	result	_	
156-15	24222-24226	from	_	
156-16	24227-24238	differences	_	
156-17	24239-24241	in	_	
156-18	24242-24245	the	_	
156-19	24246-24256	concurrent	_	
156-20	24257-24267	functional	_	
156-21	24268-24278	engagement	_	
156-22	24279-24281	of	_	
156-23	24282-24285	the	_	
156-24	24286-24290	same	_	
156-25	24291-24296	areas	_	
156-26	24297-24301	over	_	
156-27	24302-24306	time	_	
156-28	24306-24307	,	_	
156-29	24308-24310	eg	_	
156-30	24310-24311	,	_	
156-31	24312-24315	via	_	
156-32	24316-24327	differences	_	
156-33	24328-24330	in	_	
156-34	24331-24339	exposure	_	
156-35	24340-24342	to	_	
156-36	24343-24349	social	_	
156-37	24350-24361	interaction	_	
156-38	24362-24366	with	_	
156-39	24367-24372	other	_	
156-40	24373-24379	people	_	
156-41	24379-24380	.	_	

#Text=As environmental factors interplay with genetic vulnerability to schizophrenia according to the different etiological models of schizophrenia and given the substantial epidemiological evidence supporting a link between early adversity and schizophrenia, we further investigated the interplay between early adversities and PRS for schizophrenia.
157-1	24381-24383	As	_	
157-2	24384-24397	environmental	_	
157-3	24398-24405	factors	_	
157-4	24406-24415	interplay	_	
157-5	24416-24420	with	_	
157-6	24421-24428	genetic	_	
157-7	24429-24442	vulnerability	_	
157-8	24443-24445	to	_	
157-9	24446-24459	schizophrenia	_	
157-10	24460-24469	according	_	
157-11	24470-24472	to	_	
157-12	24473-24476	the	_	
157-13	24477-24486	different	_	
157-14	24487-24498	etiological	_	
157-15	24499-24505	models	_	
157-16	24506-24508	of	_	
157-17	24509-24522	schizophrenia	_	
157-18	24523-24526	and	_	
157-19	24527-24532	given	_	
157-20	24533-24536	the	_	
157-21	24537-24548	substantial	_	
157-22	24549-24564	epidemiological	_	
157-23	24565-24573	evidence	_	
157-24	24574-24584	supporting	_	
157-25	24585-24586	a	_	
157-26	24587-24591	link	_	
157-27	24592-24599	between	_	
157-28	24600-24605	early	_	
157-29	24606-24615	adversity	_	
157-30	24616-24619	and	_	
157-31	24620-24633	schizophrenia	_	
157-32	24633-24634	,	_	
157-33	24635-24637	we	_	
157-34	24638-24645	further	_	
157-35	24646-24658	investigated	_	
157-36	24659-24662	the	_	
157-37	24663-24672	interplay	_	
157-38	24673-24680	between	_	
157-39	24681-24686	early	_	
157-40	24687-24698	adversities	_	
157-41	24699-24702	and	_	
157-42	24703-24706	PRS	_	
157-43	24707-24710	for	_	
157-44	24711-24724	schizophrenia	_	
157-45	24724-24725	.	_	

#Text=We did not find early adversity by PRS interaction on interregional correlation in the face-processing network with BOLD fMRI or structural data.
158-1	24726-24728	We	_	
158-2	24729-24732	did	_	
158-3	24733-24736	not	_	
158-4	24737-24741	find	_	
158-5	24742-24747	early	_	
158-6	24748-24757	adversity	_	
158-7	24758-24760	by	_	
158-8	24761-24764	PRS	_	
158-9	24765-24776	interaction	_	
158-10	24777-24779	on	_	
158-11	24780-24793	interregional	_	
158-12	24794-24805	correlation	_	
158-13	24806-24808	in	_	
158-14	24809-24812	the	_	
158-15	24813-24828	face-processing	_	
158-16	24829-24836	network	_	
158-17	24837-24841	with	_	
158-18	24842-24846	BOLD	_	
158-19	24847-24851	fMRI	_	
158-20	24852-24854	or	_	
158-21	24855-24865	structural	_	
158-22	24866-24870	data	_	
158-23	24870-24871	.	_	

#Text=Nonetheless, we demonstrated a main effect of adversity on the correlations of the 25 ROIs.
159-1	24872-24883	Nonetheless	_	
159-2	24883-24884	,	_	
159-3	24885-24887	we	_	
159-4	24888-24900	demonstrated	_	
159-5	24901-24902	a	_	
159-6	24903-24907	main	_	
159-7	24908-24914	effect	_	
159-8	24915-24917	of	_	
159-9	24918-24927	adversity	_	
159-10	24928-24930	on	_	
159-11	24931-24934	the	_	
159-12	24935-24947	correlations	_	
159-13	24948-24950	of	_	
159-14	24951-24954	the	_	
159-15	24955-24957	25	_	
159-16	24958-24962	ROIs	_	
159-17	24962-24963	.	_	

#Text=There were several strengths in the present study.
160-1	24964-24969	There	_	
160-2	24970-24974	were	_	
160-3	24975-24982	several	_	
160-4	24983-24992	strengths	_	
160-5	24993-24995	in	_	
160-6	24996-24999	the	_	
160-7	25000-25007	present	_	
160-8	25008-25013	study	_	
160-9	25013-25014	.	_	

#Text=Using both functional and structural imaging, we were able to explore the functional and structural properties of interregional similarities in the face-processing network.
161-1	25015-25020	Using	_	
161-2	25021-25025	both	_	
161-3	25026-25036	functional	_	
161-4	25037-25040	and	_	
161-5	25041-25051	structural	_	
161-6	25052-25059	imaging	_	
161-7	25059-25060	,	_	
161-8	25061-25063	we	_	
161-9	25064-25068	were	_	
161-10	25069-25073	able	_	
161-11	25074-25076	to	_	
161-12	25077-25084	explore	_	
161-13	25085-25088	the	_	
161-14	25089-25099	functional	_	
161-15	25100-25103	and	_	
161-16	25104-25114	structural	_	
161-17	25115-25125	properties	_	
161-18	25126-25128	of	_	
161-19	25129-25142	interregional	_	
161-20	25143-25155	similarities	_	
161-21	25156-25158	in	_	
161-22	25159-25162	the	_	
161-23	25163-25178	face-processing	_	
161-24	25179-25186	network	_	
161-25	25186-25187	.	_	

#Text=For both the discovery and the replication analyses, we used a unique dataset in NFBC 1986; participants of our study were born in the same geographical region, had a similar ethnic and cultural background, and were of the same age at the time of the study.
162-1	25188-25191	For	_	
162-2	25192-25196	both	_	
162-3	25197-25200	the	_	
162-4	25201-25210	discovery	_	
162-5	25211-25214	and	_	
162-6	25215-25218	the	_	
162-7	25219-25230	replication	_	
162-8	25231-25239	analyses	_	
162-9	25239-25240	,	_	
162-10	25241-25243	we	_	
162-11	25244-25248	used	_	
162-12	25249-25250	a	_	
162-13	25251-25257	unique	_	
162-14	25258-25265	dataset	_	
162-15	25266-25268	in	_	
162-16	25269-25273	NFBC	_	
162-17	25274-25278	1986	_	
162-18	25278-25279	;	_	
162-19	25280-25292	participants	_	
162-20	25293-25295	of	_	
162-21	25296-25299	our	_	
162-22	25300-25305	study	_	
162-23	25306-25310	were	_	
162-24	25311-25315	born	_	
162-25	25316-25318	in	_	
162-26	25319-25322	the	_	
162-27	25323-25327	same	_	
162-28	25328-25340	geographical	_	
162-29	25341-25347	region	_	
162-30	25347-25348	,	_	
162-31	25349-25352	had	_	
162-32	25353-25354	a	_	
162-33	25355-25362	similar	_	
162-34	25363-25369	ethnic	_	
162-35	25370-25373	and	_	
162-36	25374-25382	cultural	_	
162-37	25383-25393	background	_	
162-38	25393-25394	,	_	
162-39	25395-25398	and	_	
162-40	25399-25403	were	_	
162-41	25404-25406	of	_	
162-42	25407-25410	the	_	
162-43	25411-25415	same	_	
162-44	25416-25419	age	_	
162-45	25420-25422	at	_	
162-46	25423-25426	the	_	
162-47	25427-25431	time	_	
162-48	25432-25434	of	_	
162-49	25435-25438	the	_	
162-50	25439-25444	study	_	
162-51	25444-25445	.	_	

#Text=Furthermore, participants in our study were in their 20s, which is the peak age for developing schizophrenia.
163-1	25446-25457	Furthermore	_	
163-2	25457-25458	,	_	
163-3	25459-25471	participants	_	
163-4	25472-25474	in	_	
163-5	25475-25478	our	_	
163-6	25479-25484	study	_	
163-7	25485-25489	were	_	
163-8	25490-25492	in	_	
163-9	25493-25498	their	_	
163-10	25499-25502	20s	_	
163-11	25502-25503	,	_	
163-12	25504-25509	which	_	
163-13	25510-25512	is	_	
163-14	25513-25516	the	_	
163-15	25517-25521	peak	_	
163-16	25522-25525	age	_	
163-17	25526-25529	for	_	
163-18	25530-25540	developing	_	
163-19	25541-25554	schizophrenia	_	
163-20	25554-25555	.	_	

#Text=In this light, the timing of our study can be considered as optimal.
164-1	25556-25558	In	_	
164-2	25559-25563	this	_	
164-3	25564-25569	light	_	
164-4	25569-25570	,	_	
164-5	25571-25574	the	_	
164-6	25575-25581	timing	_	
164-7	25582-25584	of	_	
164-8	25585-25588	our	_	
164-9	25589-25594	study	_	
164-10	25595-25598	can	_	
164-11	25599-25601	be	_	
164-12	25602-25612	considered	_	
164-13	25613-25615	as	_	
164-14	25616-25623	optimal	_	
164-15	25623-25624	.	_	

#Text=This study also has limitations that should be taken into account in future studies.
165-1	25625-25629	This	_	
165-2	25630-25635	study	_	
165-3	25636-25640	also	_	
165-4	25641-25644	has	_	
165-5	25645-25656	limitations	_	
165-6	25657-25661	that	_	
165-7	25662-25668	should	_	
165-8	25669-25671	be	_	
165-9	25672-25677	taken	_	
165-10	25678-25682	into	_	
165-11	25683-25690	account	_	
165-12	25691-25693	in	_	
165-13	25694-25700	future	_	
165-14	25701-25708	studies	_	
165-15	25708-25709	.	_	

#Text=First, we used a median split of PRS to allow for calculation of correlation matrices in structural MRI data.
166-1	25710-25715	First	_	
166-2	25715-25716	,	_	
166-3	25717-25719	we	_	
166-4	25720-25724	used	_	
166-5	25725-25726	a	_	
166-6	25727-25733	median	_	
166-7	25734-25739	split	_	
166-8	25740-25742	of	_	
166-9	25743-25746	PRS	_	
166-10	25747-25749	to	_	
166-11	25750-25755	allow	_	
166-12	25756-25759	for	_	
166-13	25760-25771	calculation	_	
166-14	25772-25774	of	_	
166-15	25775-25786	correlation	_	
166-16	25787-25795	matrices	_	
166-17	25796-25798	in	_	
166-18	25799-25809	structural	_	
166-19	25810-25813	MRI	_	
166-20	25814-25818	data	_	
166-21	25818-25819	.	_	

#Text=Our study had a relatively modest sample size for genetic analyses.
167-1	25820-25823	Our	_	
167-2	25824-25829	study	_	
167-3	25830-25833	had	_	
167-4	25834-25835	a	_	
167-5	25836-25846	relatively	_	
167-6	25847-25853	modest	_	
167-7	25854-25860	sample	_	
167-8	25861-25865	size	_	
167-9	25866-25869	for	_	
167-10	25870-25877	genetic	_	
167-11	25878-25886	analyses	_	
167-12	25886-25887	.	_	

#Text=Future studies with larger samples should expand our work by using more granular PRS-based stratification (eg, deciles).
168-1	25888-25894	Future	_	
168-2	25895-25902	studies	_	
168-3	25903-25907	with	_	
168-4	25908-25914	larger	_	
168-5	25915-25922	samples	_	
168-6	25923-25929	should	_	
168-7	25930-25936	expand	_	
168-8	25937-25940	our	_	
168-9	25941-25945	work	_	
168-10	25946-25948	by	_	
168-11	25949-25954	using	_	
168-12	25955-25959	more	_	
168-13	25960-25968	granular	_	
168-14	25969-25978	PRS-based	_	
168-15	25979-25993	stratification	_	
168-16	25994-25995	(	_	
168-17	25995-25997	eg	_	
168-18	25997-25998	,	_	
168-19	25999-26006	deciles	_	
168-20	26006-26007	)	_	
168-21	26007-26008	.	_	

#Text=Our analyses were conducted at the group level as one cannot calculate structural covariance at the level of individual participant.
169-1	26009-26012	Our	_	
169-2	26013-26021	analyses	_	
169-3	26022-26026	were	_	
169-4	26027-26036	conducted	_	
169-5	26037-26039	at	_	
169-6	26040-26043	the	_	
169-7	26044-26049	group	_	
169-8	26050-26055	level	_	
169-9	26056-26058	as	_	
169-10	26059-26062	one	_	
169-11	26063-26069	cannot	_	
169-12	26070-26079	calculate	_	
169-13	26080-26090	structural	_	
169-14	26091-26101	covariance	_	
169-15	26102-26104	at	_	
169-16	26105-26108	the	_	
169-17	26109-26114	level	_	
169-18	26115-26117	of	_	
169-19	26118-26128	individual	_	
169-20	26129-26140	participant	_	
169-21	26140-26141	.	_	

#Text=Thus, one should also interpret our results at the group level as conclusions on individual participants cannot be drawn here.
170-1	26142-26146	Thus	_	
170-2	26146-26147	,	_	
170-3	26148-26151	one	_	
170-4	26152-26158	should	_	
170-5	26159-26163	also	_	
170-6	26164-26173	interpret	_	
170-7	26174-26177	our	_	
170-8	26178-26185	results	_	
170-9	26186-26188	at	_	
170-10	26189-26192	the	_	
170-11	26193-26198	group	_	
170-12	26199-26204	level	_	
170-13	26205-26207	as	_	
170-14	26208-26219	conclusions	_	
170-15	26220-26222	on	_	
170-16	26223-26233	individual	_	
170-17	26234-26246	participants	_	
170-18	26247-26253	cannot	_	
170-19	26254-26256	be	_	
170-20	26257-26262	drawn	_	
170-21	26263-26267	here	_	
170-22	26267-26268	.	_	

#Text=Also, a limitation is the lack of BOLD fMRI in the replication sample.
171-1	26269-26273	Also	_	
171-2	26273-26274	,	_	
171-3	26275-26276	a	_	
171-4	26277-26287	limitation	_	
171-5	26288-26290	is	_	
171-6	26291-26294	the	_	
171-7	26295-26299	lack	_	
171-8	26300-26302	of	_	
171-9	26303-26307	BOLD	_	
171-10	26308-26312	fMRI	_	
171-11	26313-26315	in	_	
171-12	26316-26319	the	_	
171-13	26320-26331	replication	_	
171-14	26332-26338	sample	_	
171-15	26338-26339	.	_	

#Text=Also, questionnaires that measure early adversity may be affected by recall bias, although the TADS has been shown to be a valid and reliable instrument for assessing retrospectively reported childhood traumas.
172-1	26340-26344	Also	_	
172-2	26344-26345	,	_	
172-3	26346-26360	questionnaires	_	
172-4	26361-26365	that	_	
172-5	26366-26373	measure	_	
172-6	26374-26379	early	_	
172-7	26380-26389	adversity	_	
172-8	26390-26393	may	_	
172-9	26394-26396	be	_	
172-10	26397-26405	affected	_	
172-11	26406-26408	by	_	
172-12	26409-26415	recall	_	
172-13	26416-26420	bias	_	
172-14	26420-26421	,	_	
172-15	26422-26430	although	_	
172-16	26431-26434	the	_	
172-17	26435-26439	TADS	_	
172-18	26440-26443	has	_	
172-19	26444-26448	been	_	
172-20	26449-26454	shown	_	
172-21	26455-26457	to	_	
172-22	26458-26460	be	_	
172-23	26461-26462	a	_	
172-24	26463-26468	valid	_	
172-25	26469-26472	and	_	
172-26	26473-26481	reliable	_	
172-27	26482-26492	instrument	_	
172-28	26493-26496	for	_	
172-29	26497-26506	assessing	_	
172-30	26507-26522	retrospectively	_	
172-31	26523-26531	reported	_	
172-32	26532-26541	childhood	_	
172-33	26542-26549	traumas	_	
172-34	26549-26550	.	_	

#Text=Information from families, local international adoption consultation services, or social services, however, could have been used as additional information for the degree of experienced early adversity.
173-1	26551-26562	Information	_	
173-2	26563-26567	from	_	
173-3	26568-26576	families	_	
173-4	26576-26577	,	_	
173-5	26578-26583	local	_	
173-6	26584-26597	international	_	
173-7	26598-26606	adoption	_	
173-8	26607-26619	consultation	_	
173-9	26620-26628	services	_	
173-10	26628-26629	,	_	
173-11	26630-26632	or	_	
173-12	26633-26639	social	_	
173-13	26640-26648	services	_	
173-14	26648-26649	,	_	
173-15	26650-26657	however	_	
173-16	26657-26658	,	_	
173-17	26659-26664	could	_	
173-18	26665-26669	have	_	
173-19	26670-26674	been	_	
173-20	26675-26679	used	_	
173-21	26680-26682	as	_	
173-22	26683-26693	additional	_	
173-23	26694-26705	information	_	
173-24	26706-26709	for	_	
173-25	26710-26713	the	_	
173-26	26714-26720	degree	_	
173-27	26721-26723	of	_	
173-28	26724-26735	experienced	_	
173-29	26736-26741	early	_	
173-30	26742-26751	adversity	_	
173-31	26751-26752	.	_	

#Text=Future studies with larger sample size should also address the interaction PRS and different adversity types on the face-processing network.
174-1	26753-26759	Future	_	
174-2	26760-26767	studies	_	
174-3	26768-26772	with	_	
174-4	26773-26779	larger	_	
174-5	26780-26786	sample	_	
174-6	26787-26791	size	_	
174-7	26792-26798	should	_	
174-8	26799-26803	also	_	
174-9	26804-26811	address	_	
174-10	26812-26815	the	_	
174-11	26816-26827	interaction	_	
174-12	26828-26831	PRS	_	
174-13	26832-26835	and	_	
174-14	26836-26845	different	_	
174-15	26846-26855	adversity	_	
174-16	26856-26861	types	_	
174-17	26862-26864	on	_	
174-18	26865-26868	the	_	
174-19	26869-26884	face-processing	_	
174-20	26885-26892	network	_	
174-21	26892-26893	.	_	

#Text=Conclusions
#Text=PRS may relate to differences in the interregional correlations between the core and other face-processing regions.
175-1	26894-26905	Conclusions	_	
175-2	26906-26909	PRS	_	
175-3	26910-26913	may	_	
175-4	26914-26920	relate	_	
175-5	26921-26923	to	_	
175-6	26924-26935	differences	_	
175-7	26936-26938	in	_	
175-8	26939-26942	the	_	
175-9	26943-26956	interregional	_	
175-10	26957-26969	correlations	_	
175-11	26970-26977	between	_	
175-12	26978-26981	the	_	
175-13	26982-26986	core	_	
175-14	26987-26990	and	_	
175-15	26991-26996	other	_	
175-16	26997-27012	face-processing	_	
175-17	27013-27020	regions	_	
175-18	27020-27021	.	_	

#Text=Also, we found that both the exposure to early adversity and PRS have an additive effect on the interregional degree of similarity of BOLD signal and gray matter volume.
176-1	27022-27026	Also	_	
176-2	27026-27027	,	_	
176-3	27028-27030	we	_	
176-4	27031-27036	found	_	
176-5	27037-27041	that	_	
176-6	27042-27046	both	_	
176-7	27047-27050	the	_	
176-8	27051-27059	exposure	_	
176-9	27060-27062	to	_	
176-10	27063-27068	early	_	
176-11	27069-27078	adversity	_	
176-12	27079-27082	and	_	
176-13	27083-27086	PRS	_	
176-14	27087-27091	have	_	
176-15	27092-27094	an	_	
176-16	27095-27103	additive	_	
176-17	27104-27110	effect	_	
176-18	27111-27113	on	_	
176-19	27114-27117	the	_	
176-20	27118-27131	interregional	_	
176-21	27132-27138	degree	_	
176-22	27139-27141	of	_	
176-23	27142-27152	similarity	_	
176-24	27153-27155	of	_	
176-25	27156-27160	BOLD	_	
176-26	27161-27167	signal	_	
176-27	27168-27171	and	_	
176-28	27172-27176	gray	_	
176-29	27177-27183	matter	_	
176-30	27184-27190	volume	_	
176-31	27190-27191	.	_	

#Text=Further research with larger sample sizes and different PRS cutoffs is needed to replicate our findings.
177-1	27192-27199	Further	_	
177-2	27200-27208	research	_	
177-3	27209-27213	with	_	
177-4	27214-27220	larger	_	
177-5	27221-27227	sample	_	
177-6	27228-27233	sizes	_	
177-7	27234-27237	and	_	
177-8	27238-27247	different	_	
177-9	27248-27251	PRS	_	
177-10	27252-27259	cutoffs	_	
177-11	27260-27262	is	_	
177-12	27263-27269	needed	_	
177-13	27270-27272	to	_	
177-14	27273-27282	replicate	_	
177-15	27283-27286	our	_	
177-16	27287-27295	findings	_	
177-17	27295-27296	.	_	

#Text=We suggest that our results indicate that “high” (vs “low”) PRS may not affect the neural network responsible of recognition of faces but may lead to perturbations in the extraction of information relating to the significance of faces.
178-1	27297-27299	We	_	
178-2	27300-27307	suggest	_	
178-3	27308-27312	that	_	
178-4	27313-27316	our	_	
178-5	27317-27324	results	_	
178-6	27325-27333	indicate	_	
178-7	27334-27338	that	_	
178-8	27339-27340	“	_	
178-9	27340-27344	high	_	
178-10	27344-27345	”	_	
178-11	27346-27347	(	_	
178-12	27347-27349	vs	_	
178-13	27350-27351	“	_	
178-14	27351-27354	low	_	
178-15	27354-27355	”	_	
178-16	27355-27356	)	_	
178-17	27357-27360	PRS	_	
178-18	27361-27364	may	_	
178-19	27365-27368	not	_	
178-20	27369-27375	affect	_	
178-21	27376-27379	the	_	
178-22	27380-27386	neural	_	
178-23	27387-27394	network	_	
178-24	27395-27406	responsible	_	
178-25	27407-27409	of	_	
178-26	27410-27421	recognition	_	
178-27	27422-27424	of	_	
178-28	27425-27430	faces	_	
178-29	27431-27434	but	_	
178-30	27435-27438	may	_	
178-31	27439-27443	lead	_	
178-32	27444-27446	to	_	
178-33	27447-27460	perturbations	_	
178-34	27461-27463	in	_	
178-35	27464-27467	the	_	
178-36	27468-27478	extraction	_	
178-37	27479-27481	of	_	
178-38	27482-27493	information	_	
178-39	27494-27502	relating	_	
178-40	27503-27505	to	_	
178-41	27506-27509	the	_	
178-42	27510-27522	significance	_	
178-43	27523-27525	of	_	
178-44	27526-27531	faces	_	
178-45	27531-27532	.	_	

#Text=Funding
#Text=Finnish Medical Association (to JL); Yrjö Jahnsson’s Foundation (to JL); Psykiatrian tutkimussäätiö (Finnish Foundation for Psychiatric Research) (to JL); Jalmari and Rauha Ahokas Foundation (to JL); Academy of Finland (124257, 212818, 214273 to JV); Sigrid Juselius Foundation (to JV); Signe and Ane Gyllenberg Foundation, Finland (to JV); Alfred Kordelin Foundation (to JL); Orion Foundation (to JL).
179-1	27533-27540	Funding	_	
179-2	27541-27548	Finnish	_	
179-3	27549-27556	Medical	_	
179-4	27557-27568	Association	_	
179-5	27569-27570	(	_	
179-6	27570-27572	to	_	
179-7	27573-27575	JL	_	
179-8	27575-27576	)	_	
179-9	27576-27577	;	_	
179-10	27578-27582	Yrjö	_	
179-11	27583-27591	Jahnsson	_	
179-12	27591-27592	’	_	
179-13	27592-27593	s	_	
179-14	27594-27604	Foundation	_	
179-15	27605-27606	(	_	
179-16	27606-27608	to	_	
179-17	27609-27611	JL	_	
179-18	27611-27612	)	_	
179-19	27612-27613	;	_	
179-20	27614-27625	Psykiatrian	_	
179-21	27626-27640	tutkimussäätiö	_	
179-22	27641-27642	(	_	
179-23	27642-27649	Finnish	_	
179-24	27650-27660	Foundation	_	
179-25	27661-27664	for	_	
179-26	27665-27676	Psychiatric	_	
179-27	27677-27685	Research	_	
179-28	27685-27686	)	_	
179-29	27687-27688	(	_	
179-30	27688-27690	to	_	
179-31	27691-27693	JL	_	
179-32	27693-27694	)	_	
179-33	27694-27695	;	_	
179-34	27696-27703	Jalmari	_	
179-35	27704-27707	and	_	
179-36	27708-27713	Rauha	_	
179-37	27714-27720	Ahokas	_	
179-38	27721-27731	Foundation	_	
179-39	27732-27733	(	_	
179-40	27733-27735	to	_	
179-41	27736-27738	JL	_	
179-42	27738-27739	)	_	
179-43	27739-27740	;	_	
179-44	27741-27748	Academy	_	
179-45	27749-27751	of	_	
179-46	27752-27759	Finland	_	
179-47	27760-27761	(	_	
179-48	27761-27767	124257	_	
179-49	27767-27768	,	_	
179-50	27769-27775	212818	_	
179-51	27775-27776	,	_	
179-52	27777-27783	214273	_	
179-53	27784-27786	to	_	
179-54	27787-27789	JV	_	
179-55	27789-27790	)	_	
179-56	27790-27791	;	_	
179-57	27792-27798	Sigrid	_	
179-58	27799-27807	Juselius	_	
179-59	27808-27818	Foundation	_	
179-60	27819-27820	(	_	
179-61	27820-27822	to	_	
179-62	27823-27825	JV	_	
179-63	27825-27826	)	_	
179-64	27826-27827	;	_	
179-65	27828-27833	Signe	_	
179-66	27834-27837	and	_	
179-67	27838-27841	Ane	_	
179-68	27842-27852	Gyllenberg	_	
179-69	27853-27863	Foundation	_	
179-70	27863-27864	,	_	
179-71	27865-27872	Finland	_	
179-72	27873-27874	(	_	
179-73	27874-27876	to	_	
179-74	27877-27879	JV	_	
179-75	27879-27880	)	_	
179-76	27880-27881	;	_	
179-77	27882-27888	Alfred	_	
179-78	27889-27897	Kordelin	_	
179-79	27898-27908	Foundation	_	
179-80	27909-27910	(	_	
179-81	27910-27912	to	_	
179-82	27913-27915	JL	_	
179-83	27915-27916	)	_	
179-84	27916-27917	;	_	
179-85	27918-27923	Orion	_	
179-86	27924-27934	Foundation	_	
179-87	27935-27936	(	_	
179-88	27936-27938	to	_	
179-89	27939-27941	JL	_	
179-90	27941-27942	)	_	
179-91	27942-27943	.	_	

#Text=Supplementary Material
#Text=References
#Text=Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics
#Text=Biological insights from 108 schizophrenia-associated genetic loci
#Text=Impaired facial emotion perception in schizophrenia: a meta-analysis
#Text=Facial emotion perception in schizophrenia: a meta-analytic review
#Text=Emotion recognition deficit in schizophrenia: association with symptomatology and cognition
#Text=Creating probabilistic maps of the face network in the adolescent brain: a multicentre functional MRI study
#Text=Neurones responsive to faces in the temporal cortex: studies of functional organization, sensitivity to identity and relation to perception
#Text=Visual cells in the temporal cortex sensitive to face view and gaze direction
#Text=The role of expression and identity in the face-selective responses of neurons in the temporal visual cortex of the monkey
#Text=The distributed human neural system for face perception
#Text=Functional magnetic resonance imaging of human visual cortex during face matching: a comparison with positron emission tomography
#Text=The functional organization of human extrastriate cortex: a PET-rCBF study of selective attention to faces and locations
#Text=Global genetic variations predict brain response to faces
#Text=Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies
#Text=Childhood adversity in schizophrenia: a systematic meta-analysis
#Text=Interaction between genetic vulnerability and family environment: the Finnish Adoptive Family Study of Schizophrenia
#Text=Gene-environment interaction in vulnerability to schizophrenia: findings from the Finnish Adoptive Family Study of Schizophrenia
#Text=Recognition of emotional expression by abused children
#Text=Recognition and posing of emotional expressions by abused children and their mothers
#Text=Maternal facial behavior and the recognition and production of emotional expression by maltreated and nonmaltreated children
#Text=Recognition of emotional facial expressions by abusive mothers and their children
#Text=Recognizing emotion in faces: developmental effects of child abuse and neglect
#Text=The relationship between child maltreatment and emotion recognition
#Text=Early adversity and brain response to faces in young adulthood
#Text=Schizophrenia: a neural diathesis-stress model
#Text=A new look at the neural diathesis–stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations
#Text=Schizophrenia: a disconnection syndrome
#Text=Labour induction policy in hospitals of different levels of specialisation
#Text=Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study
#Text=Smoking in pregnancy, adolescent mental health and cognitive performance in young adult offspring: results from a matched sample within a Finnish cohort
#Text=The schizophrenia polygenic risk score: to what does it predispose in adolescence
#Text=Psychometric properties of the trauma and distress scale, TADS, in an adult community sample in Finland
#Text=
#Text=
#Text=Multilevel linear modelling for FMRI group analysis using Bayesian inference
#Text=Improved optimization for the robust and accurate linear registration and motion correction of brain images
#Text=A global optimisation method for robust affine registration of brain images
#Text=Fast robust automated brain extraction
#Text=Temporal autocorrelation in univariate linear modeling of FMRI data
#Text=Statistical analysis of activation images. ch 14
#Text=AFNI: software for analysis and visualization of functional magnetic resonance neuroimages
#Text=Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis-Oulu Brain and Mind Study
#Text=Valence scaling of dynamic facial expressions is altered in high-functioning subjects with autism spectrum disorders: an fMRI study
#Text=
#Text=lmerTest package: tests in linear mixed effects models
#Text=BrainNet Viewer: a network visualization tool for human brain connectomics
#Text=Gplots: various R programming tools for plotting data
#Text=Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling
#Text=Altered functional subnetwork during emotional face processing: a potential intermediate phenotype for schizophrenia
#Text=Imaging structural co-variance between human brain regions
#Text=The convergence of maturational change and structural covariance in human cortical networks
#Text=Childhood adversities and psychosis: evidence, challenges, implications
#Text=Do specific early-life adversities lead to specific symptoms of psychosis?
180-1	27944-27957	Supplementary	_	
180-2	27958-27966	Material	_	
180-3	27967-27977	References	_	
180-4	27978-27982	Twin	_	
180-5	27983-27990	studies	_	
180-6	27991-27993	of	_	
180-7	27994-28007	schizophrenia	_	
180-8	28007-28008	:	_	
180-9	28009-28013	from	_	
180-10	28014-28027	bow-and-arrow	_	
180-11	28028-28040	concordances	_	
180-12	28041-28043	to	_	
180-13	28044-28048	star	_	
180-14	28049-28053	wars	_	
180-15	28054-28056	Mx	_	
180-16	28057-28060	and	_	
180-17	28061-28071	functional	_	
180-18	28072-28080	genomics	_	
180-19	28081-28091	Biological	_	
180-20	28092-28100	insights	_	
180-21	28101-28105	from	_	
180-22	28106-28109	108	_	
180-23	28110-28134	schizophrenia-associated	_	
180-24	28135-28142	genetic	_	
180-25	28143-28147	loci	_	
180-26	28148-28156	Impaired	_	
180-27	28157-28163	facial	_	
180-28	28164-28171	emotion	_	
180-29	28172-28182	perception	_	
180-30	28183-28185	in	_	
180-31	28186-28199	schizophrenia	_	
180-32	28199-28200	:	_	
180-33	28201-28202	a	_	
180-34	28203-28216	meta-analysis	_	
180-35	28217-28223	Facial	_	
180-36	28224-28231	emotion	_	
180-37	28232-28242	perception	_	
180-38	28243-28245	in	_	
180-39	28246-28259	schizophrenia	_	
180-40	28259-28260	:	_	
180-41	28261-28262	a	_	
180-42	28263-28276	meta-analytic	_	
180-43	28277-28283	review	_	
180-44	28284-28291	Emotion	_	
180-45	28292-28303	recognition	_	
180-46	28304-28311	deficit	_	
180-47	28312-28314	in	_	
180-48	28315-28328	schizophrenia	_	
180-49	28328-28329	:	_	
180-50	28330-28341	association	_	
180-51	28342-28346	with	_	
180-52	28347-28361	symptomatology	_	
180-53	28362-28365	and	_	
180-54	28366-28375	cognition	_	
180-55	28376-28384	Creating	_	
180-56	28385-28398	probabilistic	_	
180-57	28399-28403	maps	_	
180-58	28404-28406	of	_	
180-59	28407-28410	the	_	
180-60	28411-28415	face	_	
180-61	28416-28423	network	_	
180-62	28424-28426	in	_	
180-63	28427-28430	the	_	
180-64	28431-28441	adolescent	_	
180-65	28442-28447	brain	_	
180-66	28447-28448	:	_	
180-67	28449-28450	a	_	
180-68	28451-28462	multicentre	_	
180-69	28463-28473	functional	_	
180-70	28474-28477	MRI	_	
180-71	28478-28483	study	_	
180-72	28484-28492	Neurones	_	
180-73	28493-28503	responsive	_	
180-74	28504-28506	to	_	
180-75	28507-28512	faces	_	
180-76	28513-28515	in	_	
180-77	28516-28519	the	_	
180-78	28520-28528	temporal	_	
180-79	28529-28535	cortex	_	
180-80	28535-28536	:	_	
180-81	28537-28544	studies	_	
180-82	28545-28547	of	_	
180-83	28548-28558	functional	_	
180-84	28559-28571	organization	_	
180-85	28571-28572	,	_	
180-86	28573-28584	sensitivity	_	
180-87	28585-28587	to	_	
180-88	28588-28596	identity	_	
180-89	28597-28600	and	_	
180-90	28601-28609	relation	_	
180-91	28610-28612	to	_	
180-92	28613-28623	perception	_	
180-93	28624-28630	Visual	_	
180-94	28631-28636	cells	_	
180-95	28637-28639	in	_	
180-96	28640-28643	the	_	
180-97	28644-28652	temporal	_	
180-98	28653-28659	cortex	_	
180-99	28660-28669	sensitive	_	
180-100	28670-28672	to	_	
180-101	28673-28677	face	_	
180-102	28678-28682	view	_	
180-103	28683-28686	and	_	
180-104	28687-28691	gaze	_	
180-105	28692-28701	direction	_	
180-106	28702-28705	The	_	
180-107	28706-28710	role	_	
180-108	28711-28713	of	_	
180-109	28714-28724	expression	_	
180-110	28725-28728	and	_	
180-111	28729-28737	identity	_	
180-112	28738-28740	in	_	
180-113	28741-28744	the	_	
180-114	28745-28759	face-selective	_	
180-115	28760-28769	responses	_	
180-116	28770-28772	of	_	
180-117	28773-28780	neurons	_	
180-118	28781-28783	in	_	
180-119	28784-28787	the	_	
180-120	28788-28796	temporal	_	
180-121	28797-28803	visual	_	
180-122	28804-28810	cortex	_	
180-123	28811-28813	of	_	
180-124	28814-28817	the	_	
180-125	28818-28824	monkey	_	
180-126	28825-28828	The	_	
180-127	28829-28840	distributed	_	
180-128	28841-28846	human	_	
180-129	28847-28853	neural	_	
180-130	28854-28860	system	_	
180-131	28861-28864	for	_	
180-132	28865-28869	face	_	
180-133	28870-28880	perception	_	
180-134	28881-28891	Functional	_	
180-135	28892-28900	magnetic	_	
180-136	28901-28910	resonance	_	
180-137	28911-28918	imaging	_	
180-138	28919-28921	of	_	
180-139	28922-28927	human	_	
180-140	28928-28934	visual	_	
180-141	28935-28941	cortex	_	
180-142	28942-28948	during	_	
180-143	28949-28953	face	_	
180-144	28954-28962	matching	_	
180-145	28962-28963	:	_	
180-146	28964-28965	a	_	
180-147	28966-28976	comparison	_	
180-148	28977-28981	with	_	
180-149	28982-28990	positron	_	
180-150	28991-28999	emission	_	
180-151	29000-29010	tomography	_	
180-152	29011-29014	The	_	
180-153	29015-29025	functional	_	
180-154	29026-29038	organization	_	
180-155	29039-29041	of	_	
180-156	29042-29047	human	_	
180-157	29048-29060	extrastriate	_	
180-158	29061-29067	cortex	_	
180-159	29067-29068	:	_	
180-160	29069-29070	a	_	
180-161	29071-29079	PET-rCBF	_	
180-162	29080-29085	study	_	
180-163	29086-29088	of	_	
180-164	29089-29098	selective	_	
180-165	29099-29108	attention	_	
180-166	29109-29111	to	_	
180-167	29112-29117	faces	_	
180-168	29118-29121	and	_	
180-169	29122-29131	locations	_	
180-170	29132-29138	Global	_	
180-171	29139-29146	genetic	_	
180-172	29147-29157	variations	_	
180-173	29158-29165	predict	_	
180-174	29166-29171	brain	_	
180-175	29172-29180	response	_	
180-176	29181-29183	to	_	
180-177	29184-29189	faces	_	
180-178	29190-29199	Childhood	_	
180-179	29200-29211	adversities	_	
180-180	29212-29220	increase	_	
180-181	29221-29224	the	_	
180-182	29225-29229	risk	_	
180-183	29230-29232	of	_	
180-184	29233-29242	psychosis	_	
180-185	29242-29243	:	_	
180-186	29244-29245	a	_	
180-187	29246-29259	meta-analysis	_	
180-188	29260-29262	of	_	
180-189	29263-29278	patient-control	_	
180-190	29278-29279	,	_	
180-191	29280-29291	prospective	_	
180-192	29291-29292	-	_	
180-193	29293-29296	and	_	
180-194	29297-29312	cross-sectional	_	
180-195	29313-29319	cohort	_	
180-196	29320-29327	studies	_	
180-197	29328-29337	Childhood	_	
180-198	29338-29347	adversity	_	
180-199	29348-29350	in	_	
180-200	29351-29364	schizophrenia	_	
180-201	29364-29365	:	_	
180-202	29366-29367	a	_	
180-203	29368-29378	systematic	_	
180-204	29379-29392	meta-analysis	_	
180-205	29393-29404	Interaction	_	
180-206	29405-29412	between	_	
180-207	29413-29420	genetic	_	
180-208	29421-29434	vulnerability	_	
180-209	29435-29438	and	_	
180-210	29439-29445	family	_	
180-211	29446-29457	environment	_	
180-212	29457-29458	:	_	
180-213	29459-29462	the	_	
180-214	29463-29470	Finnish	_	
180-215	29471-29479	Adoptive	_	
180-216	29480-29486	Family	_	
180-217	29487-29492	Study	_	
180-218	29493-29495	of	_	
180-219	29496-29509	Schizophrenia	_	
180-220	29510-29526	Gene-environment	_	
180-221	29527-29538	interaction	_	
180-222	29539-29541	in	_	
180-223	29542-29555	vulnerability	_	
180-224	29556-29558	to	_	
180-225	29559-29572	schizophrenia	_	
180-226	29572-29573	:	_	
180-227	29574-29582	findings	_	
180-228	29583-29587	from	_	
180-229	29588-29591	the	_	
180-230	29592-29599	Finnish	_	
180-231	29600-29608	Adoptive	_	
180-232	29609-29615	Family	_	
180-233	29616-29621	Study	_	
180-234	29622-29624	of	_	
180-235	29625-29638	Schizophrenia	_	
180-236	29639-29650	Recognition	_	
180-237	29651-29653	of	_	
180-238	29654-29663	emotional	_	
180-239	29664-29674	expression	_	
180-240	29675-29677	by	_	
180-241	29678-29684	abused	_	
180-242	29685-29693	children	_	
180-243	29694-29705	Recognition	_	
180-244	29706-29709	and	_	
180-245	29710-29716	posing	_	
180-246	29717-29719	of	_	
180-247	29720-29729	emotional	_	
180-248	29730-29741	expressions	_	
180-249	29742-29744	by	_	
180-250	29745-29751	abused	_	
180-251	29752-29760	children	_	
180-252	29761-29764	and	_	
180-253	29765-29770	their	_	
180-254	29771-29778	mothers	_	
180-255	29779-29787	Maternal	_	
180-256	29788-29794	facial	_	
180-257	29795-29803	behavior	_	
180-258	29804-29807	and	_	
180-259	29808-29811	the	_	
180-260	29812-29823	recognition	_	
180-261	29824-29827	and	_	
180-262	29828-29838	production	_	
180-263	29839-29841	of	_	
180-264	29842-29851	emotional	_	
180-265	29852-29862	expression	_	
180-266	29863-29865	by	_	
180-267	29866-29876	maltreated	_	
180-268	29877-29880	and	_	
180-269	29881-29894	nonmaltreated	_	
180-270	29895-29903	children	_	
180-271	29904-29915	Recognition	_	
180-272	29916-29918	of	_	
180-273	29919-29928	emotional	_	
180-274	29929-29935	facial	_	
180-275	29936-29947	expressions	_	
180-276	29948-29950	by	_	
180-277	29951-29958	abusive	_	
180-278	29959-29966	mothers	_	
180-279	29967-29970	and	_	
180-280	29971-29976	their	_	
180-281	29977-29985	children	_	
180-282	29986-29997	Recognizing	_	
180-283	29998-30005	emotion	_	
180-284	30006-30008	in	_	
180-285	30009-30014	faces	_	
180-286	30014-30015	:	_	
180-287	30016-30029	developmental	_	
180-288	30030-30037	effects	_	
180-289	30038-30040	of	_	
180-290	30041-30046	child	_	
180-291	30047-30052	abuse	_	
180-292	30053-30056	and	_	
180-293	30057-30064	neglect	_	
180-294	30065-30068	The	_	
180-295	30069-30081	relationship	_	
180-296	30082-30089	between	_	
180-297	30090-30095	child	_	
180-298	30096-30108	maltreatment	_	
180-299	30109-30112	and	_	
180-300	30113-30120	emotion	_	
180-301	30121-30132	recognition	_	
180-302	30133-30138	Early	_	
180-303	30139-30148	adversity	_	
180-304	30149-30152	and	_	
180-305	30153-30158	brain	_	
180-306	30159-30167	response	_	
180-307	30168-30170	to	_	
180-308	30171-30176	faces	_	
180-309	30177-30179	in	_	
180-310	30180-30185	young	_	
180-311	30186-30195	adulthood	_	
180-312	30196-30209	Schizophrenia	_	
180-313	30209-30210	:	_	
180-314	30211-30212	a	_	
180-315	30213-30219	neural	_	
180-316	30220-30236	diathesis-stress	_	
180-317	30237-30242	model	_	
180-318	30243-30244	A	_	
180-319	30245-30248	new	_	
180-320	30249-30253	look	_	
180-321	30254-30256	at	_	
180-322	30257-30260	the	_	
180-323	30261-30267	neural	_	
180-324	30268-30284	diathesis–stress	_	
180-325	30285-30290	model	_	
180-326	30291-30293	of	_	
180-327	30294-30307	schizophrenia	_	
180-328	30307-30308	:	_	
180-329	30309-30312	the	_	
180-330	30313-30320	primacy	_	
180-331	30321-30323	of	_	
180-332	30324-30341	social-evaluative	_	
180-333	30342-30345	and	_	
180-334	30346-30360	uncontrollable	_	
180-335	30361-30371	situations	_	
180-336	30372-30385	Schizophrenia	_	
180-337	30385-30386	:	_	
180-338	30387-30388	a	_	
180-339	30389-30402	disconnection	_	
180-340	30403-30411	syndrome	_	
180-341	30412-30418	Labour	_	
180-342	30419-30428	induction	_	
180-343	30429-30435	policy	_	
180-344	30436-30438	in	_	
180-345	30439-30448	hospitals	_	
180-346	30449-30451	of	_	
180-347	30452-30461	different	_	
180-348	30462-30468	levels	_	
180-349	30469-30471	of	_	
180-350	30472-30486	specialisation	_	
180-351	30487-30492	Young	_	
180-352	30493-30499	people	_	
180-353	30500-30502	at	_	
180-354	30503-30507	risk	_	
180-355	30508-30511	for	_	
180-356	30512-30521	psychosis	_	
180-357	30521-30522	:	_	
180-358	30523-30527	case	_	
180-359	30528-30535	finding	_	
180-360	30536-30539	and	_	
180-361	30540-30546	sample	_	
180-362	30547-30562	characteristics	_	
180-363	30563-30565	of	_	
180-364	30566-30569	the	_	
180-365	30570-30574	Oulu	_	
180-366	30575-30580	Brain	_	
180-367	30581-30584	and	_	
180-368	30585-30589	Mind	_	
180-369	30590-30595	Study	_	
180-370	30596-30603	Smoking	_	
180-371	30604-30606	in	_	
180-372	30607-30616	pregnancy	_	
180-373	30616-30617	,	_	
180-374	30618-30628	adolescent	_	
180-375	30629-30635	mental	_	
180-376	30636-30642	health	_	
180-377	30643-30646	and	_	
180-378	30647-30656	cognitive	_	
180-379	30657-30668	performance	_	
180-380	30669-30671	in	_	
180-381	30672-30677	young	_	
180-382	30678-30683	adult	_	
180-383	30684-30693	offspring	_	
180-384	30693-30694	:	_	
180-385	30695-30702	results	_	
180-386	30703-30707	from	_	
180-387	30708-30709	a	_	
180-388	30710-30717	matched	_	
180-389	30718-30724	sample	_	
180-390	30725-30731	within	_	
180-391	30732-30733	a	_	
180-392	30734-30741	Finnish	_	
180-393	30742-30748	cohort	_	
180-394	30749-30752	The	_	
180-395	30753-30766	schizophrenia	_	
180-396	30767-30776	polygenic	_	
180-397	30777-30781	risk	_	
180-398	30782-30787	score	_	
180-399	30787-30788	:	_	
180-400	30789-30791	to	_	
180-401	30792-30796	what	_	
180-402	30797-30801	does	_	
180-403	30802-30804	it	_	
180-404	30805-30815	predispose	_	
180-405	30816-30818	in	_	
180-406	30819-30830	adolescence	_	
180-407	30831-30843	Psychometric	_	
180-408	30844-30854	properties	_	
180-409	30855-30857	of	_	
180-410	30858-30861	the	_	
180-411	30862-30868	trauma	_	
180-412	30869-30872	and	_	
180-413	30873-30881	distress	_	
180-414	30882-30887	scale	_	
180-415	30887-30888	,	_	
180-416	30889-30893	TADS	_	
180-417	30893-30894	,	_	
180-418	30895-30897	in	_	
180-419	30898-30900	an	_	
180-420	30901-30906	adult	_	
180-421	30907-30916	community	_	
180-422	30917-30923	sample	_	
180-423	30924-30926	in	_	
180-424	30927-30934	Finland	_	
180-425	30937-30947	Multilevel	_	
180-426	30948-30954	linear	_	
180-427	30955-30964	modelling	_	
180-428	30965-30968	for	_	
180-429	30969-30973	FMRI	_	
180-430	30974-30979	group	_	
180-431	30980-30988	analysis	_	
180-432	30989-30994	using	_	
180-433	30995-31003	Bayesian	_	
180-434	31004-31013	inference	_	
180-435	31014-31022	Improved	_	
180-436	31023-31035	optimization	_	
180-437	31036-31039	for	_	
180-438	31040-31043	the	_	
180-439	31044-31050	robust	_	
180-440	31051-31054	and	_	
180-441	31055-31063	accurate	_	
180-442	31064-31070	linear	_	
180-443	31071-31083	registration	_	
180-444	31084-31087	and	_	
180-445	31088-31094	motion	_	
180-446	31095-31105	correction	_	
180-447	31106-31108	of	_	
180-448	31109-31114	brain	_	
180-449	31115-31121	images	_	
180-450	31122-31123	A	_	
180-451	31124-31130	global	_	
180-452	31131-31143	optimisation	_	
180-453	31144-31150	method	_	
180-454	31151-31154	for	_	
180-455	31155-31161	robust	_	
180-456	31162-31168	affine	_	
180-457	31169-31181	registration	_	
180-458	31182-31184	of	_	
180-459	31185-31190	brain	_	
180-460	31191-31197	images	_	
180-461	31198-31202	Fast	_	
180-462	31203-31209	robust	_	
180-463	31210-31219	automated	_	
180-464	31220-31225	brain	_	
180-465	31226-31236	extraction	_	
180-466	31237-31245	Temporal	_	
180-467	31246-31261	autocorrelation	_	
180-468	31262-31264	in	_	
180-469	31265-31275	univariate	_	
180-470	31276-31282	linear	_	
180-471	31283-31291	modeling	_	
180-472	31292-31294	of	_	
180-473	31295-31299	FMRI	_	
180-474	31300-31304	data	_	
180-475	31305-31316	Statistical	_	
180-476	31317-31325	analysis	_	
180-477	31326-31328	of	_	
180-478	31329-31339	activation	_	
180-479	31340-31346	images	_	
180-480	31346-31347	.	_	
180-481	31348-31350	ch	_	
180-482	31351-31353	14	_	
180-483	31354-31358	AFNI	_	
180-484	31358-31359	:	_	
180-485	31360-31368	software	_	
180-486	31369-31372	for	_	
180-487	31373-31381	analysis	_	
180-488	31382-31385	and	_	
180-489	31386-31399	visualization	_	
180-490	31400-31402	of	_	
180-491	31403-31413	functional	_	
180-492	31414-31422	magnetic	_	
180-493	31423-31432	resonance	_	
180-494	31433-31444	neuroimages	_	
180-495	31445-31455	Functional	_	
180-496	31456-31463	mapping	_	
180-497	31464-31466	of	_	
180-498	31467-31474	dynamic	_	
180-499	31475-31480	happy	_	
180-500	31481-31484	and	_	
180-501	31485-31492	fearful	_	
180-502	31493-31499	facial	_	
180-503	31500-31511	expressions	_	
180-504	31512-31514	in	_	
180-505	31515-31520	young	_	
180-506	31521-31527	adults	_	
180-507	31528-31532	with	_	
180-508	31533-31541	familial	_	
180-509	31542-31546	risk	_	
180-510	31547-31550	for	_	
180-511	31551-31565	psychosis-Oulu	_	
180-512	31566-31571	Brain	_	
180-513	31572-31575	and	_	
180-514	31576-31580	Mind	_	
180-515	31581-31586	Study	_	
180-516	31587-31594	Valence	_	
180-517	31595-31602	scaling	_	
180-518	31603-31605	of	_	
180-519	31606-31613	dynamic	_	
180-520	31614-31620	facial	_	
180-521	31621-31632	expressions	_	
180-522	31633-31635	is	_	
180-523	31636-31643	altered	_	
180-524	31644-31646	in	_	
180-525	31647-31663	high-functioning	_	
180-526	31664-31672	subjects	_	
180-527	31673-31677	with	_	
180-528	31678-31684	autism	_	
180-529	31685-31693	spectrum	_	
180-530	31694-31703	disorders	_	
180-531	31703-31704	:	_	
180-532	31705-31707	an	_	
180-533	31708-31712	fMRI	_	
180-534	31713-31718	study	_	
180-535	31720-31728	lmerTest	_	
180-536	31729-31736	package	_	
180-537	31736-31737	:	_	
180-538	31738-31743	tests	_	
180-539	31744-31746	in	_	
180-540	31747-31753	linear	_	
180-541	31754-31759	mixed	_	
180-542	31760-31767	effects	_	
180-543	31768-31774	models	_	
180-544	31775-31783	BrainNet	_	
180-545	31784-31790	Viewer	_	
180-546	31790-31791	:	_	
180-547	31792-31793	a	_	
180-548	31794-31801	network	_	
180-549	31802-31815	visualization	_	
180-550	31816-31820	tool	_	
180-551	31821-31824	for	_	
180-552	31825-31830	human	_	
180-553	31831-31836	brain	_	
180-554	31837-31849	connectomics	_	
180-555	31850-31856	Gplots	_	
180-556	31856-31857	:	_	
180-557	31858-31865	various	_	
180-558	31866-31867	R	_	
180-559	31868-31879	programming	_	
180-560	31880-31885	tools	_	
180-561	31886-31889	for	_	
180-562	31890-31898	plotting	_	
180-563	31899-31903	data	_	
180-564	31904-31914	Disordered	_	
180-565	31915-31928	corticolimbic	_	
180-566	31929-31941	interactions	_	
180-567	31942-31948	during	_	
180-568	31949-31958	affective	_	
180-569	31959-31969	processing	_	
180-570	31970-31972	in	_	
180-571	31973-31981	children	_	
180-572	31982-31985	and	_	
180-573	31986-31997	adolescents	_	
180-574	31998-32000	at	_	
180-575	32001-32005	risk	_	
180-576	32006-32009	for	_	
180-577	32010-32023	schizophrenia	_	
180-578	32024-32032	revealed	_	
180-579	32033-32035	by	_	
180-580	32036-32046	functional	_	
180-581	32047-32055	magnetic	_	
180-582	32056-32065	resonance	_	
180-583	32066-32073	imaging	_	
180-584	32074-32077	and	_	
180-585	32078-32085	dynamic	_	
180-586	32086-32092	causal	_	
180-587	32093-32101	modeling	_	
180-588	32102-32109	Altered	_	
180-589	32110-32120	functional	_	
180-590	32121-32131	subnetwork	_	
180-591	32132-32138	during	_	
180-592	32139-32148	emotional	_	
180-593	32149-32153	face	_	
180-594	32154-32164	processing	_	
180-595	32164-32165	:	_	
180-596	32166-32167	a	_	
180-597	32168-32177	potential	_	
180-598	32178-32190	intermediate	_	
180-599	32191-32200	phenotype	_	
180-600	32201-32204	for	_	
180-601	32205-32218	schizophrenia	_	
180-602	32219-32226	Imaging	_	
180-603	32227-32237	structural	_	
180-604	32238-32249	co-variance	_	
180-605	32250-32257	between	_	
180-606	32258-32263	human	_	
180-607	32264-32269	brain	_	
180-608	32270-32277	regions	_	
180-609	32278-32281	The	_	
180-610	32282-32293	convergence	_	
180-611	32294-32296	of	_	
180-612	32297-32309	maturational	_	
180-613	32310-32316	change	_	
180-614	32317-32320	and	_	
180-615	32321-32331	structural	_	
180-616	32332-32342	covariance	_	
180-617	32343-32345	in	_	
180-618	32346-32351	human	_	
180-619	32352-32360	cortical	_	
180-620	32361-32369	networks	_	
180-621	32370-32379	Childhood	_	
180-622	32380-32391	adversities	_	
180-623	32392-32395	and	_	
180-624	32396-32405	psychosis	_	
180-625	32405-32406	:	_	
180-626	32407-32415	evidence	_	
180-627	32415-32416	,	_	
180-628	32417-32427	challenges	_	
180-629	32427-32428	,	_	
180-630	32429-32441	implications	_	
180-631	32442-32444	Do	_	
180-632	32445-32453	specific	_	
180-633	32454-32464	early-life	_	
180-634	32465-32476	adversities	_	
180-635	32477-32481	lead	_	
180-636	32482-32484	to	_	
180-637	32485-32493	specific	_	
180-638	32494-32502	symptoms	_	
180-639	32503-32505	of	_	
180-640	32506-32515	psychosis	_	
180-641	32515-32516	?	_	

#Text=A study from the 2007 the adult psychiatric morbidity survey
#Text=Causes and consequences of the gender difference in age at onset of schizophrenia
#Text=Why do many psychiatric disorders emerge during adolescence
181-1	32517-32518	A	_	
181-2	32519-32524	study	_	
181-3	32525-32529	from	_	
181-4	32530-32533	the	_	
181-5	32534-32538	2007	_	
181-6	32539-32542	the	_	
181-7	32543-32548	adult	_	
181-8	32549-32560	psychiatric	_	
181-9	32561-32570	morbidity	_	
181-10	32571-32577	survey	_	
181-11	32578-32584	Causes	_	
181-12	32585-32588	and	_	
181-13	32589-32601	consequences	_	
181-14	32602-32604	of	_	
181-15	32605-32608	the	_	
181-16	32609-32615	gender	_	
181-17	32616-32626	difference	_	
181-18	32627-32629	in	_	
181-19	32630-32633	age	_	
181-20	32634-32636	at	_	
181-21	32637-32642	onset	_	
181-22	32643-32645	of	_	
181-23	32646-32659	schizophrenia	_	
181-24	32660-32663	Why	_	
181-25	32664-32666	do	_	
181-26	32667-32671	many	_	
181-27	32672-32683	psychiatric	_	
181-28	32684-32693	disorders	_	
181-29	32694-32700	emerge	_	
181-30	32701-32707	during	_	
181-31	32708-32719	adolescence	_	
